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Chapter I
Statement of the Problem
Over the past two decades substance abuse in females has
reached epidemic levels in America (Clark & McClanahan,
1998; Clark, McClanahan, & Sees, 1998; Substance Abuse and
Mental Health Services Administration [SAMHSA], 1997;
National Institute on Drug Abuse [NIDA], 1997). In fact,
recent morbidity data indicate that an estimated 200,000
females will die annually of substance-related illness
more than four times the number who will die of breast
cancer (Blumenthal, 1998)
Accumulating evidence indicates that there are
differences in both the etiology and the epidemiology of
male and female substance abuse. For instance,
neurochemical research indicates that females are more
sensitive than males to the rewarding effects of
substances. This corroborates data that indicates that
females proceed more rapidly to drug abuse and addiction
than males after initial drug use, and that substance abuse
has more severe medical implications for females than males
(Leshner, 1998). Medical data reveals that female emergency
room admissions for methamphetamine and other stimulants,
tranquilizers, and sedatives exceed those of males
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(SAMHSA,

1998b) . Females also have significant numbers of admissions
for cocaine/crack, non-smoked cocaine, and heroin (SAMHSA,
1998b) . These differences indicate that treatment
approaches for each gender should also be different
(Leshner, 1998).
While epidemiological data indicates an obvious need,
treatment for substance abuse has predominately focused on
male clients (Hatsukami et al., 1997). This is compounded
by the fact that the traditional therapeutic community
approach to drug and alcohol treatment uses behavioral
techniques that tend to be confrontational and may not be
appropriate for female substance abusers (Hatsukami et al.,
1997). In fact, current research suggests that the optimal
treatment approach for females may be to focus on the
process of negative emotions and interpersonal relations
that are more typical relapse indicators for female
substance abusers (Stocker, 1998).
Another issue in the treatment of substance abuse in
females is the fact that females have been hesitant to seek
out treatment. Research indicates that females under
utilize mental health services because of fear of personal
safety and various other reasons (Coletti, 1998). Females
also report that they are hesitant to seek out traditional
drug treatment due to issues of safety, a lack of knowledge

3

about women and drug abuse on the part of treatment
providers, transportation, long waiting lists, lack of
youth specific services such as day care, distrust of the
system (e.g., fear of children being taken from them), and
being more reluctant than males to accept random assignment
in a research protocol (NIDA, 1998) .
The barriers previously mentioned have contributed to an
under representation of females in clinical trials. Other
studies (Carroll, Rounsaville, Nich, Gordon, & Gawain,
1995; Hall, Munoz, & Reus, 1994; Hollon & Beck, 1994;
Ojehagen, Berglund, & Hansson, 1997; Woody et al., 1983)
have included females in their clinical samples, but failed
to analyze treatment outcome by gender. Traditional
approaches such as Cognitive-Behavioral Therapy (Beck et
al., 1991) and psychodynamic derivatives (Lubarsky, 1984)
have been reported as being effective, but specific outcome
data by gender is lacking. Thus, there is a need to
evaluate these treatments specifically among women who
abuse substances.
The Cognitive-Behavioral Treatment (CBT) in this study
draws from the principles of Beck (1979), Ellis (1962,
1986), and Meichenbaum (1977). The CBT principles (Carroll,
1998) diverge from the traditional behavioral approach of
the therapeutic community treatment that is typically
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applied to substance abuse, and includes a functional
analysis of the substance abuse and individualized training
related to the substance abuse. It is also more clientcentered in its approach than previous CBT models. The
client-centered aspects are designed to develop rapport and
trust between the client and therapist.
The Insight-Oriented Psychotherapy (IOP) condition is
based on contemporary psychodynamic theory espoused by
Khantzian's (1985, 1986, 1988, 1990) self-medication
theory, which posits that when some people experience
intrapsychic pain they turn to mood altering substances to
alleviate that pain. This intrapsychic pain or distress is
manifested in females as depression, anxiety, low ego
integration, and obsessiveness (Brook, Whiteman, & Cohen,
1998).
The literature suggests that aspects of both CBT and IOP
may be effective in the treatment of female substance
abuse. For instance, learning theory suggests that
educating an adult regarding the topic facilitates clinical
work. Thus, psychoeducational techniques such as those in
the CBT treatment of this study have proven effective with
adults previously and should provide similar results with a
female population. Similarly, the literature suggests that
the process orientation of the IOP treatment of this study
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should also provide efficacious treatment for females who
abuse substances. This approach may be effective with
females who turn inward and abuse substances to relieve
intrapsychic pain. The efficacy of this approach may be a
function of providing a forum for the females to discuss
their pain rather than seeking a self-soothing action such
as abusing substances.
While both of these treatment conditions have been
successfully applied to substance abuse with predominantly
male subjects, females have been underrepresented and no
study has reported their individual effectiveness with
females who abuse substances. Thus, the purpose of this
study was to determine which treatment approach, Cognitive
Behavioral Therapy or Insight Oriented Psychotherapy, is
more effective in the treatment of female substance abuse.
Background and Need for the Study
Using substances to alter one's mind is nothing new to
humans. Alcohol and tobacco are the most prevalent
substances that modern age humans abuse, however, these two
substances are relative newcomers to the arena of substance
abuse - - anthropological digs have discovered that humans
have used substances to alter mood states for thousands of
years. Papaver somniferurn (opium poppy) and Cannabis sativa
(hemp) were cultivated by stone-age farmers (Rudgley,

6

1995). In fact, recent excavations have discovered that
opium poppy was domesticated in Mediterranean areas as
early as the sixth millenium BC; charred hemp (which
indicates that it was burned and resulted in mood altered
states), opium poppy, and even Amanita muscaria (fly-agaric
mushroom

hallucinogenic) are common references in

palaeoethnobotanical literature. The oldest recorded
prehistoric use of substances was found in Spain where
burial sites that date to 4200 BC revealed opium capsules.
Similar archeological digs have unearthed hashish,
marijuana, and hallucinogens in other European sites. Never
before, however, has substance use been so prolific in
societies around the world, and especially within the
American society.
Patterns of Substance Use and Abuse in Females
Substance use has reached pandemic proportions in
America during the twentieth century (Clark & McClanahan,
1998; NIDA, 1998; SAMHSA, 1998a). Substance abuse is
generally considered a male phenomenon and has been at
epidemic proportions since the 1960s. Medical evidence,
however, reveals that females have abused substances longer
than males. For instance, females accounted for 60-75
percent of opium-morphine addicts in the 1800s (Blumenthal,
1998) .
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Recent data from the National Household Survey on Drug
Abuse, conducted annually since 1979, reports that in 1997
there were 111 million Americans age 12 and older (51
percent of the general population) who were current users
of alcohol

(SAMHSA, 1998a) . This number represents 58

percent of the male population and 45 percent of the female
population.
Of the thirty-two million Americans who engaged in binge
drinking (5 or more drinks on at least one occasion during
the past 30 days), females represent 8.1 percent (SAMHSA,
1998a) . Of the 11 million heavy drinkers (5 or more drinks
per occasion on 5 or more days during the past 30 days) ,
females represent 2.1 percent (SAMHSA, 1998a).
SAMSHA (1998a) also reports that there were an estimated
64 million Americans who were current smokers in 1997.
Females more than males (20.7 percent versus 19.1 percent)
are more dependent on tobacco and have a higher risk of
becoming addicted to psychotherapeutic medications being
used non-medically (Kandel, 1998).
Illicit drug use is equally at epidemic proportions. For
instance, in 1997 an estimated 13.9 million Americans were
current illicit drug users, which included 1.5 million
current cocaine users and 171,000 new heroin users (an
increase of 25 percent from the 1996 level)
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(SAMHSA,

1998a) . New heroin use is typically used as a barometer of
the severity of new drug use and as a general indicator of
hard drug use. Although males (8.5 percent) report a higher
current illicit drug use than females

(4.5 percent), the

current illicit drug use in females extrapolates to
approximately 4.5 million females (SAMHSA, 1998a).
The pattern of male substance use and abuse is more
prolific for most classes of illicit substances than for
females. However, female usage is equal to or exceeds that
of males in certain classes -- female admissions to the
emergency room for methamphetamine and other stimulants,
tranquilizers, and sedatives exceed those of males (SAMHSA,
1998b) .
Prevalence of Comorbid Psychiatric Illness
The use of illicit drugs often occurs with comorbid
psychiatric conditions. The landmark Epidemiologic
Catchment Area study (ECA; Reiger et al., 1990) reports
that over 53% of individuals who have a lifetime diagnosis
of a drug use disorder have a co-occurring psychiatric
diagnosis. Two-thirds of individuals with a cocaine or
opiate use disorder will have at some point in their lives
a comorbid psychiatric condition.
The National Comorbidity Survey (NCS; Kessler et al.,
1996) report similar comorbid psychiatric and substance
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abuse disorders. For instance, the NCS data indicates that
51% of those with a lifetime addictive disorder will have a
lifetime mental disorder (Kessler et al., 1996). While the
NCS study reported that drug dependence was more prevalent
in males than females in general, females are more likely
to have a comorbid anxiety and substance use disorder than
males. Comorbid depression and substance abuse is also more
prevalent in females than males (Kessler et al., 1996).
When substance use and abuse, both licit and illicit, is
combined with comorbid psychiatric conditions, the
magnitude of the problem is exponentially compounded, and
the resultant pressure on the individual, families, and
American society is also exponential. For instance, the
Center for Substance Abuse Treatment (CSAT; 1998) reports
that the economic cost of alcohol and other drug abuse in
1992, the most recent year studied, was $246 billion. Of
this $246 billion, $148 billion was attributed to alcohol
abuse and $98 billion was attributed to the abuse of other
drugs. Costs associated to alcohol abuse was illness (47%),
premature death (21%), health care costs (13%), crime (9%),
and unidentified other costs (11%) . This is compared to the
cost associated to other drug abuse, such as crime (59%),
premature death (15%), illness (16%), and health care
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(10%). These figures highlight the magnitude of the
negative effect that substance use has on American society.
Traditional Treatment
Traditionally treatment providers have maintained the
view that recovery from substance abuse or addiction is a
process. For some individuals, this process may be life
long with relapse being a part of that recovery process.
The recovery process is viewed as another symptom of
addiction, and can be broken down into a rule of thirds:
one-third of clients achieve permanent abstinence through
their first attempt at recovery; another one-third have a
period of brief relapse episodes that eventually result in
long-term abstinence; and, the last one-third have chronic
relapses that result in eventual death as a result of their
addiction (Gorski, Kelley, Havens, & Peters, 1995).
Relapse is often predicated by individual triggers
(cues), high-risk situations, or associations which set in
motion the road of relapsing to substances (Gorski et al.,
1995) . Treatment is predicated on the notion that once the
individual's particular events that lead to relapse are
identified, treatment should focus to help the individual
overcome these threats through strategies designed to
increase self-awareness, strengthen resistance, and create
positive coping options.
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Substance abuse treatment has predominately served male
clients (Hatsukami et al., 1997) with females being
underrepresented in clinical trials. This practice
continues even though there is growing evidence of
significant differences between males and females in
patterns of substance use and abuse and psychological
illness (Hatsukami et al., 1997). Furthermore, conclusions
from studies with only male clients lead to threats of the
generalizability of results to a female population
(Hatsukami et al., 1997).
Gender Specific Treatment
Research indicates that females under utilize mental
health services because of a variety of reasons (Coletti,
1998) . This may also account for some of the under
representation of females in empirical clinical trails.
Additionally, the traditional approach to drug and alcohol
treatment is a behavioral approach that tends to be
confrontational (Coletti, 1998). This contrasts to the view
that the optimal treatment approach for females may be to
focus on process and to utilize techniques that call upon
the therapeutic relationship in order to promote the
necessary motivation in the client to change their behavior
(Blumenthal, 1998; Geshshan, 1993; Hatsukami et al., 1997;
Kandel, 1998; Leshner, 1998; Moras, 1998b). Another
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complication is the fact that treatment research that
examines comorbid psychiatric conditions is not prevalent
in the professional literature (Onken, Blaine, Genser, &
Horton, 1997) . There is a similar dearth of efficacy
research with female clients who have comorbid substance
abuse (Clark, McClanahan, & Sees, 1998) .
Given the fact that females use and abuse different
substances and that those substances (including alcohol and
tobacco) affect females differently, the fundamental
question is: "Do female substance abusers require genderspecific therapies?"

(Moras, 1998b). Because females are

socialized differently than males, females present with
different problems than male substance abusers. For
instance, female substance abusers present with lower selfesteem and late entry into treatment (Coletti, 1998). These
issues may corroborate the view that treatment services for
substance-abusing females should be different than those
for males (Coletti, 1998). As an example, CBT focuses on
content and problem solving and has proven highly effective
for substance-abusing males (Becket al., 1991; Clark &
McClanahan, 1998; Liese & Najavits, 1997; O'Brien et al.,
1995; Onken et al., 1997; Woody et al., 1983). However,
negative emotions (depression and anxiety) and
interpersonal relations (lack of social support) are more
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typical relapse indicators for females and may be more
appropriate as the focus of treatment for females.
The most significant issue with regard to gender
specific treatment is the lack of empirical studies that
have examined female substance abuse. Several studies have
included females in their study sample (Carroll et al.,
1995; Hall, Munoz, and Reus, 1994; Kadden, Cooney, Getter,
and Litt, 1989; Lubarsky, 1984), however, outcome by gender
was not reported.
Principles of CBT and IOP Treatment
The Cognitive-Behavioral Treatment in this study
diverges from the traditional behavioral approach
(Hatsumakmi et al., 1997) that is typically applied to
substance abuse in a therapeutic community treatment
paradigm. Instead, the CBT approach espoused by Carroll
(1998) includes: focusing on a functional analysis of the
substance abuse, individualized training in recognizing and
coping with cravings, examining the client's cognitive
processes related to substance abuse, examining high-risk
situations, encouraging extra-session skills, and
practicing of skills within session.
The Insight-Oriented Psychotherapy (IOP) condition in
this study draws primarily from contemporary psychodynamic
theory espoused by Khantzian. Khantzian's (1985, 1986,
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1988, 1990) Self-Medication theory states that when some
people experience intrapsychic pain, they attempt to
alleviate that pain with mood altering substances. The goal
of the insight-oriented treatment condition is to develop
defenses that would remove the underlying basis for
continued substance abuse (Khantzian, 1990). The
fundamental dynamic that fosters this change in behaviors
is the therapeutic relationship (therapeutic alliance) that
the client develops toward the therapist. This alliance is
developed through the use of interpretation, clarification,
empathy, involvement, and support that the therapist
provides during treatment. The relationship allows the
client to trust the therapist and to gain the intrapsychic
insight necessary to discontinue the substance abuse.
While both of these treatment conditions have been
successfully applied to substance abuse, females have been
underrepresented and no study has examined the
effectiveness of either approach with only female subjects.
Thus, the objective of this study was to determine which
treatment approach, Cognitive Behavioral Therapy or Insight
Oriented Psychotherapy, was more effective in the treatment
of female substance abuse.
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Purpose of the Study
The purpose of this study was to determine whether
Cognitive Behavioral Therapy (CBT) that focused on
psychoeducational interventions was more effective than
Insight-Oriented Psychotherapy (IOP) which focused on
intrapersonal issues in increasing psychosocial functioning
and reducing substance abuse in females.
Psychosocial functioning is the ability of the
individual to interact with the environment in an adaptive
manner. Domains that are associated with psychosocial
functioning include: employment, family relations, and
social relations. Other areas may also indicate problematic
functioning. For instance, if a person has legal action
taken against them (i.e., on parole, probation) then their
functioning is likely to be impaired. Similarly, if a
person manifests certain medical conditions, these too may
be a result of impaired functioning.
Outcome variables (dependent variables) included: the
reduction in substance use and/or abuse, depression, and
anxiety; and, increased psychosocial functioning.
Instruments that measured the outcome variables were:

(a)

the Addiction Severity Index, Female Version (ASI-F), and
(b) the Profile of Mood States (POMS) .
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Theoretical Framework for the Study
This study draws from two theoretical frameworks:
Cognitive Behavioral Therapy and Psychodynamic
Psychotherapy. While each of the treatment regimens is
based upon the traditional theories, each has incorporated
principles of contemporary practice.
Cognitive Behavioral Therapy
The three preeminent theorists that pioneered the
development of Cognitive-Behavioral Therapy are Meichenbaum
(1977), Beck (1979), and Ellis (1962, 1986). Meichenbaum
(1977) developed Cognitive Behavior Modification (CBM);
Beck (1979) developed Cognitive Therapy (CT); and, Ellis
(1962, 1986) developed Rational Emotive Therapy (RET).
Cognitive Behavior Modification. Cognitive restructuring
is the central theme of Meichenbaum's (1977) Cognitive
Behavior Modification. According to Meichenbaum (1977),
negative self-statements are as detrimental as derogatory
statements made by another person. In order for change to
occur the individual must be able to perceive how they
think, feel, behave, and be cognizant of the impact that
they have on others. Thus, CBM treatment is a selfinstruction model wherein behavioral change occurs through
a sequence of mediating processes that involves the
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interaction of inner speech (self-deprecating statements),
cognitive structures, and behaviors.
CBM treatment is a three-phase process of change that
integrates the interaction of thinking, feeling, and
perceiving. Phase 1, self-observation, is where the
individual learns to observe their own behavior. Phase 2,
starting a new internal dialogue, begins once the client

can observe their own behaviors, but where more adaptive
behavioral alternatives are developed that lead to
behavioral, cognitive, and affective changes. Phase 3,
learning new skills, consists of teaching the individual

more effective coping skills, which are practiced in vivo.
Cognitive Therapy. Beck's approach to Cognitive Therapy
is based on the rationale that what a person feels and how
he or she behave is determined by the manner in which they
structure their experience (Corey, 1991). Beck posits that
cognitive therapy attempts to reduce excessive emotional
reactions and self-defeating behavior by modifying the
faulty or erroneous thinking and maladaptive beliefs that
underlie these reactions (Becket al., 1991). Beck (1979)
states that in order to understand the nature of an
emotional disturbance, it is essential to focus on the
cognitive content of an individual's reaction to the event
or stream of thoughts. Beck drew from his training in
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psychoanalysis and employed many of the client-centered
techniques of that theoretical paradigm. For instance, Beck
(1979) states that cognitive techniques are most
appropriate for individuals who have the capacity for
introspection and for reflecting on their own thoughts and
fantasies

both of which are central to insight oriented

therapy.
Beck (1979) posits that distortions in processing
information lead to faulty assumptions and misconceptions.

Arbitrary inferences are formed without sufficient and
relevant evidence (neurotic anxiety) . Selective

abstractions are conclusions that are based on an isolated
detail of an event and therefore misses the overall
context. Overgeneralization is a process of holding extreme
beliefs on the basis of a single incident. Magnification

and exaggeration consists of overestimating the
significance of negative events. Personalization is a
tendency for people to relate external events to
themselves, even when there is justification for doing so,
and polarized thinking involves thinking in an all-ornothing paradigm.
Rational Emotive Therapy (RET) . Ellis'

(1962) Rational

Emotive Therapy (RET) is based on the assumption that
cognitions, emotions, and behaviors interact significantly
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and have a reciprocal cause-and-effect relationship. RET is
a school of psychotherapy that provides clients with the
tools to restructure their philosophical and behavioral
styles (Ellis & Yeager, 1989). The fundamental premise of
RET is that emotions stem primarily from personal beliefs,
evaluations, interpretations, and reactions to life
situations (Corey, 1991). Ellis states that ucoulds",
ushoulds", and "musts" are the reasons that individuals
react to their environment in maladaptive ways (personal
communication, August, 1998). In other words, an activating
event (A) leads to the interjection of a personal belief
(B) , which leads to an emotional and behavioral consequence
(C) . Ellis (1986) expanded on this early theory by stating
that often there is a disputing intervention that
challenges the personal belief (D) that results in the
creation of a new feeling (E). Thus, the expanded A-B-C-D-E
theory of RET (Ellis, 1986) .
Techniques of RET include: disputing irrational beliefs,
assigning cognitive homework (i.e., lists of problems,
beliefs surrounding those problems), changing one's
language, using rational-emotive imagery, role playing,
shame-attacking exercises, and using force and vigor in the
session (a way of going from the intellectual to the
emotional level).
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Cognitive Behavioral Therapy (CBT) . The Cognitive
Behavioral Therapy model espoused by Carroll (1998) draws
from each of these three pioneers of cognitive therapy.
Carroll's model is similar to Beck's Cognitive Therapy in
that it emphasizes a functional analysis and identifies
cognitions associated with the behavior. The Carroll (1998)
model differs from Cognitive Therapy in terms of
identifying, understanding, and changing underlying beliefs
of the self and the self in relation to substance abuse.
The initial emphasis of the Carroll CBT model is on
learning and practicing a variety of coping skills, of
which only some are cognitive.
Initial CBT strategies involve behavioral aspects of
coping (i.e., avoiding high-risk situations) rather than
the cognitions associated with a high-risk situation. In
Beck's Cognitive Therapy, a reduction in substance abuse is
brought about by changing the cognitions associated with
the substance abuse. In CBT, a reduction in substance abuse
is brought about by first changing behavioral patterns
(i.e., avoiding high-risk situations) and then addressing
the cognitions.
The Cognitive Behavioral Therapy of this study (Carroll,
1998) focused on the following treatment interventions:
functional analyses of substance abuse,
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(1)

(2) examination of

the client's cognitive processes related to substance abuse
(i.e., managing thoughts associated with substance abuse,
problem solving, planning for emergencies, and refusal
skills),

(3) identification and debriefing of past and

future high-risk situations,

(4) encouragement and review

of extra-session implementation of skills, and (5) practice
of skills within session.
Specific topics covered in the sessions included:
introduction to treatment and CBT,

(2) coping with craving,

(3) shoring up motivation and commitment to stop,
refusal skills and assertiveness,
decisions,
management,

(6) coping plan,

(1)

(4)

(5) seemingly irrelevant

(7) problem solving,

(9) HIV risk reduction,

(8) case

(10) significant other

discussion, and (11) termination (Carroll, 1998).
Curative Factors of Cognitive Behavioral Therapy. There
are many parallels between the three founding theorists of
CBT. For instance, each of the theorists posits that there
is an activating event (A) in the environment that causes a
reaction of some sort in the individual

(B) that results in

a behavior (C) . Each of the theories includes selfdeprecating statements that are harmful to the individual.
Each theory also includes a component where the individual
must learn how to change themselves. Cognitive Therapy
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helps to

~cure"

a person by restructuring cognitions

associated with a particular behavior.
Cognitive Behavioral Therapy (CBT) is based on the
premise that cognitions are the primary pathway in which an
individual distorts their environment (Becket al., 1991).
These cognitive distortions encumber the individual's
ability to cope with stress in the environment. Thus, the
individual turns to alternative methods of coping, such as
substance abuse.
Several features of CBT make it a promising approach to
treatment for substance abuse. For instance, CBT is shortterm which makes it well suited for the limited resources
of most clinical programs. CBT has been extensively
evaluated in clinical trials and evidence indicates that it
is an efficacious treatment for a variety of issues (Beck
et al., 1991; Clark & McClanahan, 1998; Liese & Najavits,
1997; O'Brien et al., 1995; Onken et al., 1997; Woody et
al., 1983). CBT is structured, goal-oriented, and focused
on the immediate problems that substance abusers face in
their recovery process (NIDA, 1998) .
Insight-Oriented Psychotherapy (IOP)
The second theoretical foundation,

Insight-Oriented

Psychotherapy, is ultimately based on the extensive works
of Freud. However, much of Freud's work has been criticized
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and contemporary theorists and researchers have revised his
early formulations. For instance, contemporary insightoriented psychotherapies focus on the ability of the
individual to maintain interpersonal relations. One of
these contemporary theories that espouses a relational view
is the Time-Limited Dynamic Psychotherapy (TLDP; Levenson,
1995) .
Another contemporary theorist and researcher is
Khantzian. Khantzian's extensive work with persons addicted
to substances led to the development of the Self-Medication
Model of addiction (Khantzian, 1985; 1986; 1988; 1990),
which suggests that a person chooses a substance based on
the psychotherapeutic effects of that particular substance.
Time-Limited Dynamic Psychotherapy (TLDP) . Levenson
(1995) posits that there are seven basic conditions that
apply to the situation of an individual who has
difficulties in interpersonal relationships. These seven
fundamental conditions are:

(1) the client's problems stem

from disturbed interpersonal relationships,

(2)

dysfunctional styles were learned in the past,

(3)

dysfunctional styles are being maintained in the present,
(4) the client will reenact interpersonal difficulties with
the therapist,

(5) the therapist can and will function as a

participant observer,

(6) the therapist will help the
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client reenact difficulties, and (7) that there is one
identifiable, problematic relationship problem.
According to Levenson (1995), the basic principles of
TLDP reflects a larger paradigm shift that is occurring
with psychoanalytic theory and practice. This relational
view contrasts with the traditional psychodynamic view of
drive theory, which emphasizes predetermined mental
constructs to deal with conflicts between gratification and
social constraints (Levenson, 1995) .
The Self-Medication Model. Khantzian (1985; 1986; 1988;
1990) posits that addiction is an individual's attempt to
reach homeostasis. In essence, the individual selfmedicates in an attempt to alleviate emotional suffering.
This emotional crisis or problem is the result of
dysfunctional coping mechanisms. For instance, a functional
approach to a crisis situation is to problem solve
alternatives or solutions to the situation. In an
individual that abuses substances, this problem-solving
function either does not begin or is abandoned during the
process and the individual copes with the crisis situation
by escaping from it through a self-soothing technique of
using substances. Over time this self-soothing or selfmedication becomes the preferred manner to avoid
intrapersonal conflict or turmoil.
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According to the Self-Medication Model, substance
abusers do not choose their drugs of choice by mere
coincidence. They choose them because of the specific
psychopharmacological action of the substance that helps
the individual return to a state of homeostasis (Khantzian,
1986; 1988; 1990). For instance, the pain relieving
properties of opiates modulate feelings of rage that many
victims or perpetrators experience. The hypnotics have
sedating properties, which are attractive to the tense,
emotionally restricted individual to help them overcome
their fears surrounding intimacy and dependency. Cocaine
appeals to both high- and low-energy individuals because of
its activating properties

it can help overcome the

feelings of boredom, fatigue, or low self-esteem.
According to Khantzian (1988), individuals self-medicate
because of deficiencies in their ability to self-regulate.
The self-regulatory deficiencies include: deficits in selfcare, self-development and self-esteem, self-object
relationships, and affects. Khantzian (1988) believes that
interventions which he labels as the four "C's": control,
containment, contact, and comfort are essential to treating
substance abuse.
Control is more correctly defined as loss of control
around substances or maintaining boundaries. Through the
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empathic interaction with the drug user/abuser, the
therapist builds trust and fosters the therapeutic
alliance. The client's insight into their inability to
self-regulate their feelings and subsequent problems is
essential to effective treatment.

Containment refers to the ability of the client to rely
on the belief that the therapist can contain and ultimately
maintain appropriate stability of the client. Support and
empathy are interventions that allow this to be manifestly
true.

Contact and Comfort are human solutions that Insight
Oriented Psychotherapy provides to the alcoholic or drugabusing client who has become isolated from family and
society through their use and abuse of substances
(Khantzian, 1988) . The therapeutic relationship allows for
both the substance-abusing client and the therapist to
appreciate the extent of emotional suffering that has
contributed to the substance abuse.
The Curative Factors of Insight-Oriented Therapy. The
primary principles that foster a "cure" of the client in a
psychodynamic or insight-oriented therapy is the
therapeutic alliance, support from the therapist, and a
venue for expression of feelings. When a person introjects
the feeling of anxiety or depression, the feeling will be
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projected and manifested through acting out, which in the
case of substance abusers would be the use of a substance.
The goal of the Insight-Oriented Psychotherapy treatment
condition is to instill and build normal defenses that
remove the underlying basis for continued substance abuse
(Khantzian, 1990). The fundamental dynamic that fosters
this change in behaviors is the therapeutic relationship
(therapeutic alliance) that the client develops toward the
therapist. This therapeutic alliance is fostered by the
therapist through the use of empathy, support,
interpretation, clarification, and involvement. This
relationship enables the client to trust the therapist and
to gain the intrapsychic insights into how behaviors are
adversely affecting them, either inter- or intrapersonally.

Research Questions
This study addresses:
1.

Is Cognitive Behavioral Therapy (CBT) or Insight-

Oriented Psychotherapy (IOP) more efficacious in the
treatment of substance use/abuse in females as measured by
the Drug Status and the Alcohol Status subscales of the
Addiction Severity Index, Female Version?
2.

To what extent does CBT and IOP increase overall

psychosocial functioning of females who abuse substances as
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measured by the Employment Status, Legal Status,
Family/Social Relationship, and Psychological Status
subscales of the Addiction Severity Index, Female Version?
3.

To what extent does CBT and IOP reduce the frequency

and amount of substance use as measured by the Alcohol- and
Drug-Status subscales of the Addiction Severity Index,
Female Version?
4.

To what extent does CBT and IOP reduce feelings of

depression in females who abuse substances as measured by
the Depression-Dejection subscale of the Profile Of Mood
States?
5.

To what extent does CBT and IOP reduce feelings of

anxiety in females who abuse substances as measured by the
Tension-Anxiety subscale of the Profile Of Mood States?
Definitions of Ter.ms
Addiction is a disease caused by the continued use of

drugs that produce biological, psychological, and social
changes in an individual

(APA, 1994) .

Adaptive behavior is an appropriate response to a given

situation, that helps the individual interact more
effectively with his or her environment (Chaplin, 1985).
Route of ingestion is the means of consuming a substance

(e.g., oral, intravenous injection, smoking, intranasal).
Substance(s) include both licit (alcohol, tobacco,
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prescription medications) and illicit (sedatives, opiates,
stimulants, tranquilizers, and hallucinogens) drugs.
Substance abuse is a maladaptive pattern of substance

use that results in recurrent and significant adverse
consequences related to the repeated use of substances
(APA, 1994) .
Substance dependence is a maladaptive pattern of

substance use leading to clinically significant impairment
or distress as manifested by three of the following
criteria: tolerance; withdrawal; the substance is taken in
larger amounts or over a longer period than was initially
intended; a persistent desire or effort to cut down or
control the substance use; a great deal of time is spent in
the pursuit of the substance; social, occupational, or
recreational activities are given up or reduced because of
the substance use; or, the substance use is continued
despite knowledge of negative consequences (APA, 1994)
Substance use is the consumption of licit or illicit

drugs in a manner that is not maladaptive (e.g., does not
lead to social, legal, or medical complications or
impairment) .
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Chapter I I
Literature Review

The review of the literature can be summarized into
three general categories:

(a) components of Cognitive-

Behavioral Therapy (CBT) and Insight Oriented Psychotherapy
(IOP) in the treatment of addiction,

(b) psychosocial

functioning and substance abuse treatment, and (c)
Cognitive Behavioral Therapy and Insight Oriented
Psychotherapy comparative studies.
A significant difficulty in reviewing the literature is
the fact that there are hundreds of substances or their
derivatives, with a plethora of techniques that have been
applied to the treatment of them. The majority of the
studies, however, report equivocal or contradictory results
and virtually no study has examined the efficacy of
treatment on substance abuse in females. Therefore, for the
purposes of this study, components of the two treatment
conditions were included in the review and results have
been extrapolated for implications to this study.
Components of CBT and IOP in the Treatment of Addiction
Several components of both CBT and IOP have been
investigated in the amelioration of symptoms related to
substance abuse. For instance, the therapeutic alliance
(IOP) has been examined in numerous studies (Hentschel,
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Kiessling, & Rudolf, 1997; Horvath & Luborsky, 1993;
Ojehagen, Berglund, & Hansson, 1997). Components of
cognitive behavioral therapy (thought restructuring) have
also been investigated in the treatment of negative
symptoms that often result or are comorbid with substance
abuse, such as depression (Hall, Munoz, & Reus, 1994).
Therapeutic Alliance. Horvath and Luborsky (1993)
postulate that the therapeutic alliance should be viewed
under four categories: the relation between a positive
alliance and success in therapy, the path of the alliance
over time, an examination of the variables that lead an
individual to develop an alliance, and the exploration of
the in-therapy factors that foster the development of a
positive alliance.
Luborsky's (1984) work on the Penn Psychotherapy Project
indicated that there were two types of therapeutic
alliance: Type I, which is more evident in the early stages
of therapy where the client views the therapist as
supportive, and Type II which is more typical of later
stages of therapy where there is a sense of working
together in an effort to alleviate the impediment of the
client.
In an extensive review of the literature, Horvath and
Luborsky (1993) found that the impact of the therapeutic
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alliance has been examined in the context of behavioral
therapy, cognitive therapy, gestalt therapy, and
psychodynamic therapy. In each of these studies "a strong
alliance appears to make a positive contribution in all of
these therapies"

(p. 565).

In an attempt to evaluate the effects of the helping
alliance and treatment outcome, Ojehagen, Berglund, and
Hansson (1997) conducted a study using outpatient treatment
for the abuse of alcohol. The patients were randomly
assigned to two treatment conditions: multi-modal
behavioral therapy (MBT) and psychiatric treatment (PT)
based on a psychodynamic approach. Seventy-two patients, 60
males and 12 females, were selected for inclusion in the
two treatment conditions. Due to numerous factors, such as
not completing treatment, moving out of the area, and
death, only 35 subjects were included in the final analysis
(MBT, n=17; PT, n=18). Of these 35 participants, three
participants in the MBT and one in the PT treatment were
females. The mean number of treatment sessions were 24.7
(SD=1.7)

for MBT and 24.6

(SD=1.7) for PT.

The MBT treatment was based on Lazarus's (1981)
Multimodal Therapy. The primary principles of MBT were
based on Lazarus' BASIC ID - Behavior, Affect, Sensation,
Imagery, Cognition, Interpersonal relationships, and Drugs
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or biology. The PT model was based on Lubarsky's (1984)
Supportive-Expressive therapy that espouses the Core
Conflictual Relationship Theme (CCRT) . Luborsky posits that
supportive techniques such as supportive relationships can
foster the therapeutic alliance, which will alleviate the
intrapsychic pain that the client experiences. Luborsky
also believes that expressive techniques, such as listening
and understanding, can also foster this curative process.
Ojehagen, Berglund, and Hansson (1997) reported no
significant outcome differences between the two treatment
regimens during the course of treatment or in the third
year of follow-up. The authors assessed the magnitude of
the helping alliance and the outcome on treatment, and
reported that multi-modal therapy had significantly better
early therapist alliance in comparison with the psychiatric
treatment according to the Mann-Whitney U-test (MBT, M
67.2; PT, M

=

61.3). An ANOVA showed no differences in

early therapist or patient alliance with regard to length
of therapy. With each of the treatment conditions, there
were significant correlations (p < .001) between early
patient and therapist alliance (MBT and PT, rs=0.81).
Neither treatment condition was correlated to demographic
data. The most significant finding, however, was that there
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were no significant positive correlations between early
alliance and drinking outcome for either treatment.
The authors state that the small sample size places
limitations on the conclusiveness of their findings, and
several methodological issues also limit the
generalizability of their findings. For instance, the
therapist factor was not standardized, neither treatment
condition was manualized, and the number of therapists
differed between the two treatment conditions. The
therapist effects included the fact that only one therapist
provided the MBT treatment whereas several therapists
conducted the PT treatment - - therapist effects on the
outcome data were not reported.
The implications of these results on the current study
include the fact that the helping alliance can be measured
and is a curative factor. As Ojehagen, Berglund, and
Hansson (1997) state, the helping alliance depends upon the
style of the therapist and the structure of the treatment.
Each of these factors were incorporated into the research
design of the current study. For instance, one therapist
provided both treatment regimens in the proposed study.
Additionally, both treatment regimens in this study were
manualized and cross-checked for adherence to treatment
principles.
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Thought Restructuring. Hall, Munoz, and Reus (1994)
examined the effect of a cognitive behavioral mood
management intervention on smokers with a history of Major
Depressive Disorder (MDD).
One-hundred and forty-nine subjects were randomly
assigned to either a Mood Management condition (n = 79) or
a standard treatment condition (n = 70) . Of the 149
subjects, 71 were male and 46 were female. The mean age of
the sample was 40.6 years (SD

9.2), 131 were Caucasian,

40 had advanced degrees, 49 had completed an undergraduate
degree, and only 14 had less than a high school education.
Subjects reported smoking an average of 24.9 cigarettes per
day (SD = 10.9), and reported a regular smoking pattern for
a mean of 22.1 years (SD

=

9.5), and a majority reported

multiple previous attempts to quit

(n

=

128). Forty-six

subjects (31%) were diagnosed as having a history of MDD at
baseline.
The standard treatment condition used group support and
nicotine gum (2 mg) to aid in quitting smoking. The
standard treatment condition consisted of five sessions
over a period of 8 weeks. The sessions provided information
about smoking cessation and group support for planning
individualized strategies for quitting smoking.
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The Mood Management treatment condition met for ten twohour sessions over an 8-week period (twice a week for the
first two weeks, and once a week thereafter). Specific
cognitive behavioral methods included monitoring of
thoughts, daily activities, interpersonal contacts, and
mood. The treatment emphasized the impact of thoughts,
activities, and interpersonal contacts on mood. The
treatment also focused on thoughts and activities so that
those thoughts related to healthy mood were increased and
those that were related to negative mood and smoking were
decreased. Specific techniques included social skills
training to increase pleasant social contacts, relaxation
training, and linking maladaptive thoughts to cigarette
smoking.
Hall, Munoz, and Reus (1994) reported that the cognitive
behavioral method enhanced treatment outcome for subjects
with a history of MDD (X 2 (2, N=46)=12.795, p=.0017).
Subjects without a history of depression were more likely
to be abstinent in the control condition (13 of 53, 24%)
than in the cognitive-behavioral condition (8 of 51, 16%).
The cognitive behavioral treatment condition (POMS
Depression score, M = 53.57) achieved the best abstinence
rates of the treatment conditions (POMS Depression score,
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M

=

36.00) at assessment in week 52. Outcome data was not

provided by gender.
The authors postulate that several factors provided the
cognitive behavioral treatment condition with the more
positive outcome. First, the cognitive behavioral treatment
condition provided "tools to rethink risky situations and
to endure bouts of poor mood... "

(p. 145) . The authors

further state that the cognitive behavioral techniques that
target mood-related problems are effective with substance
abusers that have a history of MDD.
While this study involved a licit substance, tobacco, it
did investigate two variables that are germane to this
study. The first variable is the cognitive behavioral
technique of cognitive restructuring which Carroll (1998)
uses. The second variable is negative emotions such as
depression and anxiety, both of which are common symptoms
associated with substance use (i.e., cocaine and alcohol).
Psychosocial Functioning in Substance Abuse Treatment
Woody et al.

(1983) examined the effectiveness of drug

counseling, cognitive-behavioral therapy, and supportiveexpressive therapy with 100 male methadone clients. The
subjects were randomly assigned to either drug counseling
alone, or to counseling plus six months of either
supportive-expressive or cognitive-behavioral
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psychotherapy. The cognitive-behavioral (CB) therapy relied
on a directive, time-limited approach that focused on
making lists, homework, role-playing, and identifying
underlying thoughts. The CB treatment also focused on
uncovering and understanding the relationship and influence
of automatic thoughts and underlying assumptions on
problematic feelings and behaviors. Drug counseling (DC)
focused on monitoring current problems, advice giving, and
on providing external services (i.e., liaison with
physicians, courts, and social service agencies) rather
than intrapsychic processes. The supportive-expressive (SE)
therapy was analytically oriented, non-directive, and
focused on helping the client identify and work through
problematic relationships.
Subjects assigned to the supportive-expressive treatment
condition kept an average of 12 sessions with their
therapists and 12 sessions with their counselors: subjects
assigned to the cognitive-behavioral treatment condition
kept an average of 9.5 sessions with their therapists and
12 sessions with their counselors. The authors report that
85% of sessions lasted 30 minutes or longer.
While specific data are not presented, Woody et al.
(1983) state that,

uthe clear overall result was that

patients in all three groups showed improvement in many
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outcome measures, including lessened drug use, crime days,
and illegal income and improved psychological function"

(p.

643) .
The authors report that both the cognitive-behavioral
and the supportive-expressive groups were more effective
than drug counseling in the reduction of heroin use and
other illicit drugs. For instance, the mean methadone
hydrochloride dose for the drug counseling alone group went
from a dose of 30mg at baseline to 40mg at week 25; the
supportive-expressive group went from 37mg at baseline to
32mg at week 25; and the cognitive-behavioral group went
from an initial dosage of 39mg at baseline to 30mg at week
25

(Woody et al., 1983). Urine samples indicated that

subjects assigned to all groups showed a significant
decrease in positive results over the course of the study

(F

=

8.41, p < .05), but there were no significant

differences between groups (p < .1)

(Woody et al., 1983).

The authors also reported a separate analysis of opiatepositive urine samples that revealed that all three groups
showed a significant decrease in substance use over the
course of the study (F = 11.81, p < .01). However, subjects
who were assigned to either the SE or the CB group showed
significantly less use of opiates than the subjects who
received DC alone (p < .05). The authors report that
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subjects in the SE group had only an 8% rate of urine test
results positive for opiates during the latter part of the
six-month study.
Additional findings revealed that the cognitivebehavioral group showed more improvement with legal
problems, while the supportive-expressive group had more
improvement in psychological functioning and employment
(Woody et al., 1983). Woody et al. report that subjects in
the SE treatment condition had more stable work performance
and lower levels of residual psychopathology.
The implications of these findings are that both the lOP
and the CBT approaches of the current study may yield
similar results in enhancing psychosocial functioning.
However, the subjects in the Woody et al.

(1983) study were

all male, whereas the subjects in the current study were
all female. Thus, extrapolating the Woody et al. results to
the current study may have limited utility.
McKay, Alterman, Cacciola, O'Brien, Koppenhaver, and
Shepard (1999) examined the treatment effects on subjects
assigned to standard group counseling versus individualized
relapse prevention. Outcome variables included days of drug
use, days of alcohol use, and six psychosocial variables as
measured by the Addiction Severity Index (AS!; McLellan,
Lubarsky, Woody & O'Brien, 1980).
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The subjects consisted of 132 male veterans who were
diagnosed with cocaine dependence (lifetime) and who had
used cocaine in the prior six months. The subjects were
referred for inclusion in the McKay et al.,

(1999) study

following a 4-week intensive outpatient program. Subjects
were randomly assigned to either the standard treatment
(STND) or an individualized relapse prevention (RP)
treatment condition, with each treatment lasting for a
period of five months.
The STND group condition was designed as the control
group and consisted of group sessions with an
interactional, 12-step focus. The authors state that this
treatment regimen was the "treatment as usual" model in the
Veterans Affairs (VA) clinic where the study was conducted.
The STND treatment consisted of two group therapy sessions
per week. The RP treatment condition consisted of one
individual structured cognitive-behavioral relapse
prevention session and one group session per week. The
individualized RP treatment was designed for the treatment
of substance abusers in the maintenance phase of recovery.
Assessments were conducted at 6, 12, 18, and 24 months and
took approximately 90 minutes to complete.
The authors state that they used mixed-effect regression
models for the longitudinal analyses of the ASI data. The
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authors state that they chose the mixed-effect regression
model because that approach allows for the modeling of both
group and individual differences over time and the
interaction of effects of the individual's data. The
analyses included independent variables (e.g., treatment
condition, current psychiatric diagnoses, and abstinence
commitment), all two- and three-way interactions between
these variables, a time factor, and interaction between
time and other variables.
The authors reported that significant time effects (p

<

.05) were observed on the drug, psychiatric, employment,
and medical composites of the AS!. The RP produced a
significant group effect on the medical composite score of
the AS!. Similar results were observed on t tests with the
RP treatment condition producing significant differences
over the STND treatment with regard to medical outcomes at
months 6 and 18. The subjects who received the RP treatment
condition had better cocaine use outcomes if they were
committed to absolute abstinence on entering the study, but
subjects who received the STND treatment had better cocaine
use outcomes if they had a less stringent abstinence goal.
According to McKay et al.

(1999), subjects who received the

RP treatment program reported fewer heavy drinking days
(more than five drinks)

in the second year and that overall
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treatment main effects favored RP over STND in the second
year.
McKay et al.,

(1999) concluded that their results reveal

that RP is the treatment of choice for continuing care for
individuals who are committed to absolute abstinence.
However, STND is the treatment of choice for individuals
who have less stringent abstinence goals. There are,
however, several limitations to their study. For instance,
87% of the subjects were African-American, the mean number
of years of education was 12.81 (SD

=

1.55), and all

subjects reported being of lower socioeconomic status.
Thus, the findings of this study may not generalize to the
general population, however, the demographics of this study
match very closely with those of the McKay et al. sample.
There are several implications to the current study. For
instance, with the exception of the gender of the subjects,
the demographic variables parallel those of the current
sample. In addition to the homogenous study sample, the RP
treatment regimen was manualized and was based on tenets
similar to those of the CBT group in the current study. The
McKay et al.

(1999) study also used the ASI to measure

psychosocial outcomes which this study also used. The
conclusions drawn by McKay et al. indicates that aspects of
a cognitive-behavioral model is the most efficacious if the

44

subjects are committed to total abstinence. This stringent
goal, however, may be too high for most people who have a
lengthy history of substance abuse but a short history of
abstinence, both of which apply to the current sample.
CBT and lOP Comparative Studies
There is a body of literature that has compared
cognitive-behavioral therapy with derivatives of a
psychodynamic therapy model in the treatment of substance
abuse. Many of these studies have been conducted in medical
settings and compare various treatment conditions with a
psychotropic medication.
According to Onken, Blaine, and Boren (1995), substance
abuse is a behavioral problem and should be treated in
behavioral therapy. Their definition of behavioral therapy
includes behavior therapy, psychotherapy, and counseling.
In some cases pharmacotherapy may be the treatment of
choice, however, in other cases it may not be possible,
practical, or necessary (Onken et al., 1995).
Carroll et al.,

(1995) studied the effectiveness of

psychopharmacology, cognitive behavioral therapy, and
clinical management in the treatment of cocaine dependence.
Each of the treatment conditions were manual guided and
delivered to 139 patients over 12 weeks, where each session
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was videotaped and evaluated for continuity with the
manual. A breakdown of subjects by gender was not reported.
The pharmacological agent was desipramine, and was
administered in a 200mg per day dose. A placebo was used in
order to evaluate the effects of the active medication. The
cognitive behavioral treatment was an adaptation of Marlatt
and Gordon's (1985) model that focused on implementing
effective coping strategies. The coping strategies included
exploration of positive and negative effects of cocaine
use, self-monitoring for the identification of high-risk
situations for relapse, and problem-solving for avoiding
craving and high-risk situations. The clinical management
condition included medication management, a supportive
doctor [physician]-patient relationship, and medication
compliance.
The mean number of sessions completed was 7.2 (SD

=

3.6), and only 49 subjects completed treatment (12 weeks or
12 sessions) . The desipramine group had the highest number
of treatment completers with 49%. While each of the groups
showed significant improvements in the reduction of cocaine
use, outcomes failed to demonstrate significant main
effects for psychotherapy, pharmacotherapy, or their
interaction (Carroll et al., 1995).

46

The results of this study indicate that cognitive
behavioral techniques were effective in the reduction of
substance use. However, gender specifics were not provided
and therefore may not be replicated in a study of substance
abuse in a female sample.
Kadden, Cooney, Getter and Litt (1989) investigated the
effects of coping skills training, based on a cognitivebehavioral treatment paradigm, versus an interactional
therapy approach based on a psychodynamic paradigm. The
study included a sample of 96 subjects who had a mean age
of 39.1 years (SD

=

13.5), 44% were married, 53% were high

school graduates, and 30% had college degrees. Eighty-four
percent met the DSM-III criteria for alcohol dependence and
16% for alcohol abuse. Subjects reported a mean number of
45 days of heavy drinking out of the most recent 90 days.
Gender specific information was not reported.
The coping skill training group was a highly structured
group designed to foster the acquisition of skills such as
problem solving, interpersonal skills, relaxation, and
skills for coping with negative moods and urges to drink.
Homework and in-session practice were used to teach the
skills. The interactional group therapy was an adaptation
of Yalom's group therapy model and was designed to explore
participants' interpersonal relationships and pathology in
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the "here-and-now". This group encouraged expression of
immediate feelings, self-reflection, and exploration of the
meaning of experiences as they occurred in the session.
The use of the Addiction Severity Index (ASI; McClellan,
Lubarsky, Woody, & O'Brien, 1988) provided both psychiatric
diagnosis as well as patterns of drug and alcohol use. The
ASI was also used to evaluate the success of the substance
abuse treatment.
The authors report that a MANOVA analysis indicated that
there were no significant pretreatment differences between
the two treatment groups on alcohol consumption, social
functioning, psychological functioning, or
neuropsychological status (Kadden et al., 1989). The MANOVA
analysis yielded no significant differences in outcomes
(heavy drinking days, ASI Psychiatric Status, ASI
Employment) attributable to a therapist effect (p < .10).
The authors state that coping skills training and
interactional group therapy were equally effective over the
course of a 6-month aftercare period. However, coping
skills training was found to be more effective for subjects
with higher levels of psychopathology (ASI Psychiatric
Status score > 0.29), and the interactional group therapy
was more effective for subjects lower in psychopathology.
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The implication of these results is that both treatment
conditions in the current study should be effective in the
treatment of substance abuse. The fact that this study did
not control for gender causes one to be cautious in making
a hypothesis as to which treatment, if either, could be
more efficacious in treatment outcome.
Khantzian, Halliday, and McAuliffe (1990) describe an
empirical study in their treatment manual where they
investigated the effectiveness of two short-term, sixmonth, group approaches versus a no-group control
condition. The first group condition was a self-help
condition based on a cognitive-behavioral model. The second
condition was a modified dynamic group therapy, which was a
supportive-expressive psychodynamic model adapted for
cocaine abusers. The study evaluated the effects of
treatment on psychological functioning and substance use.
The sample consisted of 214 cocaine-dependent persons from
the greater Boston area. Retention, which is usually
problematic with any substance abuse clinical trial, was at
70% for the entire length of treatment. The authors state
that preliminary results indicate that short-term
psychodynamic treatment was effective in reducing substance
abuse and improving psychological health.
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The implications of these results is that treatment
based on a psychodynamic paradigm, whether it is
supportive-expressive or insight-oriented therapy, may be
effective in both the reduction of substance abuse as well
as increasing psychosocial functioning. Additionally, the
senior investigator in this study developed the principles
of the insight-oriented model that provide the basis for
the current study.
Summary

Efficacy studies in the treatment of substance abuse are
prolific, however, the results are often equivocal and
studies that have investigated female substance abuse are
virtually nonexistent.
There is a growing literature that postulates that
females respond differently to drug treatment that was
developed for use with male substance abusers (Moras,
1998a); interventions that emphasize increasing a female's
self-esteem and choosing more positive lifestyles may be
more effective in the treatment of females.

It should be

noted, however, that the majority of studies indicate that
no treatment approach is superior to all others across
psychological conditions or treatment populations (Garfield

& Bergin, 1994).

50

Several tenets of IOP treatment have been empirically
evaluated. For instance, Horvath and Lubarsky (1993) report
that the central principle in psychodynamic therapies, the
therapeutic alliance, can foster positive outcome. To this
end, Ojehagen et al.

(1997) reported that a multi-modal

behavioral therapy and psychiatric therapy based on a
psychodynamic paradigm were equally effective in reducing
alcohol use. The multi-modal therapy, however, had
significantly better early therapist alliance in comparison
with the psychiatric treatment.
Cognitive behavioral techniques such as thought
restructuring and teaching new coping skills have also
proven effective in the reduction of substance use as well
as depression. Hall, Munoz, and Reus (1994)

found that

cognitive behavioral techniques that focused on thought
restructuring, relaxation training, social skills training,
and identifying maladaptive thoughts were significantly
more effective than a standard treatment in achieving
longer periods of abstinence and reduced feelings of
negative emotions.
Studies have also evaluated treatment outcome on
psychosocial variables. For instance, Woody et al.

(1983)

reported that cognitive behavioral therapy was as effective
as supportive expressive therapy in the reduction of
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substance use. However, supportive expressive therapy was
more effective in enhancing psychological functioning and
employment. Thus, it seems that while each treatment is
effective, they differ in the aspects of the treatment
approach that is more effective with outcomes, as well as
in terms of outcomes they impact.
McKay et al.

(1999) also found equivocal and

inconclusive results in evaluating treatment on
psychosocial variables, but reported that a cognitivebehavioral program was the treatment of choice for
continuing care for individuals who are committed to
absolute abstinence. For individuals who have less
stringent abstinence goals, standard 12-step relapse
maintenance produced better treatment outcome.
Several studies have also compared treatment programs
based on cognitive-behavioral principles with those based
on psychodynamic principles. Kadden et al.

(1989) found

that coping skills training was more effective at reducing
substance use than an interactional therapy condition in
patients with high levels of pretreatment psychopathology.
Khantzian, Halliday, and McAulfie (1990) compared a selfhelp group approach with a modified psychodynamic group
approach. These investigators report that the modified
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dynamic approach has produced positive results for
substance use.
The major objective of this study concerns which
treatment is more efficacious in the treatment of substance
abuse in females. This is of importance because empirical
studies previously mentioned evaluated treatment with
primarily male subjects. These studies yielded equivocal or
contradictory results with respect to treatment outcomes
and did not identify specific aspects of treatment that
were most efficacious.
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Chapter III
Methodology
Restatement of the Problem

The purpose of this study was to determine if Cognitive
Behavioral Therapy (CBT) or Insight-Oriented Psychotherapy
(IOP) was more effective in the treatment of anxiety,
depression, and substance abuse in females. Treatment
effects were evaluated on three domains: level of
psychosocial functioning, level of drug use (frequency and
amount), and level of affective state. These domains were
measured by (a) the Addiction Severity Index - Female
Version (ASI-F) and (b) the Profile of Mood States (POMS).
Research Design

This study employed a pretest-posttest comparative
experimental design to evaluate the two interventions in
the treatment of substance abuse in a female population
(see Appendix A) .
A comparative study evaluates two or more treatments
without conceptualizing either as being a standard control
group (Basham, 1986) . This type of methodology is designed
to specifically highlight that between-group outcome
differences are caused by differences in the magnitude of
the two individual treatment effects (Basham, 1986). In
choosing the comparison groups the investigator often
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chooses the "standard treatment" and compares that
treatment to one that the research literature hypothesizes
might be more effective for the given problem or sample
population (Kazdin, 1992).
Kazdin (1986) outlines several advantages to using a
comparative research design. First, the clinical question
of which treatment is best under what condition is
answered. Second, this type of study offers a comparison of
treatment processes (similarities and differences in how
treatments are executed) . Third, a comparative design is
often more desirable than traditional methodologies because
the primary focus is on the forms of treatment rather than
between treatment and control procedures. Finally,
comparative studies highlight and crystallize differences
between alternative treatments.
Clinical research raises special issues that the
researcher must address. In clinical trials, it is often
unethical to deny or delay treatment to subjects -comparative studies addresses this problem by providing
treatment to all participants who are included in the study
(Basham, 1986; Kazdin, 1986; Kazdin, 1992).
A comparative study does, however, have some
limitations. For instance, often the most significant
limitation to a comparative design too general of a
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research question such as uwhich treatment is best?"
(Kazdin, 1986). However, this limitation can be reduced
when specific clinical problems are addressed with specific
assessment criteria and when the intervention is applied
under rigorous conditions (Kazdin, 1986) . Each of these
issues were addressed in this study. For instance, specific
outcome variables were identified and assessed through the
use of well-accepted, standardized instruments.
Additionally, the use of treatment manuals helped to
standardize the treatments and the Principal Investigator,
who facilitated both treatment conditions, has received
extensive training in each of the treatment approaches.
Crits-Christoph and Mintz (1991) state that therapist
effects should be controlled for when there are numerous
therapists. The reason that multiple therapists should be
controlled for is due to the fact that a therapist may
effect client outcomes. When there is only one therapist,
however, each group should be effected by the same
therapist effects. The issue of therapist effects was
addressed in the current study with the Principal
Investigator administering both treatment conditions.
Characteristics of the Study Sample
The sample for this study was recruited from an
outpatient community-based mental health clinic in Oakland,
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California. As individuals sought out treatment at the
clinic, they were referred to the Principal Investigator
for screening for inclusion in the current study. Flyers
(Appendix B) were also posted in the clinic and were
designed to recruit individuals who were currently or had
recently experienced a number of problems associated with
substance use. Following the conclusion of the study, the
subjects were referred back to the mental health clinic for
inclusion in an outpatient day treatment program.
Inclusionary Criteria
Criteria necessary to participate in this research
project included:

(1) subjects had to be female;

within the ages of 18 to 44; and,

(2) be

(3) have a diagnosis of

substance abuse or dependence according to the DSM-IV.
Exclusionary Criteria
Criteria used to exclude an individual from treatment in
this research protocol included:
transgender;

(1) being male or

(2) not having a diagnosis of substance abuse

or dependence according to the DSM-IV;
active psychosis; or,

(3) presence of an

(4) planning on leaving the area

prior to completion of the treatment.
Sample Population
Twenty-four adult females were recruited and screened
for participation in the current study. Fiveindividuals
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were excluded from participating in the study: four had a
diagnosis of sustained full remission from substance
dependence and one individual had a medical condition that
precluded her participation. Thus, the sample for this
study consisted of 19 participants, who were randomly
assigned to the two treatment conditions via a table of
random numbers. Ten individuals were assigned to InsightOriented Psychotherapy (IOP) treatment condition and nine
individuals were assigned to the Cognitive-Behavioral
Therapy (CBT) treatment condition. Two individuals, one
from each treatment condition, did not complete the study,
and their data were not included in the data analysis.
Thus, the final sample was comprised of 17 individuals, 9
in the IOP treatment condition and 8 in the CBT treatment
condition.
Demographic data consisted of variables such as age,
race, level of education, and psychiatric diagnosis. The
chi-square test is used to determine if there are
statistically significant differences with nominal or
categorical data. If significant differences are found, the
implication is that the independent variable may not have
caused the change but that the change may have been due to
the pre-existing differences in the sample.
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Table 1
Demographic Characteristics at Intake

CBT (n = 8)

IOP (n = 9)
Variable

M

SD

n

%

M

SD

Age (years)

35.2

2.2

34.9

4.2

Education (years)

11.9

1.8

11.8

0.9

4.1

2.9

3.5

1.6

Months Clean

n

%

Ethnicity:
African-American

8

89%

5

63%

Caucasian

0

0%

1

13%

Other

1

11%

1

13%

Alcohol, Current

1

11%

0

0%

Cocaine, Current

8

89%

7

88%

Amphet., Current

0

0%

1

12%

Sub-Related Disorder:

Table 1 presents specific demographic data by treatment
condition. Chi-square analysis revealed no statistically
significant differences between the two treatment
conditions for age [X 2 (1, n=17)=.73, p=.12], years of
education [X 2 (1, n=17)=.67, p=.19], ethnicity [X 2 (1,
n=17)=.95, p=.Sl], substance-related psychiatric diagnosis
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[X 2 (1, n~17)~.86, p~.03], or length of time since the last
substance use [X 2 (1, n=17)~.92, p~.01].
The average age for the IOP participants was 35.22 (SD
2.17) and 34.87 (SD

~

~

4.19) for the CBT participants. Both

treatment conditions had comparable levels of education,
with the IOP treatment condition having a mean of 11.89
years (SD

~

1.76) and the CBT treatment condition having a

mean of 11.75 years (SD

~

.89). Participants in both

treatment conditions also had similar ages of first
substance use with the IOP treatment condition reporting a
mean of 14.67 years (SD

~

8.97) and the CBT treatment

condition reporting a mean of 14.63 years (SD

~

2.56).

Participants reported similar patterns in the number of
months since their last substance use with the IOP
treatment condition having a mean number of months since
their last substance use of 4.11 (SD

~

2.93) and the CBT

treatment condition having a mean number of months since
their last substance use of 3.50 (SD

~

1.60).

As Table 1 indicates, African-Americans (n
comprised 82% of the total sample (n

~

~

14)

17). American Indian

(n = 1), Asian of the Pacific Islands (n = 1), and
Caucasians (n = 1) comprised the remaining 18% of the total
sample. The majority of the sample (88%) had a diagnosis of
Cocaine Dependence, Early Partial Remission. One subject in
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the IOP treatment condition was diagnosed with Alcohol
Dependence, Early Partial Remission and one subject in the
CBT treatment condition was diagnosed with Amphetamine
Dependence, Early Partial Remission.
Procedures
Two methods were used for data collection with this
study, both of which relied on self-report by the
participants of the study. The first method used to collect
data was the use of structured interviews (i.e., the
Structured Clinical Interview using the DSM and the
Addiction Severity Index, Female Version) . The second
method was the use of questionnaires (i.e., the Profile Of
Mood States) . The Principal Investigator administered each
of the assessment instruments to all study participants.
In designing this study, the Principal Investigator had
two primary concerns. The first was the recruitment of
subjects into substance abuse treatment, which has proven
problematic for reasons previously outlined. The second
concern dealt with the complexity of the assessment and the
implementation of the treatment regimens.
In order to make the prospect of treatment more
appealing several incentives were built into the design of
the study. First, the treatment was conducted at a
reputable substance abuse program centrally located with
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nearby public transportation. Another item incorporated
into the study was reimbursement, which was graduated and
disbursed on a pay-as-you-go schedule.
The second concern, the complexity of the design and
implementation of the treatments, required significant
training and expertise. An effort to recruit additional
therapists proved to be unsuccessful due to two factors: a
lack of competency of the additional therapists and the
time requirement of the study that the additional
therapists would not commit. Thus, the principal
investigator conducted the study as a sole investigator.
The research protocol was administered in the following
manner:

(a) prospective participants telephoned the

Principal Investigator who gave them a brief overview of
the study (see Appendix C),

(b) if the caller was

interested, they were asked some brief questions to
determine if they met certain conditions which would
exclude them from the study (see Appendix D) ,

(c) if the

caller remained interested an appointment was set up where
the informed consent was conducted (see Appendix E) ,

(d) if

the individual signed the informed consent, then the pretest and diagnostic assessment were administered and the
participant was scheduled for their weekly group treatment.
Treatment used a group format with each session lasting 90
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minutes and ran for eight weeks. At the conclusion of the
last treatment session, a post-test appointment was
conducted.
Telephonic Pre-Screening
The first stage in the assessment process was conducted
via the telephone in order to pre-screen the prospective
participant. The prospective subjects were read a
background statement concerning the study (e.g., rationale
of the study, length of treatment) (see Appendix C) by the
Principal Investigator. If the subject remained interested
in participating in the study, they were asked a series of
questions that might prohibit them from participating in
the study (see Appendix D) .
Specific items were chosen due to the nature of
potential problems that they might uncover. For instance, a
person who has a history or is currently experiencing a
psychosis would be inappropriate for inclusion in either
group treatment (Yalom, 1985), and would have been excluded
from participating in the study.
Informed Consent
The informed consent included potential risks, benefits,
the right to withdraw from treatment, and emergency contact
procedures (see Appendix E) . After the informed consent was
executed, the pretest assessment was conducted and the
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participant was scheduled for their first treatment
session. If the individual decided not to participate, they
were given a list of community-based agencies that provide
treatment for substance abuse. The referrals included
treatment within the referring mental health clinic as well
as other agencies that specialized in substance abuse and
mental health services.
Pre-test and Diagnostic Assessment
Pretest assessment consisted of the administration of
the Structured Clinical Interview using the DSM (SCID;
Spitzer et al., 1990), the Addiction Severity Index, Female
Version (ASI-F; SAMHSA, 1997), and the Profile Of Mood
States (POMS; McNair, Lorr, & Droppleman, 1961/1981). The
SCID is a diagnostic instrument and was used as such. The
ASI and POMS have been used extensively in the assessment
and treatment of alcohol and drug abuse treatment and are
viewed as standard assessment instruments (Clark,
McClanahan, & Sees, 1998) . Due to the varying length of
time necessary to administer the assessment instruments, a
two- to three-hour appointment was scheduled for the
initial assessment interview.
Assignment to Treatment Condition
Study participants were randomly assigned to the two
treatment conditions (CBT or IOP) via a table of random
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numbers. Thus, each participant had an equal chance of
being assigned to either treatment condition. Each
treatment condition contained a similar number of
participants and ran for eight sessions. Weekly therapy
appointments involved group counseling that used either
Cognitive Behavioral Therapy (CBT) or Insight Oriented
Psychotherapy (IOP) . Each group counseling session lasted
for 90 minutes and was conducted at the referring mental
health clinic. The Principal Investigator facilitated each
group condition.
Cognitive-Behavioral Treatment Approach. The CognitiveBehavioral Therapy developed by Carroll (1998) originally
consisted of 12 sessions. For the purposes of this study,
however, the treatment was reduced to eight sessions which
consisted of the following topics: Session 1, introduction
to treatment and coping with feelings of craving a
substance (distraction, talking about the craving, going
with the craving instead of fighting them, recalling the
negative consequences of substance abuse, and using selftalk); Session 2, shoring up motivation and commitment to
stop (addressing readiness for change, current position
toward abstinence, identifying treatment goals); Session 3,
developing refusal skills and assertiveness (how to handle
suppliers, developing appropriate refusal skills); Session
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4, seemingly irrelevant decisions (identifying personal
examples, practicing safe decision making); Session 5,
developing a coping plan (emergency phone numbers,
recalling negative consequences of substance use,
developing positive thoughts to use in high-risk
situations, developing a list of safe places to go in a
crisis; Session 6, introduction to the problem solving
model

(i.e., identifying the problem, brainstorming

solutions, generating advantages and disadvantages of each
solution, choosing the best solution); Session 7, HIV risk
reduction (assessment of risk, build motivation to change,
establish goals, problem solve barriers); and, Session 8,
termination (Carroll, 1998).
Insight-Oriented Psychotherapy. The IOP treatment
approach used in this study also consisted of eight
sessions and included: Session 1, introduction to treatment
(developing relationships with other group members) ;
Session 2, setting treatment goals (explanation of the
treatment process and setting realistic goals of
treatment); Session 3, establishing a relationship of trust
and rapport (listening, understanding, responding, and
returning to listening); Session 4, understanding and
responding to the client's problems (hidden meanings,
client's symptoms, matching goals to alleviate the
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symptoms); Session 5, identifying the importance of and
developing supportive relationships; Session 6, evaluating
and developing the helping alliance (helping the client
trust the therapist, developing understanding by the
therapist, developing optimism); Session 7, evaluating the
core conflictual relationship theme (evaluate current intreatment relationship, current out-of-treatment
relationships, past relationships) to determine patterns
and linkage to maladaptive coping mechanisms; and, Session
8, termination.
Posttest Assessment
At the end of their eight-week treatment, a final
assessment was conducted using the POMS and the ASI-F. The
final assessment interview took between 1 and 2 hours to
complete. This time requirement was less than the initial
appointment because the SCID was not administered during
this final interview.
Reimbursement
Treatment was provided free of charge to the clients and
subjects were reimbursed for their time while participating
in the study. Subjects were paid $10 for completing the
pretest assessment, $5 for each therapy session, $10 for
the posttest assessment, and a $10 bonus for completing
each requirement of the study (see Appendix F) . Thus, the
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total reimbursement possible was $70 if the participant
completed each requirement. Subjects were reimbursed at
each stage of the study in which they completed. For
instance, each subject was reimbursed following: the intake
assessment, each therapy session, and the posttest
assessment. The bonus was paid after the post test
assessment to each subject that completed all study
requirements.
Protection of Human Subjects

Prior to client contact, the University of San
Francisco's Institutional Review Board for the Protection
of Human Subjects (IRBPHS) reviewed and approved this
study.
To ensure the protection of the rights of human
subjects, this research project adhered to the American
Psychological Association's Ethical Principles and Code of
Conduct

(American Psychological Association [APA], 1992).

The participants were thoroughly briefed concerning the
nature of the study, their rights to treatment, rights to
not participate, potential risks, potential benefits, right
to withdraw from treatment, time required for assessments,
and reimbursement for being in the research project
(Appendix F) .
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Subjects' confidentiality was protected through the use
of numbers, which each participant agreed to, on charts,
instruments, and notes. All study materials were kept in a
locked filing cabinet which only the Principal Investigator
had access.
Instrumentation
The Structured Clinical Interview using the DSM-IV
(SCID; Spitzer et al., 1990) and the Addiction Severity
Index Female Version (ASI-F; Substance Abuse and Mental
Health Services Administration, 1997) were utilized in this
study to obtain a history of substance use, abuse, and
addiction in order to develop a psychiatric diagnosis. The
ASI-F was also used to obtain information on psychosocial
functioning. The Profile of Mood States (POMS; McNair,
Lorr, & Droppelman, 1961/1981) was used as an outcome
measure for treatment effects on anxiety and depression.
Each of the assessment instruments is discussed separately.
The assessment instruments were selected based on the
four criteria espoused by Patterson and McClanahan (1999) :
(1) appropriateness or goodness of fit,

(2) empirically

based psychometric principles (i.e., normative criteria,
reliability and validity),

(3) preponderance of research

literature that utilizes the instrument, and (4)

69

practicalities (e.g., availability, ease of administration
and scoring) .
Qualifications of the Principal Investigator
The Principal Investigator administered, scored, and
interpreted each of the data collection instruments. The
Principal Investigator has specific training which
demonstrates his competence, and includes: administration,
scoring, and interpretation of 169 SCIDs; administration,
scoring and interpretation of 29 POMS; three years of
experience in the application of Cognitive-Behavioral
Therapy with substance abusers; completion of a graduate
degree in Clinical Psychology specializing in Psychodynamic
Psychotherapy; three years of experience in the application
of psychodynamic theory with substance abuse; and, at the
time of treatment the Principal Investigator was a doctoral
candidate (successful completion of coursework, written and
oral comprehensive examinations, and defense of the
dissertation proposal)

in Counseling Psychology.

Structured Clinical Interview using the DSM-IV (SCID)
The Structured Clinical Interview using the DSM (SCID;
Spitzer et al., 1990) is a series of questions contained
within specific modules (e.g., psychotic screen, PTSD, mood
disorders, etc.) (see Appendix G). The SCID provides
diagnosis(es) of each Axis I category of the DSM-IV (i.e.,

70

Mood Disorders, Substance-Related Disorders, Schizophrenia
and other Psychotic Disorders) .
For the purposes of this study, only the Psychotic
Screening and the Substance Use Disorder modules were used.
The Psychotic Screening Module contains 15 questions with
regard to unusual experiences that the individual may have
experienced. The specific questions relate to criterion set
forth in the DSM-IV. Positive responses to the questions
yield a diagnosis; negative responses result in not meeting
threshold criteria and no diagnosis, whereby the examiner
proceeds to the next module of questions. Specific
questions include:
1. Has it ever seemed like people were talking about
you or did you think it might have been your
imagination?
2. What about receiving special messages from the TV,
radio, or newspaper, or from the way things were
arranged around you?
3. What about anyone going out of their way to give
you a hard time, or trying to hurt you?
The Substance Use Disorder module contains numerous
questions that pertain to the use of substances, both licit
and illicit. The questions correlate to the criteria set
forth in the DSM-IV for a diagnosis of Substance Use
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Disorders. Positive responses to the questions yield a
diagnosis as well as a severity specifier (Mild, Moderate,
or Severe). Specific questions include:
1. What are your drinking habits like?
2. When in your life were you drinking the most?
3. During that time .
How often were you drinking?
What were you drinking?
4. Have you ever missed work or school because you
were intoxicated, high, or very hung over?
5. Did you ever drink in a situation in which it
might have been dangerous to drink at all?
Similar questions are presented for illicit substances
(i.e., stimulants, opioids, etc.). These questions attempt
to determine if there is abuse, tolerance, or dependence as
set forth in the DSM-IV. Responses to questions are either
a yes or no.
Psychometric Principles. Traditional psychometric
principles are not applicable to the SCID. The reason for
this is that the SCID is an exact duplicate of the DSM-IV,
where verbiage has been added to DSM criteria in order for
the question to read grammatically correct. Goldfinger et
al.

(1996) reported that the SCID correctly identified 87%
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of subjects which corroborative data revealed were
substance abusers.
It is assumed that the person administering the SCID is
experienced with psychopathology and clinical knowledge.
This is required in order that additional queries can be
posed in order to clarify sub-threshold responses.
Scoring. The layout of the instrument allows the
administrator to score the SCID as the particular questions
are asked. For instance, a page of questions has three
columns of information. The far left column contains the
question, the middle columns contains the DSM-IV criteria
that correlates to that particular question, and the far
right column contains a Likert-like rating scale (?, 1, 2,
3). The (?) indicates that the individual provided a
response that requires further inquiry. The (1)

indicates

that the individual responded with a negative response. The
(2) indicates that the response was positive, but did not
meet all of the requirements of the criterion. The score of
(3) indicates that the response was positive and meets the
criteria of the question that was posed.
Once the entire module is completed, the scorer counts
the number of 3s that were assigned. If a sufficient number
of 3s were scored, then a diagnosis that corresponds to
DSM-IV diagnostic criteria will be given.
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Use. The SCID was used for purposes of excluding anyone
who was experiencing psychosis or had a history of it
(Psychotic Screening Module) . The SCID was also used for
establishing a diagnosis of a Substance-Use Disorder
(Substance Use Disorder module) .
Addiction Severity Index - Female (ASI-F)
The Addiction Severity Index (ASI; SAMHSA, 1997) is the
most widely used instrument in drug treatment in America
today (Liese & Najavits, 1997). The ASI-F
an expanded version of the ASI

(Appendix H) is

(5th Edition) , and has two

primary purposes: to provide systematically quantitative
information to aid in the planning of treatment of the
individual in drug treatment programs, and to measure
treatment progress of the individual client and treatment
outcome of a group of clients in a particular treatment
program (US Department of Health and Human Services [DHHS],
1997).
The ASI-F contains seven sections and a section for
demographic information. The demographic data that is
collected includes name, mailing address, date of birth,
race, language, religion, number of pregnancies, and age
and location of children.
The Medical Status section, which is not typically used
for evaluative purposes, asks questions that pertain to
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medical conditions that the individual may have
experienced, such as: chronic medical problems (i.e.,
hepatitis, chalmydia, syphilis), seizures, and the
importance of receiving medical treatment. The Employment-

Support Status section contains questions such as highest
education completed, valid driver's license, length of
employment, employment patterns, and income received from
various sources. The Drug-Alcohol Use section asks three
questions in regard to 26 substances. The questions are how
many days in the past 30 days has the person used that
particular substance, how many months has the individual
used the substance in their lifetime, and what was the age
that they first used the substance. This section also asks
questions such as which substance is their major problem
and how long was their last period of abstinence from that
substance. The Legal Status section asks questions that
pertain to legal problems that the individual may have
experienced. For example, are you on probation or parole,
how many times in your life have you been arrested and
charged with (shoplifting, vandalism, drug charges,
forgery, etc.). The Family-Social Relationships section
pertains to social relationships that the individual has
had. Specific questions asked include: marital status, if
they have been homeless in the past 30 days, usual living
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arrangements, close friends, family history, and if they
are satisfied with these relationships. The Psychiatric

Status section contains questions such as, have you had a
significant period in which you have experienced serious
depression, serious anxiety or tension, hallucinations,
trouble understanding, concentrating or remembering,
thoughts of suicide, and attempted suicide.
Psychometric Principles. The ASI-F was normed on a
population of 405 substance abusing females in order to
develop specific situations and problems that are germane
to female substance abusers. Reliability of the ASI-F using
Cronbach Alpha coefficients are reported as: Medical Status
.53; Alcohol Use .83; Drug Use .83; Legal Status .80;
Family/Social Relationships .71; and Psychiatric Status
.80. Interrater reliability was judged using the Guilford
Chi Square formula and was found to have a very highly
significant degree of agreement
(p<

(Chi square

=

211.6

.01)).

Discriminant validity (the ability of the test to
accurately differentiate various domains) of the ASI-F has
also been reported as being superior in its ability to
discriminate female drug abusers from female subjects who
are from relatively similar backgrounds and circumstances
but who are not drug abusers (DHHS, 1997). A sample of 135
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subjects revealed that with the exception of a correlation
of r=.41 between the Family/Social Relationships and the
Psychiatric Status subsections, composite scores of all
seven sections were small. The authors state that a
correlation of .41 is high enough to negate the usefulness
of a composite score between these two subscales whereas
all other subscales were found to justify separate
composite scores. Correlations between other subscales
ranged from a low of -.09 (Alcohol and Legal) to a high
correlation of .23

(Drug and Family/Social).

Construct validity was tested via factorial analysis,
which indicated that the seven domains measured by the ASIF were unique and distinct. Varimax rotation yielded 14
factors that included items that had factor loadings from
.47 to .96. The authors state that,

"the basic concept of

the ASI, to the effect that each of the seven problem area
sections was measuring a type of problem that was
relatively distinct and unique, was supported by several
results of this factor analysis"

(DHHS, 1997, p. 8).

Predictive validity was evaluated as to whether the ASIF could be used to predict treatment outcome. The methods
used to determine this was a comparison of the percentage
of reduction in the ASI-F drug problem composite scores
from pretreatment to post-treatment six months later. The
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percentages of the ASI-F compared to the ASI were similar
(47% versus 46%), which further establishes the predictive
validity of the ASI-F.
Scoring. Scoring of the ASI-F is based on the summation
of critical items within each subscale. Composite scores
for each subscale is based on the following formulas:

Medical Status

(AB/30)

Employment Status [1-(A4+B4+C120+log D36)]
Alcohol Status
Drug Status

(A210+B210+C210+D28+E56+logF32+logG63)
(A,B,C,D,E,F,G,H,I,K,L,M450+1og N69+0450)

Family-Social (A20+B20+C,D,E30+E,F,G,H10+I300)
Psychiatric

(A,B,C,D,E,F,G,H,I14+J,K,L,M42+N420)

The scores can range from 0 to 1, with scores
approaching 1 indicative of more severe impairment and
lower scores indicating more adaptive functioning. A
computerized program, which was made available to the
Principal Investigator from the Center for Substance Abuse
Treatment (CSAT), Washington, DC, was used to generate
composite scores for the ASI-F.
Use. The ASI-F was developed in order to assess the
types of problems and situations that are more likely to be
relevant for females, although the additional items (i.e.,
trading sex for illicit substances) are also relevant for
male drug abusers (DHHS, 1997).
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The ASI-F is in the public domain, with no copyright
restrictions. Therefore, not only is it the most widely
used instrument for data collection regarding substance
use, it is also the most readily available.
Two subscale scores of the ASI-F (Alcohol- and DrugStatus) were used to determine which treatment condition
was more efficacious in the reduction of substance use.
Four subscales of the ASI-F (Employment, Legal Status,
Family/Social Relationships, and Psychiatric) were used to
determine if the treatment conditions affected the level of
psychosocial functioning of the study participants.
Traditional parametric statistical procedures were used to
calculate quantitative findings and to evaluate within
group differences on the data generated by the ASI-F.
MANOVA procedures were used to determine statistical
significance for between group differences.
Profile of Mood States (POMS)
The Profile of Mood States (POMS; McNair, Lorr, &
Droppleman, 1961/1981) is a 65-item self-report instrument
designed to measure six mood or affective states: TensionAnxiety; Depression-Dejection; Anger-Hostility; VigorActivity; Fatigue-Inertia; and, Confusion-Bewilderment (see
Appendix I) . Each item is rated on a 5-point scale (O=not
at all, 1=a little, 2=moderately, 3=quite a bit,
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4=extremely). There are two versions of the POMS, an
Outpatient Form (OP) and a College Form (C) . The Outpatient
form was used for the current study. Administration time is
approximately five minutes.
Psychometric Principles. The Outpatient Form is based on
norms collected for 650 female and 350 male psychiatric
outpatients. Ninety-five percent of respondents will yield
a total score of between 30 and 70. Internal reliability
(alpha coefficients) ranged from .87 to .95 for the male
psychiatric patients and alpha coefficients ranged from .84
to .95 for the female patients. Stability coefficients (rtt)
ranged from .66 to .74 from intake to pre-therapy, and from
.43 to .52 from intake to six weeks. These coefficients are
considered stable for predicting a variable state such as
one's mood.
In regard to validity data, the publishers report that
six studies have been conducted to establish the validity
of the POMS domains. Of the fifteen items that comprise the

Depression-Dejection (D) domain, factor loadings (decimals
omitted) ranged from 34 to 58 in study 1; from 24 to 54 in
study 2; from 38 to 57 in study 3; from 25 to 64 in study
4; from 31 to 48 in study 5; and from 25 to 46 in study 6.
Symptom distress correlates of the POMS with a female
sample (n=650) found that the depression mood factor
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correlated with the Tension-Anxiety (T) mood factor (.70),
the Anger-Hostility (A) factor (.58), the Vigor (V) factor
(-.42), the Fatigue (F) factor (.69), and with the
Confusion-Bewilderment (C) factor (.70) (McNair, Lorr, &
Droppleman, 1961/1981) . Validity coefficients for this same
sample revealed that the anxiety mood factor correlated
with the Dejection-Depression factor (.69), the AngerHostility factor (.52), the Vigor factor (-.30), the
Fatigue factor (.61), and with the Confusion-Bewilderment
factor (. 68) .
Concurrent validity of the POMS has also been
established. Coefficients for the Tension-Anxiety mood
factor of the POMS correlated with the Manifest Anxiety
Scale (r=.80); and the Dejection-Depression mood factor of
the POMS correlated to the Inpatient Multidimensional
Psychiatric Scale (r=.30)
It should be noted that in the validity studies, women
tended to score higher than males on the Tension,
Depression, Fatigue, and Confusion scales, and older
patients tended to score somewhat lower on the Anger and
Confusion scales (Lorr et al., 1961). The authors report
that POMS scores are little affected by background
differences.
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Scoring. To obtain a score for the POMS, individual
subscale item responses are added together to obtain a
subscale score. All items are scored in the same direction
except for Item 2 and Item 54, a higher score in either of
which indicates a less favorable state. A Total Mood
Disturbance (TMD) score can be obtained by summing the
scores on the six mood factors. The TMD score was not used
in the current study.
Use. The Depression-Dejection (D) and the TensionAnxiety (T) subscale scores of the POMS were used in the
current study. The Depression-Dejection subscale consists
of 13 items that indicates feelings of personal
worthlessness, a sense of emotional isolation, sadness, and
guilt. The maximum score that can be assessed on the
Depression-Dejection subscale is 56.
The Tension-Anxiety subscale consists of 9 items, and
represents observable somatic states (e.g., Tense, On
Edge) . The maximum score that can be assessed on the
Tension-Anxiety subscale is 36.
Unlike many instruments, the authors (McNair, Lorr, &
Droppleman, 1961/1981) do not provide data on the
interpretation of scores, but state that the POMS should be
used to assess the degree of change in individual scores.
Scores in the current study were obtained in both the
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pretest and posttest stages of treatment to determine if
the treatment conditions produced any affect in the two
domains of functioning -- depression and anxiety.
Data Analysis
Several instruments were used to collect data in this
study. The SCID and the ASI-F were used to collect
demographic data (please refer to page 56 for an in-depth
analysis of demographic variables) . Parametric statistical
procedures such as means, standard deviations, effect
sizes, and Multivariate Analysis of Variance (MANOVA) were
used to analyze the ASI-F and POMS results.
Effect Size. Effect size for the t test for independent
means is the difference between the population means
divided by the standard deviation of the population,
ES= [ (Ml-M2) / SDpooledl

(Aron

&

Aron, 1997; Kazdin, 1992) .

Effect size was used to determine whether the difference
between populations was due to the independent variable and
if so, to determine the magnitude of that difference.
Effect size increases with greater differences between mean
scores and decreases with greater standard deviations in
the population (Aron & Aron, 1997) . Cohen (1988)
established levels of effect sizes for small, medium, and
large differences for both a one-tailed test (a directional
hypothesis) as well as with a two-tailed test (a non-
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directional hypothesis) . According to Cohen (1988), for a
sample of 10 individuals in each group,
a small effect size,

.07 would equate to

.18 would equate to a medium effect

size, and .39 would equate to a large effect size.
Power Analysis. A priori power analysis was conducted
prior to the initiation of the study in order to address
the issue of effect size and its relationship to sample
size. Cohen (1988) suggested that research should have a
.80 power coefficient; others (Aron & Aron, 1997; Kazdin,
1986, 1992), however, have stated that expecting a large
power coefficient makes clinical trials a virtual
impossibility because of the economics needed to generate a
sample size large enough to yield a power of 80%.
Kazdin (1992) suggests that other statistical analyses
are just as meaningful as power analysis and are more
reasonable for clinical trials. For instance, statistical
significance in clinical psychology research can be
achieved by using parametric statistical procedures (e.g.,
means, standard deviations, effect size) to evaluate
outcome data.
Stevens (1992) offers several suggestions to improve
power analysis: adopt a more lenient alpha level (a= .10),
employ more stringent sample selection (i.e., increased
homogeneity between subjects, use of repeated measures
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designs), and ensure the linkage between the treatment and
the dependent variable. For the purposes of this study, all
statistical analyses use an alpha level of .10 unless
stated otherwise.
MANOVA Analysis. There is a large debate over whether an
Analysis of Variance (ANOVA) or Multivariate Analysis of
Variance (MANOVA) should be used in the analysis of an
experimental design with multiple dependent variables. An
ANOVA is the statistical procedure that tests the variation
among the means of several groups, and answers the question
of whether the means differ more than expected from
sampling fluctuation.
The central issue in determining whether to use the
ANOVA or the MANOVA is controlling the alpha level. If the
alpha level is not controlled, the Bonferroni Inequality
effect becomes an issue. For instance, when an investigator
is evaluating the results of statistical procedures, they
set an alpha level

(a~

.10,

.05,

.01,

.001), usually at

.05. The Bonferroni Inequality states that when an
experimenter has numerous outcome tests, the upper bound on
overall a will be the sum of the a levels. In the case of
the current study, the overall Bonferroni would equal .80
(8 dependent variables X the a of .10). This would increase
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the likelihood of falsely rejecting the null hypothesis to
a very high and unacceptable level. A MANOVA controls a to
a level of reasonableness, while still evaluating
interrelationships among the variables. This is the most
compelling argument for the use of the MANOVA versus the
ANOVA.
The MANOVA is similar to the ANOVA, but the MANOVA can
analyze multiple independent variables on several dependent
variables simultaneously, focusing on cases where the
variables are correlated and share a common conceptual
meaning (Stevens, 1992) . Thus, the second major rationale
for using the MANOVA instead of the ANOVA. Stevens (1992)
concurs with this rationale and posits that the
multivariate analysis of variance is indicated in the
present study because this study used several criterion
measures, which allows for a more comprehensive description
of the phenomenon being evaluated.
For the purposes of the current analysis, three MANOVAs
are indicated. Stevens (1992, 1996) states that separate
MANOVAs should be run for the dependent variables where the
literature indicate that main effects should be generated,
and secondary MANOVAs should be run on the dependent
variables that are being evaluated on a heuristic nature.
Thus, one MANOVA would analyze the Drug- and Alcohol-
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Status, another would analyze the Anxiety and Depression
outcomes, and a third would analyze the psychosocial
results.
The first step in conducting a MANOVA analysis is
generating input data. Brogan and Kutner (1980) state that
the most reasonable data to be used for the MANOVA analysis
is the difference score (sometimes referred to as gain
score) . The difference score is computed by taking the
posttest score minus the pretest score and computing the
gain difference score, then the MANOVA is run on the gain
scores. According to Stevens (1992, 1996), the experimenter
should run the MANOVA analysis, and the first step in the
analysis is to evaluate the Wilk,s Lambda, the Roy,s
largest root, the Hotelling T2 , and the Pillai,s Trace to
determine if these statistics are significant.
Wilk,s Lamda is a measure of within-group variability
and is a multivariate generalization of the univariate sum
of squares within. Roy,s largest root and Hotelling T
statistics are generalizations of the univariate F
statistic. The multivariate two-group test, Hotelling,s ~,
is analogous to the univariate t test used in the ANOVA
(Stevens, 1996). Tabachnick and Fidell (1996) state that
when an effect has only two levels (df = 1, s = 1), the
statistical value for Wilk,s Lambda, Hotelling,s Trace, and
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Pillai's Trace are identical. When an effect has more than
two levels (df > 1), the F statistics are slightly
different but all three will be either significant or
nonsignificant, thus it is left to the researcher to decide
which to use. If the Wilks' Lambda, Roy's largest root, the
Hotelling's Trace, or the Pillai's Trace are significant,
then the researcher can proceed to analyzing the MANOVA F
statistic. If, however, the Wilk's Lambda, Roy's largest
root, the Hotelling's Trace, or the Pillai's Trace is not
significant, then the researcher should discontinue the
MANOVA analysis. Stevens (1992, 1996) states that when
there are two groups with multiple dependent variables,
such as in the current study, the Hotelling T2 is the
preferred multivariate statistic to determine if the
analysis should proceed to the second level of analysis.
Thus, the current study used the Hotelling T2 as the
multivariate statistic.
The second step in analyzing MANOVA results is to
determine if the F statistic is significant. If the F
statistic is significant, then Stevens (1996) states that
post hoc procedures should be conducted to determine which
dependent variable(s) contributed to the significance.
Stevens (1992, 1996) suggests three post hoc procedures to
determine which dependent variable contributed to the
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significance:

(1) one approach is the Roy-Bose simultaneous

confidence interval,

(2) a second approach is to conduct

separate univariate t's on each of the dependent variable
within that particular MANOVA, and (3) the final procedure
is to conduct separate univariate (ANOVA) tests for the
dependent variables of that particular MANOVA. The first
post hoc procedure, the Roy-Bose analysis, reduces the
power analysis and since the current study has a small
sample size this procedure would increase the likelihood of
falsely rejecting the null hypothesis and thus was not
used. The second post hoc procedure (conducting t tests)
and the third procedure (conducting separate ANOVAs)
essentially generate similar results (the t 2 equals the
ANOVA F statistic). Thus, MANOVA analyses were followed by
conducting separate t tests for dependent variables where
the MANOVA F statistic was significant (p divided by the
number of dependent variables)

(Stevens,

19~6).

Research Question One. In relation to research question
one (Which treatment condition [CBT or IOP] is more
efficacious in the treatment of substance abuse in
females?), the Alcohol- and Drug-Status subscale composite
scores of the ASI-F were utilized as outcome measures. Each
of these scores are ratio data, therefore means, standard
deviations, and effect sizes were used to compare the
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within group scores. Between group scores were analyzed
following established MANOVA procedures.
Research Question Two. In relation to research question
two (To what extent does CBT and lOP increase overall
psychosocial functioning of females who abuse substances?),
composite scores from four subscales of the ASI-F were used
(i.e., employment/support, legal status, family/social
relationships, and psychiatric status). Each of these
scores are ratio data, therefore means, standard
deviations, and effect sizes were used to compare within
group scores. MANOVA procedures were used to determine if
there were any between group statistical significance.
Research Question Three. In regard to research question
three (To what extent does CBT and lOP reduce the frequency
and amount of substance use) , frequency and amount of
substance use was used for evaluative purposes. The
frequency and amount of substance use, for the purposes of
this study, are reported in the amount of substance used
and the number of days of use.
Research Questions Four and Five. In regard to research
question four (To what extent does CBT and lOP reduce
feelings of depression?) and research question five

(To

what extent does CBT and lOP reduce feelings of anxiety?),
subscale scores from the Profile of Mood States (POMS) were
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used. Due to the type of data generated by the Depression-

Dejection and Tension-Anxiety subscales of the Profile of
Mood States (POMS), means, standard deviations, and effect
sizes were used to compare the within group scores. MANOVA
procedures were used to determine if there were any
statistical differences between group scores.
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CHAPTER IV
Results
This chapter presents a comparative analysis of the data
for the outcome variables (alcohol and drug use, anxiety,
depression, and psychosocial functioning) . For the purposes
of this study, please refer to page 56 for the analysis of
the demographic data. The Addiction Severity Index, Female
version (ASI-F) was used to gather data on substance use
(alcohol and drug use) and general psychosocial
functioning. The Anxiety and Depression subscales of the
Profile of Mood States (POMS) were used to gather data on
these two affective states.
Addiction Severity Index Composite Scores
Research question one examined,

"Is Cognitive Behavioral

Therapy (CBT) or Insight-Oriented Psychotherapy (IOP) more
efficacious in the treatment of substance use/abuse in
females, as measured by the Alcohol- and Drug-Use subscales
of the ASI-F?"
Means and standard deviations were used to analyze
variability in the data for research question one; effect
sizes (ES=(M1-M2)/SDpooled) were used to determine statistical
significance in the variance between sample means; and, a
MANOVA analysis was conducted to determine if there were
any statistical significance between-groups. Table 2
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presents the data for each group for the Alcohol and the
Drug subscale composite scores of the ASI-F.

Table 2
Alcohol- and Drug-Use ASI-F Composite Scores

IOP
Pre-test

Post-test

SD

M

CBT

M

SD

Pre-test
M

Post-test

SD

SD

M

Alcohol

0.29

0.25

0.42

0.01

0.24

0.28

0.07

0.13

Drug

0.19

0.06

0.18

0.05

0.22

0.07

0.13

0.05

IOP Within-Group Analysis. Table 2 indicates that for
the IOP treatment condition, there was an increase in the
Alcohol Status composite score from pre- to post-test
assessment. These scores yielded a large negative effect
size (ES
.25)

=

-.53)

from pre-test assessment (M

to the post-test assessment (M

.42,

SD

=
=

.29, SD

=

.01). The

reason for this negative effect was a result of three
individuals who relapsed during the course of treatment;
additional data for these individuals is reported under
Research Question Three below.
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Treatment yielded a small effect size (ES = .04) on Drug
Status from the pre-test assessment (M = .19, SD = .06) to
the post-test assessment (M = .18, SD = .05) for subjects
assigned to the IOP treatment condition.
CBT Within-Group Analysis. Table 2 also indicates that
subjects in the CBT group reported significant changes in
both the Alcohol- and the Drug-Status composite scores from
pre- to post-test assessment. Treatment yielded a large
effect size (ES

.55) on Alcohol Status from pre-test

assessment (M = .24, SD = .28) to the post-test assessment
(M =

.

07

I

SD =

.13) .

The CBT treatment also resulted in a large effect size

(ES

=

1.03) on Drug Status from the pre-test assessment (M

= .22, SD = .07) to the post-test assessment (M = .13, SD =
. 07) .
Figure 1 indicates that the CBT treatment resulted in a
71% reduction of mean Alcohol-Status composite score from
the pretest assessment

(M

=

.24) to the posttest assessment

(M = .07). This is contrasted to a 45% increase in mean
Alcohol-Status composite score for the IOP treatment
condition from the pretest assessment (M = .29) to the
posttest assessment (M

=

.42).
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Mean ASI-F Alcohol-Status
Composite Score

Mean ASI-F Drug-Status
Composite Score
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Figure 1. Mean ASI-F Alcohol and Drug-Status composite
scores at pretest and posttest assessment.

Figure 1 also represents the effect of treatment on mean
ASI-F Drug-Status composite scores. While there was
virtually no change in mean composite scores for the IOP
treatment condition from pretest assessment (M

.19) to

=

the posttest assessment (M = .18), the mean composite score
for the CBT group was reduced by 32% (pretest M
posttest M

=

.13).
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=

.19;

Between-Group Analysis. Table 3 presents the results
from the first step in the multivariate analysis of
variance for the two dependent variables: Alcohol Status
and Drug Status as measured by the ASI-F. Hotelling's T2
indicated that there was a main effect for the dependent
variables.

Table 3
Multivariate Test for Alcohol- and Drug-Status

Source

Hotelling's Trace

*

2

Value

sig.

1.280

.056*

p < .05

Since the initial step in the MANOVA procedure indicated
that there was a main effect on the dependent variables,
the F statistic was analyzed. Table 4 indicates that both
the Drug Status, F(1, 17):10.236, p

.013, and the effect

for Alcohol Status, F(1, 17):5.566, p: .046, were
statistically significant at the .10 level.
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Table 4
Multivariate Analysis of Variance for Alcohol- and Drug-Status

Source

sig.

F

Alcohol

1

5.566

. 046*

Drug

1

10.236

. 013*

* p

<

.05

In order to determine which dependent variable was
contributing to the overall F statistic, separate t tests
were conducted for each dependent variable. The Alcohol
Status t test was statistically significant,

t(1,

17)=2.359, p = .046, as was the Drug Status t test,
t(1,17)=3.199, p = .013. Therefore, both dependent
variables contributed to the significance of the MANOVA F
statistic, which indicates that both dependent variables
were statistically significant. Thus, treatment yielded
significant outcome on both dependent variables
Alcohol- and Drug-Status.
Research Question Two.
Research question two examined,

"To what extent does CBT

and IOP increase overall psychosocial functioning of
females who abuse substances as measured by the Employment
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Status, Legal Status, Family/Social Relationship, and
Psychological Status subscales of the ASI-F?"
Means and standard deviations were used to analyze
variability in the data for research question two, effect
sizes were used to determine statistical significance in
the variance between sample means, and a MANOVA analysis
was conducted to determine if there were any statistical
significance between-groups.

Table 5
PsychoSocial Composite Scores of the ASI-F

CBT

IOP
Pre-test
M

SD

Post-test
M

SD

Pre-test
M

SD

Post-test
M

SD

Employ

0.91

0.18

0.91

0.18

0.72

0.23

0.69

0.20

Legal

0.26

0.23

0.26

0.14

0.21

0.17

0.19

0.17

Fam/Soc

0.48

0.13

0.48

0.13

0.41

0.15

0.39

0.14

Psych

0.45

0.18

0.45

0.27

0.29

0.20

0.25

0.19

IOP Within-Group Analysis.

Table 5 presents the means

data for pre- and post-test psychosocial composite scores
of the ASI-F for both treatment conditions. The IOP
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treatment produced virtually no change from pre-test to
post-test for Employment Status (ES

=

.00), Legal Status

(ES = .01), Family/Social Status (ES = .00), or Psychiatric
Status (ES = .00).
The lack of significant effect size indicates that the
IOP treatment was not effective with increasing
psychosocial functioning for the subjects assigned to this
treatment condition.
CBT Within-Group Analysis. Table 5 also indicates that
subjects who received the CBT treatment condition yielded a
small to medium effect size (ES

.10) on Employment Status

from the pre-test assessment (M = .72, SD = .23) to the
post-test assessment (M

= .69, SD = .20). Treatment

resulted in a small effect size (ES = .05) on Legal Status
from the pre-test assessment (M

.21, SD

=

.17) to the

post-test assessment (M = .19, SD = .17). There was a small
to medium effect size (ES = .12) in Family/Social Status
from the pre-test assessment (M = .41, SD
post-test assessment (M
a medium effect size (ES

=

.15) to the

= .39, SD = .20). Treatment yielded

=

the pre-test assessment (M
test assessment (M

=

.17) in Psychiatric Status from

= .29, SD = .20) to the post.19) .

.25, SD

Between-Group Analysis. The multivariate analysis of
variance for Employment status, Legal status, Family/Social
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status, and Psychiatric status was conducted to determine
is there were any between group differences. As Table 6
indicates, Hotelling's T2 was not statistically significant
for the psychosocial dependent variables.

Table 6
Multivariate Tests for Psychosocial Variables

Source

Hotelling's Trace

* p

<

Value

sig.

.329

.451

4

.025

Due to the fact that the analysis of the Hotelling's
Trace did not yield a statistically significant difference,
the MANOVA F statistic was not analyzed. The lack of
statistical significance indicates that neither treatment
condition produced a main effect for any of the
psychosocial outcome variables.
Research Question Three.
Research question three examined, "To what extent does
CBT and IOP reduce the frequency and amount of substance
use as measured by the Alcohol- and Drug-Status subscales
of the ASI-F?"
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The data used for this analysis was ratio data therefore
means and standard deviations were used in the analysis.
Due to the fact that only three individuals relapsed,
additional statistical analysis such as ANOVA and MANOVA
were not used.
Data from the ASI-F indicated that three individuals
assigned to the IOP treatment condition reported that they
relapsed during treatment. The number of days of their use,
however, was dramatically reduced from the pre-test
assessment (M = 20, SD = 12.91) to the post-test assessment
(M

= 4, SD = 2.31). Although these three individuals

relapsed, the amount of their substance use was also
significantly reduced from a pre-test level (M = 46 oz., SD

=

31.09) to a post-test level (M

=

24 oz., SD

=

19.60). No

subjects assigned to the CBT treatment condition relapsed
during treatment.
This finding is contradictory in nature. First, the
three individuals relapsed during treatment, which suggests
that treatment produced a negative effect. However, the
amount of substance use and the number of days of substance
use were both reduced, which suggests that treatment was
effective. This finding indicates that treatment was
clinically significant, even though the individuals
relapsed during the course of treatment.
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The Profile of Mood States

Research question four examined/ "To what extent does
CBT and IOP reduce feelings of depression in females who
abuse substances as measured by the Depression-Dejection
subscale of the POMS?"
Research question five examined 1

"To what extent does

CBT and IOP reduce feelings of anxiety in females who abuse
substances as measured by the Tension-Anxiety subscale of
the POMS?"
Means 1 standard deviations/ and effect sizes were used
to analyze within-group differences for the POMS data.
MANOVA procedures were used to evaluate the between-group
differences. Pearson correlations were significant (p <
.01) from pre-test to post-test for both depression
(rtt=.81) and anxiety (rtt=.89) subscale scores.
IOP Within-Group Analysis. Table 7 presents data for
both treatment conditions on the POMS Anxiety and
Depression subscales. Subjects in the IOP treatment
condition reported a reduction in Depression scores from a
pre-test mean score of 22.89 (SD = 13.40) to a post-test
mean score of 20.56 (SD = 11.42). This resulted in a medium
effect size (ES

=

.20).

The IOP subjects also reported a reduction in feelings
of Anxiety from the pre-test (M = 19.33 1 SD = 12.27) to the
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post-test assessment (M

=

16.44, SD

10.70) which produced

a medium effect size (ES = .27).

Table 7
Profile of Mood States Subscale Scores

IOP

Pretest

CBT

Post test

Pretest

Post test

SD

M

14.38

5.57

9.88

6.43

7.75

4.63

5.13

5.82

M

SD

M

SD

M

DEP

22.89

13.40

20.56

11.42

~X

19.33

12.27

16.44

10.70

SD

CBT Within-Group Analysis. Subjects assigned to the CBT
treatment condition reported a greater reduction in the
feelings of depression than the IOP subjects; these
individuals reported a reduction from a pre-test group mean
score of 14.38 (SD = 5.57) to a post-test group mean score
of 9.88 (SD

=

6.43). This difference resulted in a large

effect size (ES = .70).
The CBT subjects also reported a reduction in Anxiety
scores from a pre-test group mean of 7.75 (SD = 4.63) and a
post-test group mean of 5.13 (SD = 5.82). This too resulted
in a large effect size (ES

=

.45).
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Figure 2. Mean POMS Anxiety and Depression scores
at pretest and posttest assessment.

Figure 2 graphically presents the main effects for mean
POMS Anxiety and Depression scores by treatment condition.
The IOP treatment resulted in a 15% reduction of mean
Anxiety score from the pretest assessment
the posttest assessment

(M

=

(M = 19.33) to

16.44). This is contrasted to

the 34% decrease in mean Anxiety score for the CBT
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treatment condition from the pretest assessment (M = 7.75)
to the posttest assessment (M

=

5.13).

Figure 2 also represents the effect of treatment on mean
POMS Depression scores. While the IOP treatment condition
produced a 10% reduction in scores from pretest assessment
(M

= 22.89) to the posttest assessment (M = 20.56), the

mean score for the CBT group was reduced by 31% (pretest M
14.38; posttest M

=

9.88).

Between-Group Analysis. The multivariate tests were
conducted to determine if there were any main effects for
Anxiety and Depression. As Table 8 indicates, Hotelling's T
indicated that there was no main effect for either of the
two dependent variables.

Table 8
Multivariate Test for Anxiety and Depression

Source

Retelling's Trace

* p

<

2

value

sig.

.107

.491

.05

Analysis of the Hotelling's

r

indicates that neither of

the dependent variables, anxiety or depression, yielded a
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statistically significant difference, therefore the MANOVA
F statistic was not analyzed.

The lack of statistical

significance indicates that neither treatment condition
produced a main effect for the treatment of anxiety or
depression.
Because the CBT treatment condition produced large
effect sizes, and the fact that a MANOVA may not be
sensitive enough to detect significance in a small sample
(Stevens, 1996), subsequent t tests were conducted on the
dependent variables (Anxiety and Depression) . This analysis
indicated that there was a statistical significance for
anxiety,

t(1, 17)

depression,

= 3.43,

p

= .08, as well as for

t(1, 17) = 3.09, p = .10. This confirmatory

statistical analysis indicates that treatment produced
significant outcome for both a reduction in the feelings of
depression as well as anxiety.
Summary

The objective of the current study was to determine if
either group was efficacious in the treatment of females
who use and abuse substances.
The major findings in this study include: CBT treatment
was effective in the reduction of alcohol and drug use,
depression, and anxiety; IOP was not effective in the
reduction of alcohol use; neither IOP or CBT was effective
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in increasing psychosocial functioning of the current
sample (employment, legal, family relations, psychiatric);
CBT was more than ten times more effective than IOP in the
reduction of alcohol use; CBT was four times more effective
than IOP in the reduction of drug use; CBT was two times
more effective than IOP in the reduction of anxiety; and
CBT was three times more effective than IOP in the
reduction of depression. Perhaps the most significant
finding, however, is the fact that a CBT treatment
developed at a Veterans Affairs Medical Center on male
clients can be generalized to treat female outpatient
clients.
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Chapter V
Limitations, Discussion, Recommendations, and Implications
Overview

Empirically supported treatment for substance abuse has
predominately focused on male clients (Hatsukami et al.,
1997), and the traditional approach to drug and alcohol
treatment uses techniques that tend to be confrontational
which has led clinicians to question their appropriateness
with female substance abusers (Hatsukami et al., 1997).
Current research posits that the optimal treatment approach
for females may be to focus on the process of negative
emotions (i.e., depression and anxiety) and interpersonal
relations, both of which are more typical relapse
indicators for female substance abusers (Stocker, 1998).
The Cognitive-Behavioral Treatment (Carroll, 1998) in
this study included: focusing on a functional analysis of
the substance abuse, individualized training in recognizing
and coping with cravings, examining the client's cognitive
processes related to substance abuse, examining high-risk
situations, encouragement of extra-session skills, and
practicing of skills within session.
The Insight-Oriented Psychotherapy (IOP) condition in
this study draws from Khantzian's Self Medication Model
(1985, 1986, 1988, 1990), and included: improving deficits
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in self-care, self-esteem, self-object, and affective
states.
The purpose of this study was to determine if CognitiveBehavioral Therapy (CBT) or Insight-Oriented Psychotherapy
(IOP) was more effective in the treatment of female
substance abuse. Outcome variables included amount and
frequency of drug use, the level of feelings of anxiety,
and the level of feelings of depression. Measures that
evaluated these domains included the Addiction Severity
Index, Female version (ASI-F) and the Profile of Mood
States (POMS) .
This study was designed to (a) evaluate the
effectiveness of empirically validated treatment protocols
with female substance abusers, and (b) to identify
potentially useful treatment techniques with this
population.
This chapter will present:

(a) limitations of the study,

(b) a discussion of the findings,
from the results,
future research,

(d)

(c) conclusions drawn

recommendations for practice and

(e) and implications for practice.

Limitations
This study is limited in generalizability because
outcome measures were based on client self-report data,
which may be subject to problems with recall and
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truthfulness of the subject when reporting their substance
use history. For instance, the study participants were
previously involved with Child Protective Services and they
might have wanted to portray themselves in a more favorable
light during the assessments, which would have lowered the
pre-test assessment scores.
Sample and Generalizability
There are several other threats to the external validity
of this study: the subjects in this study were from an
urban inner city on the West Coast, and the subjects were
primarily women of color with histories of primarily
cocaine and alcohol abuse. Either of these variables may
affect the generalizability of the results of the study due
to demand characteristics. For instance, the pattern of
drug use of inner city African-Americans on the West Coast
may be different from that of inner city African-Americans
on the East Coast. There may also be differences in
cultural values. For instance, the West Coast may have a
more liberal view of substance use than the East Coast, or
visa versa. Either of these conditions, if present, might
limit the ability to generalize the current findings to
other females of color or Caucasian females.
This study employed controls that were designed to
reduce many of the threats to the internal and external
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validity of the study. For instance, treatment conditions
were implemented following standardized implementation
protocols (i.e., manual driven sessions). Assessment
instruments that are industry standards and well-validated
were used, and outcome variables were analyzed through
statistical procedures other than power, such as effect
size (Basham, 1986; Kazdin, 1986, 1992). Additionally,
specific inclusionary and exclusionary parameters were
designed to reduce the threat to the generalizability of
the study by generating a homogenous sample. A homogenous
sample, in theory, would highlight change caused by the
independent variables rather than from demand
characteristics of the sample.
The small sample size may reduce the statistical power
of the study. Power is the ability of the researcher to
reject the null hypothesis when it is false (Stevens,
1992). Power is effected by sample size, alpha level, and
effect size. A priori power analysis indicates that for a
two group sample of fifteen subjects in each sample, with
an alpha level of .10, the power or ability to correctly
reject the null hypothesis is .63. This equates to a 63%
probability of correctly rejecting the null. In order for
the researcher to have a power coefficient of .80 (which
Cohen, 1998 suggests), with an alpha of .01, each group
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would require in excess of 100 subjects, which is often not
practical in clinical research (Kazdin, 1992; Stevens,
1996) .
Extraneous Variables. Another possible limitation may be
extraneous variables. Confounding exists when some
uncontrolled factor other than the independent variable may
be responsible for the results. The extraneous variables,
in this study, could include: simultaneous substance abuse
treatment from another provider, family dynamics, or social
variables that interfere with the treatment variable. None
of the subjects who participated in this study were
concurrently enrolled in another treatment program. Thus,
this threat was reduced.
Therapist Effects. Another limitation to this study is
the possibility of therapist effects. It is theoretically
possible that having only one therapist could lead to
skewed outcome. Having only one therapist who facilitates
both treatment condition raises the issue that the
therapist may have been better trained in one theoretical
orientation, the therapist may have been more aligned with
one theory and thus more motivated and enthusiastic in its
application.
An attempt was made at the outset of the study to
address this possible limitation. For instance, a concerted
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effort was made to recruit additional therapists to
facilitate treatment conditions, but due to the length of
training required and the commitment to the length of
treatment additional therapists could not be recruited.
Crits-Christoph (1991) state that when there are numerous
therapists, therapist effects should also be controlled
for. The therapist can effect outcome by virtue of their
experience, theoretical orientation, motivation, and even
the number of therapists involved in a study. Thus, having
only one therapist would counter the effect of having
multiple therapists. According to Crits-Christoph (1991) if
there is only one therapist, the therapist will effect each
treatment condition equally. This argument is analogous to
the placebo effect in clinical pharmacological studies.
This threat was addressed in the current study through the
strict adherence to treatment manuals. Adhering to the
treatment manuals theoretically should minimize any
therapist effects.
It should also be noted that the CBT manual

(Carroll,

1998) was more thoroughly developed than the lOP manual
(Lubarsky, 1984). CBT is also better suited than a
psychodynamic paradigm to manualized treatment, this too
may have affected the outcomes.
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Methodologies Designed to Reduce Additional Threats
Many of the Kazdin (1992) suggestions were incorporated
into the current study. For instance, assessment
instruments with high reliability and validity were used.
Each of the outcome measures generated data where
traditional parametric statistical analyses (e.g., means,
standard deviations, effect sizes, and MANOVAs) could be
used to evaluate the data. As far as sample selection is
concerned, the current study incorporates all of the
suggestions offered by Stevens (1992, 1996). For instance,
the sample is highly homogenous with no statistical
difference on any demographic area (see page 56) . The
current study also used repeated measures to collect
outcome data, and there is a strong linkage between
treatments and the dependent variables.
Discussion
Research Question One
Is Cognitive Behavioral Therapy (CBT) or InsightOriented Psychotherapy (lOP) more efficacious in the
treatment of substance use/abuse in females as measured by
the Alcohol- and Drug-Status subscales of the ASI-F?
The current study found that for both within- and
between-groups, the CBT treatment condition was more
efficacious than the lOP treatment condition for both Drug-
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and Alcohol-Status as measured by the ASI-F. For instance,
the CBT treatment condition resulted in lower drug use and
alcohol use than the IOP treatment condition. The data also
reveal that the IOP treatment condition resulted in a
negative treatment effect for alcohol use. Between-group
analysis indicated that these findings reached statistical
significance.
These findings are consistent with previous research.
For instance, Hall, Munoz, and Reus (1994) found that
cognitive behavioral techniques (thought restructuring,
relaxation training, social skills training, and
identifying maladaptive thoughts) were significantly more
effective than a standard treatment in achieving longer
periods of abstinence. Becket al.

(1991) also reported

similar results where cognitive behavioral interventions
were effective in the treatment of cocaine addiction. The
research of Carroll et al.

(1995) further supports the

fundamental premise that substance use or addiction can be
successfully treated through a cognitive-behavioral
treatment approach. Woody et al.

(1983) also reported that

cognitive behavioral therapy was more effective than
supportive expressive therapy in the reduction of substance
use.
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Ojehagen et al.

(1997), however, found that a multi-

modal behavioral therapy and psychiatric therapy based on a
psychodynamic paradigm were equally effective in reducing
alcohol use.
There are several hypotheses as to why the cognitivebehavioral treatment condition produced statistically
significant results for the participants of this study.
First is the fact that individuals in the early stages of
recovery need concrete direction in learning the steps
necessary to break the cycle of addiction. For instance,
the cognitive-behavioral treatment condition included
specific sessions on several relapse prevention techniques
(coping with cravings, developing the motivation to stop,
and developing skills to help the user decline invitations
to use substances)

(Carroll, 1998).

Another reason is that before individuals can stop using
substances, they first must be committed to abstinence
(Buelow & Buelow, 1998). The CBT subjects may have been
more committed to abstinence or the concrete material
covered in the CBT sessions most likely gave these
individuals the skills necessary for abstinence.
A third reason is that cognitive-behavioral therapy is
structured, goal-oriented, and focused on the immediate
problems that substance abusers face in their recovery
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process (NIDA, 1998) . Problem-solving approaches are viewed
as preferred treatment approaches for African-Americans and
other ethnic groups (Clark, McClanahan, & Sees, 1998).
Research Question Two
To what extent does CBT and IOP increase overall
psychosocial functioning of females who abuse substances as
measured by four subscale scores of the ASI-F (employment,
legal status, family/social relationships, and psychiatric?
The current study found that with regard to these four
dependent variables (employment, legal, family/social, and
psychiatric), the IOP condition resulted in negligible
within-group improvement and the CBT condition showed
minimal within-group improvements. Between-group analysis
found that neither group difference was statistically
significant.
This finding is not consistent with previous studies.
For instance, Woody et al.

(1983) reported that both

cognitive behavioral therapy and supportive-expressive
therapy, based on a psychodynamic paradigm, had more
improvement in psychological functioning and employment.
Subjects assigned to the cognitive behavioral treatment,
however, showed more improvement with legal problems. It
should be noted, however, that the length of treatment in
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the Woody et al. study was lengthy, whereas the length of
treatment in the current study was quite short.
Khantzian et al.

(1990) also reported patterns where

both cognitive behavioral treatment and supportive
expressive treatment was effective in improving
psychological functioning.
The primary reason that explains the current findings is
the fact that neither treatment specifically incorporated
strategies to gain employment, improve legal situations, or
to improve psychological well being. Each of these domains
was used to illustrate the negative impact that substance
abuse can have on one's life, however, each area would
require in-depth work in order to produce significant
results. This in-depth work was outside the purview of this
study, and any improvements in these areas would have been
an artifact extant to the current study, and not a result
that the current treatment was entirely responsible for
producing.
Research Question Three
To what extent does CBT and IOP reduce the frequency and
amount of substance use as measured by the Drug- and
Alcohol-Use subscales of the ASI-F?
The current study found that (a) subjects assigned to
the CBT treatment condition reported a statistically
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significant reduction in both drug and alcohol use, and (b)
there was a negative effect in alcohol usage for subjects
assigned to the IOP treatment condition. Three individuals
assigned to the IOP treatment condition relapsed during the
course of treatment.
The primary reason that the CBT treatment produced
significant reductions in both alcohol and drug use is the
fact that this treatment condition was specifically
designed for the treatment of substance abuse. Sessions
were designed to help the individual participant develop
skills necessary for abstinence. Thus, the CBT treatment
regimen attempted to develop functional coping skills in
the participants which they could draw upon rather than
turning to substances as a coping mechanism.
There are numerous reasons as to why the three
individuals assigned to the IOP condition relapsed during
treatment. One is that relapse is a part of treatment and
is traditionally viewed as a symptom of recovery from
substance abuse and not a failed treatment (Buelow &
Buelow, 1998). Treatment may have uncovered psychological
pain that the participants were unable to deal with, which
resulted in their continued maladaptive coping mechanism -the use of substances.
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Another view of the relapse of these individuals is that
the lOP treatment was at least partially effective.
Treatment based on an insight oriented treatment paradigm
is designed to discuss and uncover material that is often
painful (Khantzian, 1985, 1988). Viewed from this
perspective, the lOP treatment condition was partially
successful, with the individuals needing further treatment
in order to develop more adaptive coping mechanisms.
Previous research has indicated that longer treatment
results in better outcome or prognosis (CSAT, 1997). Thus,
the current treatment may have been too time-limited in
order to develop positive outcome.
Research Question Four and Five
To what extent does CBT and lOP reduce feelings of
depression in females who abuse substances as measured by
the Depression-Dejection subscale of the POMS?
To what extent does CBT and lOP reduce feelings of
anxiety in females who abuse substances as measured by the
Tension-Anxiety subscale of the POMS?
Within-group analysis indicated that both treatment
conditions yielded positive results in the reduction of
anxiety as well as depression. The lOP treatment condition
produced a small effect size difference for anxiety and a
medium effect size change for depression. The CBT treatment
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condition, however, produced large effect size differences
in the reduction of both anxiety and depression. Betweengroup analyses indicated that the CBT group difference was
statistically significant.
These statistical findings corroborate previous and
extensive research on the treatment of depression (Beck et
al., 1991; Hall, Munoz, & Reus, 1994) and anxiety (Hollon &
Beck, 1994; Wolpe, 1990), which indicates that these
disorders can be successfully treated with psychotherapy.
Initial analysis indicated that the CBT treatment
condition produced large effect sizes, yet the betweengroup MANOVA difference was not statistically significant.
If only the effect size was used to analyze the results,
then one would conclude that the CBT treatment condition
yielded significant results. Stevens (1996) states that a
MANOVA analysis may not be sensitive enough to detect
significance in a small sample. Due to conflicting
statistical results, separate t tests for these two
independent variables were conducted (Stevens, 1996). This
analysis resulted in statistical significance and
corroborated the large effect size differences.
The primary reason that the CBT treatment condition
produced significant results in the treatment of anxiety is
that individuals who abuse substances tend to be anxious
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over not being able to properly handle situations.
Substance abusers often form the opinion that when they are
under the influence of a substance that they can handle a
problematic situation better than if they are clean. This
is in fact a distorted perception, yet a firmly held one.
The CBT treatment condition covered various high-risk
situations with specific sessions devoted to coping with
these situations. This is designed to give the subjects the
confidence that they might be able to handle a problematic
situation without turning to substances.
Similar to the distortions associated around false
esteem is the fact that many individuals who abuse
substances feel guilty because of the negative impact that
substances have had on their lives (i.e., the removal of
children, loss of employment) . This quilt often generates
feelings of shame and embarrassment. The CBT treatment
condition included in-session discussions of the negative
consequences of their substance use. Thus, the CBT
treatment approach provided specific awareness, skills, and
a change of perception. Whereas, the lOP was more
relational based, and produced minimal effects.
Conclusions
Epidemiologic research has established the fact that
anxiety and depression are potentiating factors that often
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lead to substance use and abuse by females (Reiger et al.,
1990). Etiological research has also established that
substance use and abuse in females progresses faster and is
more destructive than in males who abuse substances. With
these facts in mind, contemporary research has consistently
shown that treatment can produce significant outcomes with
substance abuse (Becket al., 1991; Buelow & Buelow, 1998;
Carroll, 1998; Clark, McClanahan, Smith, & Landry, in
press; Hall, Munoz, & Reus, 1994; Haller, 1991; Khantzian,
1985, 1986, 1988; Luborsky, 1984; Moras, 1998a; O'Brien et
al., 1995; Onken et al., 1997; Woody et al., 1983), anxiety
(Beck, 1979; Ellis & Yeager, 1989; Hollon & Beck, 1994;)
and depression (Beck, 1979; Hall, Munoz, & Rues, 1994;
Meichenbaum, 1977; McNair, Lorr, & Droppelman, 1981;
Weissman et al., 1977; Wolpe, 1990).
It should be noted that the conclusions drawn from the
current findings should be taken with caution due to the
aforementioned limitations of this study. For the purposes
of this section, conclusions are presented by treatment
condition.
Insight-Oriented Psychotherapy
The current findings suggest that IOP treatment is not
the treatment of choice for females with a history of
substance use and abuse who are in the early stages of
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recovery. Others have suggested that treatment based on a
psychodynamic paradigm should not be used with individuals
who are in the early stages of recovery because these
treatments are often anxiety provoking and could lead to
further substance use (Levenson, 1995) . The current
findings corroborate this viewpoint. Both the current
findings, as well as previous research, suggest that
substance abuse treatment based on psychodynamic paradigms
might be used with individuals who are committed to
abstinence and who have demonstrated a history of being
abstinent.
Since the IOP treatment condition did not specifically
cover psychosocial domains, it is difficult to reach any
definitive conclusions from the current findings. Previous
research, however, has established that IOP can be more
efficacious than CBT in the treatment of certain
psychosocial functioning domains, such as psychological
functioning and employment (Woody et al., 1983).
It is theoretically logical that a relational therapy,
such as the IOP treatment condition, should be more longterm. Thus, the eight-session limit may have negatively
affected the outcomes of the IOP treatment condition.
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Cognitive-Behavioral Therapy
The fact that the CBT treatment condition resulted in
statistically significant outcomes leads one to conclude
that the subjects in this study responded well to treatment
based on a cognitive-behavioral paradigm. This contradicts
the traditional clinical bias that females respond best to
process oriented treatment.
Previous research of substance abuse has been conducted
primarily in Veteran Affairs Medical Center settings with
male clients, and the findings of this study indicate that
a treatment approach designed for male veterans can be
transported to:

(1) a female population, and (2) to an

outpatient community mental health setting. The findings
indicate that substance abuse is a cross-cultural variable
that often subsumes cultural differences, and this view is
shared by other researchers (Clark & McClanahan, 1998;
Clark, McClanahan, & Sees, 1998).
The CBT treatment condition also produced significant
differences in the reduction of both anxiety and depression
for the study sample. While this corroborates previous
research, this study is the first to empirically evaluate
outcomes with a female sample. The findings corroborate the
fact that a CBT treatment paradigm can be used successfully
with a female sample.

125

Recommendations
The results of this study suggest that clinicians and
researchers should follow several tenets when conducting
research with females who abuse substances.
Recommendations for Clinicians
1. Substance abuse treatment for individuals in the
early stages of recovery should be based on a cognitivebehavioral paradigm. Individuals in early stages of
recovery require concrete direction in identifying their
particular patterns and associating those patterns with the
negative consequences of their substance use.
2. Substance abuse treatment based on a psychodynamic
paradigm might be useful for individuals who are in the
latter stages of recovery and who have a history of
abstinence.
3. In order that an outcome variable can be evaluated
properly, each variable should be incorporated into the
treatment paradigm. For instance, if an experimenter is
evaluating the treatment outcome effect on employment, then
the treatment should include employment strategies, such as
resume building, into the treatment regimen.
4. Clinicians should conduct thorough assessments using
empirically-validated instruments. One of the instruments
used in this study, the SCID, is generally viewed as
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cumbersome and requires fairly extensive training in order
to develop a level of competency that is fundamental to its
administration. In a clinical setting, however, this
instrument can be shortened and only critical items
included in an intake interview. This would increase the
clinical utility of the instrument while gathering
pertinent data. The general criticism to creating a
shortened instrument is the fact that the instrument's
validity would be invalid. Item analysis can re-establish
validity coefficients quite easily, thereby addressing this
criticism, while making the instrument more user friendly.
5. Clinicians should establish realistic goals of
treatment and adapt the treatment regimen accordingly. By
incorporating each individual's history into the treatment
regimen, clients can make the linkage from substance use to
other life problems, such as involvement with Child
Protective Services. Clients can often gain insight into
their own problems vicariously through others sharing their
"stories".
6. A final point is the growing position that abstinence
is not an all or nothing proposition. Reduced substance use
is in itself a great accomplishment and should not be
viewed as failure. Instead, reduced substance consumption
should be rewarded.
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Recommendations for Further Research
This study focused on the evaluation of which treatment
approach was the most efficacious in the .treatment of
female substance abuse and ancillary issues, such as
anxiety and depression.
These findings suggest several recommendations for
future research, such as:
1. The ideal comparative study would follow a Solomon
Four Group design where two therapists who would provide
each of the treatment conditions. Therapist effects could
then be measured and controlled for by treatment cell.
2. Subsequent research should evaluate the aspects of
the CBT treatment approach that resulted in a reduction in
alcohol use, drug use, depression, and anxiety (i.e., insession discussions, didactic approach, problem solving
exorcises) .
3. Research should be conducted using an IOP treatment
condition with a sample of individuals who are in the
latter stages of recovery to determine if this treatment
approach is effective.
4. Research should be conducted using the CBT treatment
manual

(Carroll, 1998) for females with a history of

substance abuse and who are in the latter stages of
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recovery to determine if this treatment approach is
effective for females.
5. Research should be conducted that compares this CBT
manualized treatment with IOP treatment with a sample of
individuals in the latter stages of recovery to determine
which, if either, treatment is more effective in the
treatment of substance abuse for females.
6. Researchers should evaluate the individuals'
motivation for change and determine the appropriateness for
inclusion in the research. For instance, an individual in
the early stages of recovery but who is not committed to
abstinence should be excluded from treatment. The reason
for this exclusion is that the individual would not benefit
from treatment and may even have a negative affect on other
participants.
7. Research should be conducted to determine the leading
cause(s) of relapse, and these causes should be
incorporated into all treatment regimens, regardless of
theoretical paradigm.

Implications for Practice
The ultimate objective of this study was to determine if
a traditional approach to treating male substance abuse
(Cognitive Behavioral Therapy)

is a more efficacious

treatment than a process oriented approach (Insight-
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Oriented Psychotherapy) . Previous results indicate that
components of each treatment approach may be efficacious
for certain subtypes of substance abuse or mood factors. As
Najavits, Weiss, and Shaw (1997) state, finding the best
type of treatment for the substance-abusing female is
tantamount.
To this end, the current findings suggest that a
treatment program based on the tenets of cognitivebehavioral therapy is the treatment of choice for females
in the early stages of recovery. Additional research is
needed in order to conclude whether a treatment program
based on a psychodynamic paradigm is efficacious in the
treatment of substance abuse for individuals in the early
stages of recovery. Additional research is also needed in
order to determine which, if either, treatment (CBT or IOP)
is efficacious in the treatment of substance abuse for
individuals in the latter stages of recovery.
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Appendix A
Research Design Schematic

Study Design:
Pretest-Posttest Comparative Experimental Design.
"R(cognitive Behavioral Therapy)

01 X 02

"R(Insight Oriented Psychotherapy)

01 X 02

Variables:
Independent V ariable 1:
Independent Variable2 :

Cognitive Behavioral Treatment (CBT)
Insight Oriented Psychotherapy (lOP)

Dependent V ariable 1:
Dependent V ariable2 :
Dependent Variable3 :
Dependent V ariable4 :
Dependent V ariable4 :

Drug- and Alcohol-Status
Psychosocial Functioning
Frequency and Amount of Substance Use
Depression
Anxiety

Screening:

Telephone pre-screening

Diagnostic evaluation:

Structured Clinical Interview using the DSM

Outcome measures:

DV2

DVs

ASI-F,

Drug- and Alcohol-Status subscales

ASI-F,

Composite Scores

ASI-F,

Drug- and Alcohol Use subscales

POMS,

Depression subscale

POMS,

Anxiety subscale
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Appendix B
Research Participant Recruitment

Do life's pressures cause you to drink or use drugs?
Are you concerned that your drinking is out of control?
Are you using more drugs than you think you should be?
Do friends comment about your drinking or drug use?
Have you been neglecting your obligations?

Ifyou are a female, between the ages of 17 and 44, and would like to receive counseling
regarding your alcohol or drug use, please call Terry at (415) 422-6037. After an initial intake
session regarding your drinking or drug use, you will receive eight group counseling sessions
with others who have concerns similar to your own. Counseling is free and confidential. You
will be paid for your time after each session. Your name will not be included on any records.
Please call Terry at (415) 422-6037, leave a message that indicates the best time to reach you.
Your call will be promptly returned.
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Appendix C
Telephone Screening Script
Introduction. Thank you for taking an interest in the study. I
would like to give you a brief description of the project.
Afterward, if you're still interested I'll ask you some
questions to see if you meet the basic requirements of the
study.
Studv Overview. This research study is investigating which
treatment is more effective in the treatment of substance abuse
in females. Everyone who participates in the study will receive
one group counseling session per week for a period of eight
weeks. Half of the people participating in the study will
receive Cognitive-Behavioral (CBT) counseling and the other half
will receive Insight Oriented Psychotherapy (IOP) .

Prior to being accepted into the study, you will be asked to
complete a thorough evaluation that will involve one two-hour
appointment. After which, if you are still eligible and you
decide to participate, you will be given a schedule for your
counseling sessions. After each appointment you will be
reimbursed for your time.
Questions & Answers.
Q. Do you have any questions?
Q. Are you interested in participating in the program?

If yes, proceed to the Telephone Pre-Screening
Inclusionary/Exclusionary Form.
If no, thank the subject for their inquiry, and inquire if
they would like a referral to a community treatment facility.

146

Appendix D
Telephone Pre-Screening Inclusionary/Exclusionary For.m

Screening ID #
Interviewer
Date
Demographic:
Caller's name:
Phone number: (home)
Date of Birth:
Age:
Ethnicity:

(other)
SSN:
Marital Status:

Gender:

Current Drug Use Patterns:
Do you currently use any street drugs?
____Yes ____No
What is your drug of choice?
How many days/weeks have you used in the past month?
How much did you use in the past month?
What was the dollar value of the drug you used (per day for the
last 4 weeks)?
Medical:
Have you ever had any of the following: (Y/N)
___ Seizures
___ Kidney Disease
___ Stroke
___Liver Disease
___Bulimia
___Heart Attack
___Heart Disease or Angina
___ Irregular Heart Rhythm
___High Blood Pressure

Do you have any other significant medical problems?
Are you currently taking any prescribed medications?

Have you ever been told that you have a manic-depressive
disorder? (Y/N)
Have you ever heard voices or seen things that you knew
were not there? (Y/N)
If yes, was it due to your drug use? (Y/N)
If yes, did anyone tell you that you had schizophrenia?
(Y/N)
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Appendix E
Consent to Participate in A Research Project
Title of Study:

A Comparative Evaluation of CognitiveBehavioral Therapy (CBT) and Insight Oriented
Psychotherapy (IOP) in the Treatment of
Substance Abusing Females.

Investigator:

Terry Michael McClanahan, M.A.
Doctoral Candidate
Dept of Counseling Psychology
University of San Francisco
(415) 422-6037

Purpose:
This study is investigating the effectiveness of two treatments to
reduce the symptoms associated with substance abuse in females.
Procedures:
If you decide to participate in the study, an initial two-four
hour appointment will be scheduled. During this appointment you
will be asked to complete various questions concerning your drug
use history, and occurrences in your life. Following this initial
appointment, if you decide to participate in the study, you will
be scheduled for your counseling sessions. At the end of your
treatment, a final 1-3 hour appointment will also be necessary.
During this final appointment you will also be asked to complete
various questions concerning your drug use. There are two groups
in this research project, and you have an equal chance of being
assigned to either treatment. Treatment lasts eight sessions.
Risks:
There are no known risks aside from the time involved to
participate, which is a total of approximately 15 hours for the
entire study, and includes the 2-4 hours for the initial
interview, the 1 hour per counseling session, and the 1-3 hours
for the post-therapy appointment. While there are no known risks
associated with either treatment, you will be asked to discuss
some things in depth that have happened to you. This may cause
discomfort to you, but each therapy is designed for you to raise
this discomfort with your therapist.
Benefits:
This study may be beneficial to you. Therapy has been proven to be
effective at reducing suffering in people with severe emotional
distress.
Confidentiality:
All information concerning you will be held in confidence. A file
is necessary for each person that participates in the study,
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however, you will be assigned a number, and that number will be
how your file is maintained. In addition, you will be instructed
to use only your particular number on any questionnaire that you
complete during the study.
By agreeing to participate in this study, you agree that the
Principal Investigator is allowed to use the findings of this
study in professional literature that includes professional
presentations, journal articles, books, etc. In the event that the
investigator uses the information derived from this study, the
information will contain only your subject number.
Names and addresses of both yourself and your contacts will be
maintained separately from your treatment chart, in a locked file
to which only the principle investigator has access.
Costs and Compensation:
The treatment is provided at no cost to the study participants.
Study participants may be compensated for participating in the
study at the following rates: completion of the initial assessment
interview ($10), each weekly therapy appointment ($5), final posttherapy appointment ($10), and a bonus for completing all
requirements ($10) . This equals to a total of $70 that is possible
for completing all requirements.
Right to Refuse or Withdraw from Treatment:
Participation in this study is voluntary. At any point in time
during the treatment, you have the right to refuse to participate
and may withdraw from the treatment study.

A pager number of Terry Michael McClanahan (Principal
Investigator) will be given to you for emergency use (e.g.,
relapse, medical emergency) if you decide to participate in the
study. Your signature below indicates that you have read and
understand the information contained in this document, that you
have agreed to participate in the study, that you understand that
your participation is voluntary, and that you have the right to
withdraw from the study at any time, should you decide to do so.

Signature of Research Participant

Date

Signature of Principal Investigator

Date

Informed Consent Page 2
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Appendix F
Research Study Participant Reimbursement Schedule

Research Participant Name __________________________________
Please initial beside the appropriate line that you have
received the amount of the reimbursement for participating in
this research project:
Intake Assessment ($10.00)

(initials)

Counseling session #1 ($5.00)

(initials)

Counseling session #2

($5.00)

(initials)

Counseling session #3

($5.00)

(initials)

Counseling session #4

($5.00)

(initials)

Counseling session #5 ($5.00)

(initials)

Counseling session #6 ($5.00)

(initials)

Counseling session #7 ($5.00)

(initials)

Counseling session #8 ($5.00)

(initials)

End-of-Treatment Assessment ($10.00)

(initials)

Bonus for all requirements ($10.00)

(initials)
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Appendix G
Structured Clinical Interview using the DSM (SCID)
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..,CID-I/NP or P W/PSY SCREEN (for DSM-IV)

Psychotic Symptoms

B/C PSYCHOTIC SCREENING MODULE (FOR SCID-I/NP OR

p

(FEB 1996 FINAL).

B/C. 1

W/PSYCHOTIC SCREEN)

THIS. MODULE IS FOR CODING PSYCHOTIC AND ASSOCIATED SXS THAT HAVE
BEEN PRESENT AT ANY POINT IN THE PERSON'S LIFETIME.
IT CAN BE USED FOR
CLINICAL AND RESEARCH SETTINGS WHERE THOSE WITH A HISTORY OF PSYCHOTIC SXS
THAT ARE NOT DUE TO SUBSTANCE USE OR A GENERAL MEDICAL CONDITION OR THAT
OCCUR OUTSIDE THE CONTEXT OF A MOOD DISORDER ARE TO BE EXCLUDED.
FOR EACH PSYCHOTIC SYMPTOM CODED "3," DESCRIBE THE ACTUAL CONTENT AND
INDICATE THE PERIOD OF TIME DURING WHICH THE SYMPTOM WAS PRESENT.
FOR ANY PSYCHOTIC AND ASSOCIATED SYMPTOMS CODED "3," DETERMINE
WHETHER THE SYMPTOM IS DEFINITELY "PRIMARY" OR WHETHER THERE IS A
POSSIBLE OR DEFINITE ETIOLOGIC SUBSTANCE (INCLUDING MEDICATIONS) OR
GENERAL MEDICAL CONDITION.
THE FOLLOWING QUESTIONS MAY BE USEFUL IF
THE OVERVIEW HAS NOT ALREADY PROVIDED THE INFORMATION:
Just before (PSYCHOTIC SXS) began, were you using drugs? ... on any
medications?
... did you drink much more than usual or stop drinking after you had been drinking a lot for a while?
... were you
physically ill?
IF YES TO ANY:
Has there been a time when you had (PSYCHOTIC SXS)
and were not (USING DRUGS/TAKING MEDICATION/CHANGING YOUR DRINKING HABITS/ILL)?
Now I am going to ask you about
unusual experiences that people
sometimes have.

Has it ever seemed like people
were talklng about you or taking
special notice of you?
IF YES: Were you convinced
they were talking about you or
did you think it might have
been your imagination?

DELUSIONS
False personal beliefs based on incorrect
inference about external reality and firmly
sustained in spite of what almost everyone
else believes and in spite of what constitutes incontrovertible and obvious proof or
evidence to the contrary. The belief is not
one ordinarily accepted by other members of the
person's culture or subculture.
Code overvalued
ideas (unreasonable and sustained beliefs
that are maintained with less than delusional
intensity) as "2."
Delusion of reference, i.e.,
events, objects, or other
people in the individual's
immediate environment have a
particular or unusual significance.
DESCRIBE:

What about receiving special
messages from the TV, radio, or
newspaper, or from the way things
were arranged around you?

?=inadequate information

l=absent or false

152

2=subthreshold

I
I
I
?
1
2
3
I BC.
I
I
II
1
3
I I BC.
II
POSS/DEF PRI-1 I
SUBST /GMC MARY I I
II
I
I
I
I
I

3=threshold or true

- SCID-I/NP or P W/PSY SCREEN {for DSM-IV)

What about anyone going out of
their way to give you a hard
time, or trying to hurt you?

Psychotic Symptoms

(FEB 1996 FINAL)

Persecutory delusion, i.e.,
the individual {or his or her
group) is being attacked,
harassed, cheated, persecuted,
or conspired against.
DESCRIBE:

Did you ever feel that you
were especially important in
some way, or that you had special
powers to do things that other
people couldn't do?

Grandiose delusion, i.e.,
content involves exaggerated
power, knowledge or importance,
or a special relationship to a
deity or famous person.
DESCRIBE:

Did you ever feel that something
was very wrong with you physically even though your doctor
said nothing was wrong ... like
you had cancer or some other
terrible disease?

Somatic delusion, i.e.,
content involves change or
disturbance in body appearance
or functioning.
DESCRIBE:

Have you ever been convinced that
something was very wrong with the way
a part or parts of your body looked?

1
2
?
3
______ I

{Did you ever feel that you had
committed a crime or done something terrible for which you
should be punished?)

BC.

BC.
BC.

BC.
BC.

I
I
I
I
I
I
?
1
2
3
______ !

Other delusions
Check if:
religious delusions
delusions of guilt
jealous delusions
erotomanic delusions

1=absent or false
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I
I
II
1
3
II
II
POSS/DEF PRI-ll
SUBST/GMC MARY! I
_ _ _ _ _ _ _ II

BC.
BC.
BC.
BC.
BC.
BC.

I
I

DESCRIBE:

?=inadequate information

L

I
I
I BC.

I
II
1
3
II
II
POSS/DEF PRI-ll
SUBST/GMC MARY II
_ _ _ _ _ _ _ II
I
I
I
?
1
2
3
I
_____ !
I
II
1
3
II
i I
POSS/DEF PRI-ll
SUBST/GMC MARY!!
_ _ _ _ _ _ _ II
I
I
I
1
2
?
3
I
_____ !
I
II
1
3 II
II
POSS/DEF PRI-ll
SUBST/GMC MARY!!
_ _ _ _ _ _ II

{Did you ever feel that something
strange was happening to parts of
your body?)
{Did you ever have any unusual
religious experiences?)

1:ff';;.-.

2=subthreshold

3=threshold or true

SCIO-I/NP or P W/PSY SCREEN (for DSM-IV)

Psychotic Symptoms

B/C. 3

(FEB 1996 FINAL)

HALLUCINATIONS (PSYCHOTIC)
A sensory perception that has
the compelling sense of reality
of a true perception but occurs
without external stimulation of
the relevant sensory organ.
(CODE "2" FOR HALLUCINATIONS
THAT ARE SO TRANSIENT AS TO
BE WITHOUT DIAGNOSTIC SIGNIFICANCE)
Did you ever hear things
that other people couldn't
hear, such as noises, or the
voices of people whispering
or talking? (Were you awake
at the time?)

Auditory hallucinations
when fully awake, heard
either inside or outside
of head
DESCRIBE:

IF YES: What did you hear?
How often did you hear it?

IF VOICES: Did they comment
on what you were doing or
thinking?

A voice keeping up a
running commentary
on the individual's
behavior or thoughts
as they occur

How many voices did you
hear? Were they talking
to each other?

Two or more voices
conversing with each
other

Did you ever have visions or
see things that other people
couldn't see?
(Were you
awake at the time?)

Visual hallucinations
DESCRIBE:

NOTE: DISTINGUISH FROM AN ILLUSION, I.E., A MISPERCEPTION OF
A REAL EXTERNAL STIMULUS.

1

2

I
I
I
I
I
I
I
I
I
I
II
1
3
II
II
POSS/DEF PRI-1 I
SUBST/GMC MARY II
_ _ _ _ _ _ _ II
I
?
1
2
3
I
I
I
I
I
I
?
1
2
3
I
I
I
I
?
l
2
3
______ I
I
II
1
3
II
II
POSS/DEF PRI-ll
SUBST/GMC MARY II
_ _ _ _ _ _ _ II
I

?

3

BC.

BC.

BC.

BC.

BC.
BC.

I

?=inadequate information

l=absent or false
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2=subthreshold

3=threshold or true

SCID-I/NP or P W/PSY SCREEN (for DSM-IV)
What about strange sensations

Psychotic Symptoms

Tactile hallucinations, e.g.,
electricity

in your body or on your skin?

B/C. 4

(FEB 1996 FINAL)
?

DESCRIBE:

I BC.
I
II
1
3 I I BC.
II
POSS/DEF PRI-1 I
SUBST/GMC MARY! I
1

2

3
I

-------''I
(What about smelling or tasting
things that other people couldn't
smell or taste?)

I

Other hallucinations, e.g.,
gustatory, olfactory

?

Check if:
gustatory
--olfactory
DESCRIBE:

I
I
II
1
3 II
II
POSS/DEF PRI-J I
SUBST/GMC MARY! I
II
I
I
1

2

3
I

BC.
BC.
BC.
BC.

I
I

ANY ITEM CODED "3" IN "PRIMARY"
SECTION

IF A MAJOR DEPRESSIVE OR MANIC
EPISODE HAS EVER BEEN PRESENT:
Has there ever been a time when
you had (PSYCHOTIC SXS) and you
were not (DEPRESSED/MANIC)?

?

3
I BC.
I
I
/GO TO -I lA PRI=-1 I
I I MARY
II
I NEXT
!MODULE I I PSYCHO-I I
JITIC SX II
I
II
I HAS
!BEEN
II
I PRESENT I I
1

I

I

Psychotic symptoms occur at
times other than during mood
syndromes
NOTE: CODE "3" IF NO MOOD
SYNDROMES OR PSYCHOTIC SXS
W/0 MOOD EPISODES. CODE
"1" ONLY IF PSYCHOTIC SYMPTOMS OCCUR EXCLUSIVELY OURING UNEQUIVOCAL MOOD SYNDROMES .

?

1

3

I

I

I BC.
I
I

I

I

I

1-:: :P-:: S-;-;Y-;: :;C-;-;H-;:;0-;:; T-::;I-;: :;C I
!MOOD DIS- I
!ORDER. IF I
!ALLOWED BYI
!STUDY, GO I
ITO NEXT
I
I MODULE.
I

IPSY- -II
ICHOTIC I I
JDISOR- I I
IDER
II
!LIKELY I I
I
I
I
I

----------------------------------------------------------------------1

I
I
EXPLORE DETAILS AND DESCRIBE DIAGNOSTIC SIGNIFICANCE:

?=inadequate information

l=absent or false
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Alcohol Use Disorders

E.

(FEB 1996 FINAL)

1

SUBSTANCE USE DISORDERS

ALCOHOL USE DISORDERS (LIFETIME)
IF SCREENING QUESTION lll ANSWERED "NO," CHECK HERE
*NON-ALCOHOL SUBSTANCE USE DISORDERS,* E. 10

!SCREEN Q#l I
I YES II NO I
I
II
I

AND SKIP TO

-,-

1IF NO: GO TO

!*NON-ALCOHOL
I
!USE DISORDERS*!

IF SCREENER NOT USED OR IF QUESTION #1 IS
ANSWERED "YES," CONTINUE:

I E.

When in your life were you
drinking the most?
(How long
did that period last?)

10

I

I
I
I
I

What are your drinking habits
like?
(How much do you drink?)
(Has there ever been a time in your
life when you had five or more drinks
on one occasion?)

I

RECORD DATE OF HEAVIEST
USE AND DESCRIBE PATTERN:

During that time ...

I
I
I
I
I
I
I

I
I
I
I
I
I
I
I
I
I
I
I

how often were you drinking?
what were you drinking?

how much?

During that time ...
did your drinking cause problems
for you?
did anyone object to your drinking?
IF ALCOHOL DEPENDENCE SEEMS LIKELY,
CHECK HERE
AND SKIP TO *ALCOHOL
DEPENDENCE,-*--£. 4.

I

IF ANY INCIDENTS OF EXCESSIVE DRINKING OR
ANY EVIDENCE OF ALCOHOL-RELATED PROBLEMS, CONTINUE WITH
*ALCOHOL ABUSE,* ON NEXT PAGE.
IF NEVER HAD ANY INCIDENTS OF EXCESSIVE DRINKING AND
THERE IS NO EVIDENCE OF ANY ALCOHOL-RELATED PROBLEMS,
SKIP TO *NON-ALCOHOL SUBSTNCE USE DISORDERS,* E. 10

?=inadequate information

!=absent or false
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I EA.
I
I
I
I
I
I
I
I

3=threshold or true
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E. 2

(FEB 1996 FINAL)

Alcohol Abuse

*LIFETIME ALCOHOL ABUSE*

ALCOHOL ABUSE CRITERIA

.et me ask you a few more
questions about your drinking
habits.

A. A maladaptive pattern of
substance use leading to clinically
significant impairment or distress,
as manifested by one (or more) of
the following occurring within a
twelve month period:

I
I
I
I

I
I

I
I

I

Have you ever missed work or
school because you were intoxicated, high, or very hung over?
(How often? What about doing
a bad job at work or failing
courses at school because of your
drinking?)
IF NO: What about not keeping
your house clean or not ~aking
proper care of your children
because of your drinking?
(How often?)

(1) recurrent alcohol use
resulting in a failure to
fulfill major role obligations
at work, school, or home
(e.g., repeated absences or poor
work performance related to
alcohol use; alcohol-related
absences, suspensions, or
expulsions from school; neglect
of children or household)

1

?

2

3

EB.

I

I
I
I
I

I
I

I
I
I
I
I
I
I

IF YES TO EITHER OF ABOVE: How
often? (Over what period of time?)
Did you ever drink in a situation in which it might have
been dangerous to drink at all?
(Did you ever drive while you
were really too drunk to drive?)

(2) recurrent alcohol use in
situations in which it is
physically hazardous (e.g.,
driving an automobile or
operating a machine when
impaired by alcohol use)

?

1

2

3

EC.

(3) recurrent alcohol-related
legal problems (e.g., arrests
for alcohol-related disorderly
conduct)

?

1

2

3

ED.

(4) continued alcohol use
despite having persistent or
recurrent social or interpersonal problems caused or
exacerbated by the effects of
alcohol (e.g., arguments with
spouse about consequences
of intoxication, physical
fights)

?

1

2

3

EE.

IF YES AND UNKNOWN:
How often?
(Over what period of time?)
Has your drinking gotten you into
trouble with the law?
IF YES AND UNKNOWN:
How often?
(Over what period of time?)
IF NOT ALREADY KNOWN: Has your
drinking caused problems with
other people, such as with
family members, friends, or people at work?
(Have you ever gotten into physical fights or had
bad arguments about your
drinking?)
IF YES: Did you keep on
drinking anyway?
(Over what
period of time?)

?=inadequate information

l=absent or false
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Alcohol Abuse
AT LEAST ONE "A" ITEM
CODED "3"

I
IF NO POSSIBILITY OF PHYSIOLOGICAL DEPENDENCE OR COMPULSIVE
USE, GO TO *NON-ALCOHOL USE DISORDERS,* E. 10 OTHERWISE,
CONTINUE ASKING ABOUT DEPENDENCE, E. 4.

?=inadequate information

!=absent or false
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2=subthreshold

1

E. 3
I EF.
I
I
I
I
I
I
I
I
I
I
I
II
ALCOHOL II
ABUSE
II
CONTINUE II
ASKING
II
ABOUT
II
DEPENDII
ENCE
II
E. 4
II
(UNLESS
II
ALREADY
II
ASKED)
II
3

3=threshold or true

SCID-I Version 2.0 (for DSM-IV)

Alcohol Abuse

(FEB 1.996 FINAL)

ALCOHOL DEPENDENCE

ALCOHOL DEPENDENCE CRITERIA

I'd now like to ask you some
more questions about your
drinking habits.

A maladaptive pattern of
alcohol use, leading to
clinically significant
impairment or distress, as
manifested by three (or more)
of the following occurring
at any time in the same
twelve month period:

E.

4

NOTE: CRITERIA FOR ALCOHOL
DEPENDENCE ARE NOT IN OSM-IV
ORDER
I

Have you often found that when you
started drinking you ended up
drinking much more than you ·
were planning to?

(3) alcohol is often taken
in larger amounts OR
over a longer period than
was intended

?

1

2

3

I EG.

I
I

I
I

IF NO: What about drinking
for a much longer period of
time than you were planning
to?

I
I
I
I

I
Have you tried to cut down or stop
drinking alcohol?
IF YES:
Did you ever
actually stop drinking altogether?

(4) there is a persistent
desire OR unsuccessful
efforts to cut down or control substance use

?

1

2

3

I
I
I

I
I
I
I

(How many times did you try
to cut down or stop altogether?)

I
I

IF NO: Did you want to stop
or cut down? (Is this something
you kept worLying about?)

I
I
I
(5) a great deal of time is
spent in activities necessary to obtain alcohol, use
alcohol, or recover from its
effects

Have you spent a lot of time
drinking, being high, or hung
over?

I EH.
I

?

1

2

3

I EI.

I
I
I
I
I

Have you had times when you would
drink so often that you started to
drink instead of working or spending time at hobbies or with your
family or friends?

(6) important social, occupational, or recreational
activities given up or reduced
because of alcohol use

?

1

2

3

I
I EJ.
I
I
I
I

I

?=inadequate information

l=absent or false
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Alcohol Dependence

IF NOT ALREADY KNOWN: Has your
drinking ever caused any psycho.ogical problems like making you
depressed or anxious, making it
difficult to sleep, or causing
"blackouts?"
IF NOT ALREADY KNOWN: Has your
drinking ever caused significant
physical problems or made a
physical problem worse?

E. 5

(FEB l996 FINAL)

(7) alcohol use is continued
despite knowledge of having
a persistent or recurrent
physical or psychological
problem that is likely to
have been caused or exacerbated by alcohol (e.g., continued drinking despite recognition that an ulcer was made
worse by alcohol consumption)

?

1

2

3

(1) tolerance, as defined by
either of the following:

?

1

2

3

?

1

2

3

EK.

IF YES TO EITHER OF ABOVE: Did
you keep on drinking anyway?
Have you found that you needed to
drink a lot more in order to get
the feeling you wanted than you
did when you first started drinking?
IF YES: How much more?
IF NO: What about finding that
when you drank the same amount, it
had much less effect than before?
Have you ever had any withdrawal
symptoms when you cut down or
stopped drinking like ...

(a) a need for markedly increased amounts of alcohol
to achieve intoxication or
desired effect
(b) markedly diminished
effect with continued use
of the same amount of
alcohol
(2) withdrawal, as manifested
by either (a) or (b):

I

I
I
I
I
I
I
I
I

(a) at least TWO of the
following:
... sweating or racing heart?

autonomic hyperactivity
(e.g., sweating or pulse
rate greater than 100)
increased hand tremor
insomnia
nausea or vomiting
psychomotor agitation
anxiety

... hand shakes?
... trouble sleeping?
... feeling nauseated or vomiting?
... feeling agitated?
... or feeling anxious?
(How about having a seizure or
seeing, feeling, or hearing things
that weren't really there?)
IF NO: Have you ever started the day
with a drink, or did you often drink
to keep yourself from getting the
shakes or becoming sick?

?=inadequate information

I
I EL.
I
I
I
I
I
I
I
I
I
I
I
I
I EM.

grand mal seizures
transient visual, tactile, or
auditory hallucinations or
illusions
(b) alcohol (or a substance from
the sedative/hypnotic/anxiolytic
class) taken to relieve or avoid
withdrawal symptoms

1=absent or false
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Alcohol Dependence

IF UNKNOWN: When did (SXS CODED "3"
ABOVE) occur? (Did they all happen
1round the same time?)

E. 6

(FEB 1996 FINAL)

AT LEAST THREE "A" ITEMS
CODED "3" AND ITEMS OCCURRED
WITHIN THE SAME TWELVE MONTH
PERIOD

I EO.
I
I
I
I
I
I
I
I ALCOHOL
II
I
I DEPENDENCE I I
I
I
I
I
I
Indicate if:
I EP.
I
I
1 - With Physiological Dependence
I
I
(current evidence of tolerance or
I
withdrawal)
I
I
I
2 - Without Physiological Dependence
I
I
(no current evidence of tolerance
I
I
or withdrawal)
I
I
I
I
I
I
I
I GO TO DEPENDENCE CHRONOLOGY, E. 7 I
I
I
I
IF ALCOHOL ABUSE QUESTIONS (PAGES E.1-E.3) HAVE NOT YET
I
BEEN ASKED, GO TO PAGE E.1. AND CHECK FOR ABUSE.
I
I
IF ABUSE QUESTIONS HAVE BEEN ASKED AND ABUSE IS PRESENT, CODE "3"
1
3
I EQ.
OTHERWISE, IF QUESTIONS HAVE BEEN ASKED AND ABUSE IS NOT PRESENT,
I
GO TO *NON-ALCOHOL USE DISORDERS,* E.10.
I
I
I GO TO *NON- I I ALCOHOL I I
I ALCOHOL USE I I ABUSE
II
!DISORDER,*- I
I
I
JE. 10
I
I
I
1

3

--------------------------------------------------------------------------1
How old were you when you first
had (ABUSE SXS CODED "3")?

Age at onset of Alcohol
Abuse (CODE 99 IF UNKNOWN)

IF UNCLEAR: During the past
month, have you had anything
at all to drink?

Criteria for Alcohol Abuse
met at any time in past
month

IF YES: Tell me more about it.
(Has your drinking caused you
any problems?)

?=inadequate information

l=absent or false
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2=subthreshold

I

I
I ER.
I
I
?
1
3
I ES.
I
I
I
!
I PAST I I CURRENT I I
I ABUSE I I ABUSE I I
---1
I
I
I GO TO *NONII
I ALCOHOL USE
II
I DISORDER,*
II
IE. 10
II

3=threshold or true
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Alcohol Dependence

E. 7

(FEB 1996 FINAL)

*CHRONOLOGY FOR DEPENDENCE*
~ow old were you when you first
had (LIST OF ALCOHOL DEPENDENCE
OR ABUSE SXS CODED "3")?

Age at onset of Alcohol
Dependence or Abuse (CODE
99 IF UNKNOWN)

IF UNCLEAR: During the past
month, have you had anything
at all to drink?

Full criteria for Alcohol
Dependence met at any time
in past month (or never had
a month without symptoms of
Dependence or Abuse since
onset of Dependence)

IF YES: Tell me more about it.
(Has your drinking caused you
any problems?)

1

?

I
I
I
I
I
I

1-=G-=o--=T-=o----I *REMISSION
I SPECIFIERS*
I E. 8

I
I
I ET.
I
I
I
3
I EU.
I
I
I
I CURRENT I I
I DEPEND-II
II
IENCE
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I

-----------------------------------------------------------------------------1

I
*SEVERITY SPECIFIERS FOR DEPENDENCE*

I
I
I EV.
I
I
I
I
I
I
I
I
I
I

NOTE SEVERITY OF DEPENDENCE FOR WORST WEEK OF PAST MONTH
(Additional questions about the effect of alcohol on social
and occupational functioning may be necessary.)
1

Mild:

2

Moderate: Symptoms or functional impairment between "mild" and
"severe."

3

Severe:

II

Few, if any, symptoms in excess of those required
to make the diagnosis, and the symptoms result in
no more than mild impairment in occupational functioning or in usual social activities or relationships
with others (or criteria met for Dependence in the
past and some current problems).

I

Many symptoms in excess of those required to make the
diagnosis, and the symptoms markedly interfere with
occupational functioning or with usual social activities
or relationships with others.

I
I
I
I
I
I
I

GO TO NON-ALCOHOL USE DISORDERS, E.lO

?=inadequate information

l=absent or false
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E. 8

*REMISSION SPECIFIERS FOR DEPENDENCE*
THE FOLLOWING REMISSION SPECIFIERS CAN BE APPLIED ONLY AFTER NO CRITERIA
FOR DEPENDENCE OR ABUSE HAVE BEEN MET FOR AT LEAST ONE MONTH IN THE PAST.
Note: These specifiers do not apply if the individual is On
Agonist Therapy or In a Controlled Environment (next page).
EW.

Number of months prior to interview when last
had some problems with Alcohol
l

Early Full Remission: For at least one month, but less than
twelve months, no criteria for Dependence or Abuse have been met.

2

Early Partial Remission: ·For at least one month, but less than
twelve months, one or more criteria for Dependence or Abuse have
been met (but the full criteria for Dependence have not been met).

3

Sustained Full Remission: None of the criteria for Dependence
or Abuse have been met at any time during a period of twelve
months or longer.

4

Sustained Partial Remission: Full criteria for Dependence have
not been met for a period of twelve months or longer; however,
one or more criteria for Dependence or Abuse have been met.

?=inadequate information

l=absent or false
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Alcohol Dependence

(FEB 1996 FINAL)

E. 9

Check

if On Agonist Therapy:
The individual is on a prescribed
agonist medication (e.g., valium) and no criteria for
Dependence or Abuse have been met for that class of medication for at least the past month (except tolerance to,
or withdrawal from, the agonist).
This category also
applies to those being treated for Dependence using
a partial agonist or a mixed agonist/antagonist.

EY.

Check

if In A Controlled Environment: The individual is in an
environment where access to alcohol and controlled
substances is restricted and no criteria for Dependence
or Abuse have been met for at least the past month.
Examples are closely-supervised and substance-free jails,
therapeutic communities, and locked hospital units.

EZ.

?=inadequate information

l=absent or false
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*NON-ALCOHOL SUBSTANCE USE DISORDERS*

E. 10

(LIFETIME DEPENDENCE AND ABUSE)

~F

SCREENING QUESTIONS i2 AND i3 ARE BOTH ANSWERED "NO," CHECK HERE
AND SKIP TO THE NEXT MODULE.
IF SCREENER NOT USED OR IF QUESTION i2 OR QUESTION i3 WAS
ANSWERED "YES," CONTINUE:
Now I am going to ask you about
your use of drugs or medicines.
SHOW DRUG LIST TO SUBJECT.

!SCREEN Qi 21
I YES II NO I
II
I
I

_____-,-

1SCREEN Qi 3 I I
I YES II NO I I
I
II
I I
I
I
I __I_,F--,-.,N"'"O___,-T-0-BOTH:IGO TO NEXT
I MODULE

Have you ever taken any of
these to get high, to sleep
better, to lose weight, or to
change your mood?
REFERRING TO LIST ON NEXT PAGE, DETERMINE LEVEL OF DRUG USE USING GUIDELINES BELOW

I
I
I

GUIDELINES FOR RATING LEVEL
OF DRUG USE:
FOR EACH DRUG GROUP EVER USED:
-> IF STREET DRUG: When were you
I
using (DRUG) the most?
I
I
(Has there ever been a time
I
when you used it at least
I
ten times in a one-month
I
period of time?)
I
-> IF PRESCRIBED:
Did you ever
get hooked (become dependent)
on (PRESCRIBED DRUG) or take
much more of it than was
prescribed?

I
I

Either (1) or (2):
(1) has ever taken street drug
more than 10 times in a one-month
period

(2) reports becoming dependent
on a prescribed drug OR using
much more of it than was prescribed

-> IF DRUG GROUP NEVER USED OR USED ONLY ONCE, OR IF PRESCRIBED DRUG USED
I
AS DIRECTED, CIRCLE "1" FOR DRUG GROUP ON E.ll
I
-> IF DRUG GROUP USED AT LEAST TWICE, BUT LESS THAN LEVEL INDICATED ON
( 1), CODE "2" FOR DRUG GROUP ON E .11
-> IF DRUG GROUP USED AT LEVEL INDICATED IN ITEM(1} OR IF POSSIBLY
DEPENDENT ON PRESCRIBED DRUG (ITEM (2) IS TRUE), CODE "3" ON E.11.

I
I
I
I
I
I
I
I
I
I
I
I
I
I

I
I
I
I
I
I
I
I
I

--------------------------------------------------------------'

?=inadequate information

l=absent or false
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CIRCLE THE NAME OF EACH DRUG EVER
JSED (OR WRITE IN NAME IF "OTHER")

RECORD PERIOD OF HEAVIEST USE
(AGE OR DATE, AND DURATION)
AND DESCRIBE PATTERN OF USE

INDICATE LEVEL
OF USE (USE
GUIDELINES,
E. 10)

Sedatives-hypnotics-anxiolytics:
Quaalude, Seconal, Valium, Xanax,
Librium, barbiturates, Miltown,
Ativan, Dalmane, Halcion, Restoril, or other:

?

1

2

3

Cannabis: mar1JUana, hashish, THC,
or other:

?

1

2

3

Stimulants: amphetamine, "speed",
crystal meth, dexadrine, Ritalin,
"ice", or other:

?

1

2

3

Opioids: heroin, morphine, opium,
Methadone, Darvon, codeine, Percodan, Demerol, Dilaudid, unspecified or other:

?

1

2

3

Cocaine: intranasal, IV, freebase,
crack, "speedball," unspecified
or other:

?

1

2

3

?

1

2

3

?

1

2

3

Other: steroids, "glue," paint, inhalants, nitrous oxide ("laughing
gas"), amyl or butyl nitrate ("poppers"), nonprescription sleep or
diet pills, unknown, or other:

ANY DRUG GROUPS CODED "2"
OR "3"

1

I
IGOTO I
I NEXT
I
I MODULE I

1 nadequdte information

1~

drug never used

I
I

I
I
I
I
I
IEAA.
I
I
I
I EBB.
I
I
I
I
IECC.
I
I
I
I
I

Hallucinogens/PCP: LSD, mescaline,
peyote, psilocybin, STP, mushrooms, PCP ("angel dust"), Extasy,
MDMA, or other:

?~

11

2s 510 times in a month
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3

IEDD.
I
I
I
I
IEEE.
I
I
I
I
I
I
IEFF.
I
I
I
I
I
I
I EGG.
I
I
IEHH.
I
I

I
I
I

3•>10 times or dependence on prescribed drug
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IF AT LEAST THREE DRUG GROUPS USED
AND PERIOD OF INDISCRIMINANT USE
Behavior during the same 12-month
1
"EEMS LIKELY, ASK THE FOLLOWING:
period in which the person was repeatedly using at least three groups
You've told me that you've used
of substance (not including caffeine
(DRUG/ALCOHOL). Was there a
and nicotine), but no single substance
period where you were using a lot predominated.
Further, during this
of different drugs at the same
period, the Dependence criteria were
time and that it did not matter
(likely) met for substances as a group
what you were taking as long as
but not for any specific substance.
you could get high?
NOTE: IN CASES THAT INCLUDE PERIODS OF
INDISCRIMINATE USE AND OTHER PERIODS
OF USE OF SPECIFIC DRUGS, POLY DRUG
SHOULD BE CODED IN ADDITION TO SPECIFIC
DRUG COLUMNS.

2

3

I
I EII.

I
I
I
IUSE-11
I POLY II
IDROG II
ICOL- II
IUMN
II
--I
I
I
I

I
I
I

IF NO DRUG CLASSES WERE CODED "3" ON PREVIOUS PAGE (I.E., "2"S ONLY),
GO TO *SUBSTANCE ABUSE*, E. 22
FOR DRUG CLASSES CODED "3" CIRCLE THE APPROPRIATE COLUMNS ON PAGES E. 12 TO E. 18
Now I'm going to ask you some specific questions
about your use of (DRUGS CODED "3").
ASK EACH OF THE FOLLOWING QUESTIONS FOR
EACH DRUG CODED "3":
For (DRUG) ...
Have you often found that when you
started using (DRUG) you ended up
1sing much more of it than you
were planning to?
IF NO: What about using it
over a much longer period of
time than you were planning to?
NOTE: CRITERIA FOR DEPENDENCE
ARE IN A DIFFERENT ORDER THAN
IN DSM-IV.

SED/
HYPN/
ANX

CANN
ABIS

STIMU
LANTS

OPI
OID

coc
AINE

HALL/
PCP

POLY

OTHER

(3) The substance is often
taken in larger amounts OR

3

3

3

3

3

3

3

3

over a longer period than
was intended

2

2

2

2

2

2

2

2

1

1

1

1

1

1

1

1

?

?

?

?

?

?

?

?

EJJ.

EKK.

ELL.

EMM.

ENN.

EOO.

EPP.

EQQ.

?=inadequate information

l=absent or false
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E.

l3

Have you tried to cut down or stop
using (DRUG)?
IF YES: Have you ever actually
stopped using (DRUG) altogether?
(How many times did you try to
cut down or stop altogether?
IF UNCLEAR: Did you want to stop
or cut down?
IF YES: Is this something
you kept worrying about?
SED/
HYPN/
ANX
(4) There is a persistent
desire OR unsuccessful efforts
to cut down or control
substance use

CANN
ABIS

OPI
OID

coc
AINE

HALL/
PCP

POLY

OTHER

3

3

3

3

3

3

3

3

2

2

2

2

2

2

2

2

l

l

l

l

1

1

1

1

?

?

?

?

?

?

?

?

ESS.

ETT.

EUU.

EVV.

EWW.

EXX.

EYY.

ERR.

?=inadequate information

STIMU
LANTS

l=absent or false
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Have you spent a lot of time
using (DRUG) or doing whatever
fOU had to do to get it?
Did it
take you a long time to get back
to normal? (How much time? As long
as several hours?)
SED/
HYPN/
ANX
(5) A great deal of time is
spent in activities necessary
to obtain the substance, use
the substance, or recover from
its effects

CANN
ABIS

STIMU
LANTS

OPI
OID

coc
AINE

HALL/
PCP

POLY

OTHER

3

3

3

3

3

3

3

3

2

2

2

2

2

2

2

2

l

l

l

l

l

l

1

1

EZZ.

EAAA.

EBBS.

ECCC.

EDDD.

EEEE.

EFFF.

EGGG.

Have you had times when you would use
(DRUG) so often that you used (DRUG) instead
of working or spending time on hobbies
or with your family or friends?
SED/
HYPN/
ANX
(6) Important social, occupational, or recreational
activities given up or
reduced because of substance
use

STIMU
LANTS

OPI
OID

coc
AINE

HALL/
PCP

POLY

OTHER

3

3

3

3

3

3

3

3

2

2

2

2

2

2

2

2

1

1

1

1

1

1

1

1

?

?

?

?

?

?

?

?

EHHH.

?=inadequate information

CANN
ABIS

EIII.

l=absent or false
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E.

15

IF NOT ALREADY KNOWN:
Has (DRUG)
caused psychological problems, like
laking you depressed?
IF NOT ALREADY KNOWN:
Has (DRUG)
ever caused physical problems or
made a physical problem worse?
IF YES TO EITHER OF ABOVE:
Did
you keep on using (DRUG) anyway?
SED/
HYPN/
ANX
(7) The substance use is contin3
ued despite knowledge of having
had a persistent or recurrent
2
physical or psychological
problem that is likely to have
1
been caused or exacerbated by
by the substance (e.g.,
?
recurrent cocaine use despite
recognition of cocaine-related EPPP.
depression)

CANN
ABIS

STIMU
LANTS

OPI
OID

coc
AINE

HALL/
PCP

POLY

OTHER

3

3

3

3

3

3

3

2

2

2

2

2

2

2

1

1

1

1

1

1

1

?

?

?

?

?

?

?

EQQQ.

ERRR.

ESSS.

ETTT.

EUUU.

EVVV.

EWWW.

Have you found that you needed to
use a lot more (DRUG) in order
:o get high than you did when
you first started using it?
IF YES:

How much more?

IF NO: What about finding that
when you used the same amount,
it had much less effect than
before?

Tolerance, as defined by
either of the following:
(1)

(a) a need for markedly increased amounts of the substance to achieve intoxication or desired effect
(b) markedly diminished effect
with continued use of the
same amount of the substance

SED/
HYPN/
ANX

CANN
ABIS

STIMU
LANTS

OPI
OID

coc

HALL/

AINE

PCP

POLY

OTHER

3

3

3

3

3

3

3

3

2

2

2

2

2

2

2

2

1

1

1

1

1

1

1

1

?

?

?

?

?

?

?

?

EXXX.

EYYY.

EZZZ.

EAAAA.

EBBBB.

ECCCC. EDDDD.

EEEEE.

?=inadequate information

!=absent or false
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THE FOLLOWING ITEM MAY NOT APPLY TO
:ANNABIS AND HALLUCINOGENS/PCP
Have you ever had withdrawal symptoms,
that is, felt sick when you cut down
or stopped using (DRUG)?
IF YES: What symptoms did
you have? REFER TO LIST OF
WITHDRAWAL SYMPTOMS ON E. 17
IF HAD WITHDRAWAL SXS: After not
using (DRUG) for a few hours or
more, have you often used it to keep
yourself from getting sick with
(WITHDRAWAL SXS)?
What about using (DRUG IN SAME
GROUP) when you were feeling
sick with (WITHDRAWAL SXS) so
that you would feel better?
(2) Withdrawal, as manifested
by either of the following:
(a) the characteristic
withdrawal syndrome for the
substance
(b) the same (or a closely
related) substance is taken
to relieve or avoid withdrawal symptoms

SED/
HYPN/
ANX

CANN
ABIS

STIMU
LANTS

OPI

coc

OID

AINE

HALL/
PCP

POLY

OTHER

3

3

3

3

3

3

3

3

2

2

2

2

2

2

2

2

1

1

1

1

1

1

1

1

?

?

?

?

?

?

?

?

EFFFF.

EGGGG.

EHHHH.

EIIII.

EJJJJ.

EKKKK.

ELLLL.

MMMM.

?=inadequate information

l=absent or false
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E.

17

LIST OF WITHDRAWAL SYMPTOMS (FROM DSM-IV CRITERIA)
Listed below are the characteristic withdrawal symptoms for those classes of
psychoactive substances for which a withdrawal syndrome has been identified.
(NOTE: A specific withdrawal syndrome has not been identified for CANNABIS
AND HALLUCINOGENS/PCP). Withdrawal symptoms may occur following the cessation
of prolonged moderate or heavy use of a psychoactive substance or a reduction
in the amount used.
SEDATIVES, HYPNOTICS, AND ANXIOLYTICS:
Two (or more) of the following, developing within several hours to a few days
after cessation (or reduction) of sedative, hypnotic, or anxiolytic use, which
has been heavy and prolonged:
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)

autonomic hyperactivity (e.g., sweating or pulse rate greater than 100)
increased hand tremor
insomnia
nausea or vomiting
transient visual, tactile, or auditory hallucinations or illusions
psychomotor agitation
anxiety
grand mal seizures

STIMULANTS/COCAINE
Dysphoric mood AND two (or more) of the following physiological changes,
developing within a few hours to several days after cessation (or reduction of
substance use which has been heavy and prolonged) :
1)
(2)
(3)
(4)
(5)

fatigue
vivid, unpleasant dreams
insomnia or hypersomnia
increased appetite
psychomotor retardation or agitation

OPIOIDS:
Three (or more) of the following, developing within minutes to several days after
cessation (or reduction) of opioid use which has been heavy and prolonged (several weeks
or longer) or after administration of an opioid antagonist (after a period of opioid use):
(1)
( 2)
(3)
(4)
(5)
(6)
(7)
(8)
( 9)

dysphoric mood
na"usea or vomiting
muscle aches
lacrimation or rhinorrhea
pupillary dilation, piloerection, or sweating
diarrhea
yawning
fever
insomnia
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IF UNKNOWN: When did (SXS CODED
"3" ABOVE) occur?
(Did they all
tappen around the same time?)

SED/
HYPN/
ANX

SUBSTANCE DEPENDENCE At least 3
items are code "3" AND items
occurred within the same twelvemonth period
I
Indicate type:
With Physiological Dependence
(current evidence of tolerance or
withdrawal)
Without Physiological Dependence
(no current evidence of tolerance
or withdrawal)

CANN
ABIS

E. 18

(FEB 1996 FINAL)

STIMU
LANTS

OPI
OID

coc
AINE

HALL/
POLY
PCP

OTHER

3

3

3

3

3

3

3

3

XX

XX

XX

XX

XX

XX

XX

XX

3

3

3

3

3

3

3

3

1

1

1

1

1

1

1

1

XX

XX

XX

XX

XX

XX

XX

XX

I
FOR EACH CLASS CODED "3", GO TO *CHRONOLOGY*, E. 19
Fewer than 3 items coded "3"

1

1

1

1

1

1

XX

XX

XX

XX

XX

XX

I
GO TO *LIFETIME SUBSTANCE ABUSE*, E. 23
AND ASK THE FOUR ABUSE ITEMS FOR EACH
DRUG CLASS CODED "1" ABOVE.
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*CHRONOLOGY*
·F UNCLEAR:
During the past month,
.1ave you used (DRUG) at all?
IF YES: Has your (DRUG) use
caused you any problems?
(How about being high when you were
at school or work, or taking care of
children? How about missing something important because of being high
or hung over? How about using (DRUG)
while you were driving? How about
getting into trouble with the law
because of your use of (DRUG)?)
NOTE: YOU MAY NEED TO REFER TO
ABUSE CRITERIA, PAGE E. 23.

SED.HYPN.- CANN
ABIS
ANX.

Full criteria for Dependence met
at any time in past month (or
never had a month without symptoms of Dependence or Abuse
since onset of Dependence)

STIMU
LANTS

OPI
OID

cocAINE

HALLPCP

3

3

3

3

3

3

XX

XX

XX

XX

XX

XX

OTHER

3

3

XX

XX

---

I
FOR EACH CLASS CODED "3" INDICATE
SEVERITY SPECIFIERS ON FOLLOWING PAGE

No symptoms of Dependence or
Abuse in past month or meets
partial criteria after one
month without symptoms

POLY

1

1

1

1

1

1

XX

XX

XX

XX

XX

XX

I
FOR EACH CLASS CODED "1" INDICATE
REMISSION SPECIFIERS E. 21
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FOR EACH DRUG CLASS WITH CURRENT DEPENDENCE, CODE SEVERITY:
JSE SCALE BELOW TO RATE SEVERITY
OF DEPENDENCE FOR WORST WEEK OF
PAST MONTH (Additional questions
about the effect of the substance
on social and occupational
functioning may be necessary)

SED.HYPN.- CANN
ABIS
ANX.

STIMU
LANTS

OPI
OID

cocAINE

HALLPCP

POLY

OTHER

1

1

1

1

1

1

1

1

2

2

2

2

2

2

2

2

3

3

3

3

3

3

3

3

1

Mild:

Few, if any, symptoms in excess of those required
to make the diagnosis, and the symptoms result in
no more than mild impairment in occupational functioning or in usual social activities or relationships
with others.

2

Moderate: Symptoms or functional impairment between "mild" and
"severe."

3

Severe:

Many symptoms in excess of those required to make the
diagnosis, and the symptoms markedly interfere with
occupational functioning or with usual social activities
or relationships with others.
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*REMISSION SPECIFIERS*
THE FOLLOWING REMISSION SPECIFIERS CAN BE APPLIED ONLY AFTER NO CRITERIA
FOR DEPENDENCE OR ABUSE HAVE BEEN MET FOR AT LEAST ONE MONTH IN THE PAST.
Note: these specifiers do not apply if the individual is
On Agonist Therapy or In a Controlled Environment.
(See page E 9 for definitions of these specifiers).
1

Early Full Remission: For at least one month, but for less than
twelve months, no criteria for Dependence or Abuse have been met.

2

Early Partial Remission: For at least one month, but less than
twelve months, one or more criteria for Dependence or Abuse have
been met (but the full criteria for Dependence have not been met).

3

Sustained Full Remission: None of the criteria for Dependence
or Abuse have been met at any time during a period of twelve
months or longer.

4

Sustained Partial Remission: Full criteria for Dependence have
not been met for a period of twelve months or longer; however,
one or more criteria for Dependence or Abuse have been met

USE SCALE BELOW TO INDICATE TYPE
OF REMISSION

SED.HYPN.- CANN
ANX.
ABIS

STIMU
LANTS

OPI
OlD

cocAINE

HALLPCP

POLY

OTHER

Early Full Remission

1

1

1

1

1

1

1

1

Early Partial Remission

2

2

2

2

2

2

2

2

Sustained Full Remission

3

3

3

3

3

3

3

3

Sustained Partial Remission

4

4

4

4

4

4

4

4

XX

XX

XX

XX

XX

XX

XX

XX

Check if On Agonist Therapy
Check if In a Controlled Environment
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*LIFETIME SUBSTANCE ABUSE*
->FOR EACH DRUG CLASS CODED "2" (I.E., DRUGS USED
AT A LEVEL OF <10 TIMES IN ANY ONE MONTH), START
THIS SECTION WITH THE FOLLOWING INTRODUCTION:
Now I'm going to ask you some specific
questions your use of (DRUGS CODED "2").
-> FOR EACH DRUG CLASS CODED "3" ON PAGE E. 18
THAT DID NOT MEET CRITERIA FOR DEPENDENCE.
Now I'd like to ask you a few
more questions about your use
of (DRUGS CODED "3" THAT DID
NOT MEET CRITERIA FOR DEPENDENCE).
SUBSTANCE ABUSE CRITERIA
A. A maladaptive pattern of
substance use leading to
clinically significant impairment or distress, as manifested by one (or more) of the
following occurring within a
twelve month period:

Have you ever missed work or school
because you were intoxicated, high,
or very hung over?
(How often? What
about doing a bad job at work or failing
courses at school because of your [DRUG]
use?)
IF NO: What about not keeping your
house clean or not taking proper
care of your children because of
your (DRUG) use?
IF YES TO EITHER OF ABOVE:
How often?
(Over what period of time?)
(1) Recurrent substance use
resulting in a failure to fulfill major role obligations at
work, school, or horne (e.g.,
repeated absences or poor
work performance related to
substance use; substancerelated absences, suspensions,
or expulsions from school;
neglect of children or household)

SED/
HYPN/
ANX

CANN
ABIS

STIMU
LANTS

OPI
OID

coc
AINE

HALL/
PCP

POLY

OTHER

3

3

3

3

3

3

3

3

2

2

2

2

2

2

2

2

1

1

1

1

1

1

1

1

XX

XX

XX

XX

XX

XX

XX

XX
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Have you ever used (DRUG) in a situation
in which it might have been dangerous
to be using (DRUG) at all?
(Have you ever driven while you were
really too high to drive?)
IF YES AND UNKNOWN:
How often?
(Over what period of time?)
SED/
HYPN/
ANX

CANN
ABIS

STIMU
LANTS

OPI
OID

coc
AINE

HALL/
PCP

POLY

OTHER

(2)

Recurrent substance use
in situations in which it is
physically hazardous (e.g.,
driving an automobile or
operating a machine when
impaired by substance use)

3

3

3

3

3

3

3

3

2

2

2

2

2

2

2

2

1

1

1

1

1

1

1

1

XX

XX

XX

XX

XX

XX

XX

XX

STIMU
LANTS

OPI
OID

AINE

HALL/
PCP

POLY

OTHER

Has your use of (DRUG) ever gotten you
into trouble with the law?
IF YES AND UNKNOWN:
How often?
(Over what period of time?)
SED/
HYPN/
ANX
(3) Recurrent substancerelated legal problems (e.g.,
arrests for substancerelated disorderly
conduct)

CANN
ABIS

coc

3

3

3

3

3

3

3

3

2

2

2

2

2

2

2

2

1

1

1

1

1

1

1

1

XX

XX

XX

XX

XX

XX

XX

XX
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IF NOT ALREADY KNOWN: Has your
use of (DRUG) caused problems with
'ther people, such as with
family members, friends, or
people at work? (Did you ever
get into physical fights or
bad arguments about your
drug use?)
IF YES: Did you keep on using
(DRUG) anyway? (Over what period
of time?)
(4) Continued substance use
despite having persistent or
recurrent social or interpersonal problems caused or
exacerbated by the effects
of the substance (e.g.,
arguments with spouse about
consequences of intoxication,
physical fights)

SED/
HYPN/
ANX

FOR DRUG CLASSES WITH LIFETIME
ABUSE (I.E., CODED "3" ON PRIOR
ITEM):
Has some symptoms of Substance
Abuse in past month
IF UNCLEAR: When was the last
time you had problems with
(SUBSTANCE)?

STIMU
LANTS

OPI
OID

coc
AINE

HALL/
PCP

POLY

OTHER

3

3

3

3

3

3

3

3

2

2

2

2

2

2

2

2

1

1

1

1

1

1

1

1

XX

XX

XX

XX

XX

XX

XX

XX

STIMU
LANTS

OPI
OID

AINE

SED/
HY.PN/
"AN X
SUBSTANCE ABUSE (LIFETIME):
At least one "A" item
is coded "3"

CANN
ABIS

CJWN
ABIS

coc

HALL/
PCP

POLY

OTHER

3

3

3

3

3

3

3

3

1

1

1

1

1

1

1

1

XX

XX

XX

XX

XX

XX

XX

XX

POLY

OTHER

SED/
HYPN/
ANX

CANN
ABIS

OPI

STIMU
LANTS

oro

coc
AINE

HALL/
PCP

3

3

3

3

3

3

3

3

1

1

1

1

1

1

1

1

XX

XX

XX

XX

XX

XX

XX

XX
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Addiction Severity Index (AS/) Instrument,
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ADDICTION SEVERITY INDEX
FEMALE VERSION
AS I-F
SEVERITY RATINGS

INSTRUCTIONS
/.

Leave no blanks. Where appropriate code items:
X=question not answered
N=question not applicable
Use only one character per item.

2.

Item numbers circled are to be asked at follow-up. Items with
an asterisk are cumulative and should be rephrased at followup (See Manual).

3.

Space is provided after sections for additional pertinent
comments.

The severity ratings are interviewer estimates of the patient's
need for additional treatment in each area. The scales range
from 0 (no treatment necessary) to 9 (treatment needed to
intervene in life-threatening situation). Each rating is based
upon the patient's history ofproblem symptoms. present
condition and subjective assessment of her treatment needs in
a given area. For a detailed description of severity ratings'
derivation procedures and conventions, see manual.

IDENTIFICATION INFORMATION
LAST 4 DIGITS OF SOCIAL SECURITY NUMBER:
INTERVIEWER CODE NUMBER: _ _ __
DATE OF ADMISSION: _ _ _ _ _ _ DATE OF INTERVIEW: _ _ _ _ __
TIME BEGUN: _ _ _ _ : _ _ _ _ !=A.M. 2=P.M. (circle one)
GENDER
!=Male 2=Female
CLASS: _ _ !=Intake 2=Follow-up CONTACT CODE: _ _ !=In Person 2=Phone
SPECIAL:
!=Terminated 2=Refused 3=Unable to respond

Severity Profile
0

I
PATIENTS RATING SCALE
O=Not at all
l=Slightly
2=Moderately
3=Considerably
4=Extremely

2
3
4

5

6
7

-·

·-·

8

INTERVIEWER SEVERITY RATING
0-1 No real problem
2-3 Slight problem
4-5 Moderate problem
6-7 Considerable problem
8-9 Extreme problem

9
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E
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PREPARED BY ALFRED FRIED, Ph.D.

1.0._
GENERAL INFORMATION

N~

-----------------------------------------------------------------

CURRENT ADDRESS

GEOGRAPlllC CODE

l. How long have you lived at this address?
Years
2. Is this residence owned by you or your family?__

Months
O=No l=Yes

3. Whatisyourdateofbirth? _ _ _ _ ! _ _ _ _ ! _ _ _ _
4. In what country were you born?_ _ _ _ _ _ _ _ _ _ _ code: _ _ __
4a If other than U.S., how many years have you lived in U.S.? _ _ __
S. In what country was your mother born?_ _ _ _ _ _ _ _ code: _ _ __
6. In what country was your father born?_ _ _ _ _ _ _ _ code: _ _ __
7. What race do you consider yourself to be? _ _ _ _ __
1:White (not of Hispanic origin)
2:Black (born in U.S.)
J=Black (other)
4"' Native American
S: Alaskan Native
6: Asian of Pacific Islander

7= Hispanic - Mexican
8= Hispanic - Dominican
9= Hispanic - Puerto Rican
10= Hispanic- Cuban
11 = Other Hispanic
12= O t h e r - - - - - - - - - - - -

8. What is the rust language that you learned?--!=English
2=Spanish
J=French
4=Haitian Creole

S=Portuguese
6=Portuguese/Cape Verdean
7=0ther
9=Unknown!Don't know

9. What language do you usually speak? _ __
!=English
2=Spanish
3=French
4=Haitian Creole

S=Portuguese
6=Portuguese/Cape Verdean
7=0ther
9:Unknown!Don't know

10. What language do you prefer to speak? _ __
!=English
2=Spanish
3=French
4=Haitian Creole

S=Portuguese
6=Portuguese/Cape Verdean
7=0ther
9=Unknown/Don't know
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11. Do you have a particular religion that you follow? _ __
l =Protestant
2=Catholic
3=Jewish

4=Islarnic
5=0ther - - - - 6=None

12. Have you been in any kind of a controlled residential setting like a hospital or a jail (but not a shelter) in the
past 30 days?
O=No l=Yes
If YES, cheek all that apply:
For each setting, indicate number of days
Yes/No
O=No l=Yes

a Jail
b.
c.
d.
e.

Alcohol or drug treatment
Medical treatment
Psychiatric treatment
Other

13. Who is the head of your household?
l=Self
2=Spouse/Partner
3=Parent

4=Gt-andparent
5=0ther Relative
6=0ther

14 .. What is the occupation of the head of household?
1=Higher Executives; Large Proprietors; Major Professionals
2=Business Managers; Medium Proprietors: Lesser Professionals
3=Administrative Personnel; Small Proprietors; Minor Professionals
4=Clerical!Sales Workers; Technicians
5:eSkilled Manual Employees
6=Machine Operators; Semi-skilled Employees
7=Unskilled Labor
8=Disabled
9=Welfare
IO=None; No Work History

15. How many times have you been pregnant?

_ _ _ _ __

16. How many times have you actually given birth?
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#of days
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17. How old were you when the fU"St baby was born?

_ _ __

18a.Starting with the youngest child, what is the sex and birthdate of each of your children?
NOTE SEX IN COLUMN A; ENTER BIRTIIDA TES (COLT TMN B) IN CHART BELOW.
FOR EACH CHILD ASK:
l8b. Where is
living now? ENTER CODE IN COLUMN C Of CHART;
ASK FOR ADDITIONAL INFORMATION FOR CODES 5, 6, 7.
O=With patient
1=Care of family member
2=Foster care
3=Fathers's care
(A)

4=Adopted
S=Institution
6=Died ( W h e n ) - - - - - 7=0ther ________________
(C)

(B)

l=Male
2=Female

..

______
SEX

2------3. _ _ _ _ __

4. _ _ _ _ __
5. _ _ _ _ __

6 _ _ _ _ _ __

7 _ _ _ _ _ __

s_______
9. _ _ _ _ __

10. _ _ _ _ __

WHERE LIVING

DOB

-'--'-'--'-

-'--'-'--'-'--'-'--'-'--'-'--'-'--'-

19. Are there other children living with you now that you take care of? NOTE SEX AND AGES:
SEX
(l=MALE 2=FEMALE)

AGE
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MEDICAL STATUS
I. How many times in your life have you been hospitalized for medical
problems? (INCLUDE ODs, DTs; EXCLUDE DETOX, PREGNANCY) _ _ _ __
2. How long ago was your last hospitalization for a physical problem
(NOT PREGNANCY)? _ _ _ _ _ _ __
Years
Months
3. Do you have any chronic medical problems which continue to interfere with
yourlife? _ _ _ O=No l=Yes _ _ _ _ _ _ _ __
Specify
4. Have you ever had any of the following health problems? USE STREET TERMS
AS NEEDED TO BE SURE TIIE PATIENT UNDERSTANDS TIIE QUESTION.
O=No l=Yes
Hepatitis
Chlamydia
Syphilis
Gononbea
Pelvic Inflammatory Disease

HIV+
AIDS

5. Have you ever had a fit or a seizure? _ _ _ O=No

1=Yes

6. Are you taking any prescribed medication on a regular basis for a physical
problem? _ _ _ O=No l=Yes
7. Do you receive a pension for a physical disability? (EXCLUDE PSYClllATRIC
DISABILITY) _ _ O=No l=Yes _ _ _ _ _ _ _ _ __
Specify
8. How many days have you experienced medical problems in the past 30?
(NOT PREGNANCY RELATED) _ _ __
FOR QUESTIONS 9 & I 0 PLEASE ASK PATIENT TO USE TIIE PATIENTS RATING SCALE
9. How troubled or bothered have you been by these medical problems in the
past 30 days? _ __
10. How important to you NOW is treatment for these medical problems? _ __
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INTERVIEWER SEVERITY RATING
11. How would you rate the patient's need for medical treatment?
CONFIDENCE RATINGS
Is the above information significantly distorted by:
12. Patient's misrepresentation? ___ O=No l=Yes
13. Patient's inability to understand? ___ O=No 1=Yes

COMMENTS

EMPLOYMENT/SUPPORT STATUS
1. Educationcomp1eted (GED=l2 years) _ _ __

Years

Months

2. Training or technical education completed
Months
3. Do you have a profession, trade or skill?
O=No
l=Yes _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __
Specify
4. Do you have a valid driver's license? ___ O=No 1=Yes

S. Do you have an automobile available for use?
(ANSWER NO IF NO VALID DRIVER'S LICENSE)

O=No l=Yes

6. How long was your longest full-time job?
Years

Months

7. Usual (orlast) occupation.
(Specify in detail)
S. Does someone contribute to your support in any way?

O=No l=Yes

(Sa AND Sb APPLY ONLY IF ITEMS IS YES)
Sa Who is that person? (RELATIONSHIP) _ _
1=Spouse/partner
4=Grandparent
S=Other relative
2=Parent/foster parent
3=Brother/sister
6=Unrelated other
Sb. Does this constitute the majority of your support? ___ O=No I=Yes
9. Usual employment pattern. past 3 years. _ __
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I =full time (40 hrslweek)
2=part time (regular hours)
3=part time (irregular, daywork)
4=student

S=service
6=retired/disability
?=unemployed
8=in controlled environment

10. How many days were you paid for working in the past 30? _ _ _ _ __
(INCLUDE "UNDER 1HE TABLE" WORK)

How much money did you receive from the following sources in the past 30 days?
11. Employment (net income)
12. Unemployment compensation
13. Welfare (DPA) (AFDC)
14. WlC
15. Food stamps
16. Pension, benefits or social security
17. Mate, family or friends
(Money for personal expenses)
18. Illegal activities
19. How many people depend on you for the majority of their food, shelter,
etc.?
20. How many days have you experienced employment problems in the past 30?

FOR QUESTIONS 21 & 22 PLEASE ASK PATIENT TO USE THE PATIENT'S RATING SCALE
21. How troubled or bothered have you been by these employment problems in the past 30 days?
22. How important to you NOW is counseling for these employment problems?

INTERVIEWER SEVERITY RATING
23. How would you rate the patient's need for employment or support
counseling? _ __

CONFIDENCE RATINGS
Is the above information significantly distorted by:
24. Patient's misrepresentation? _ _ _

O=No l=Yes

25. Patient's inability to understand? O=No l=Yes

COMMENTS
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DRUG/ALCOHOL USE
LIFETIME USE
MONTHS

PAST30DAYS

1. Alcohol, any use
2. Alcohol, to intoxication
3. Heroin, total
4. Heroin, snorting

S. Heroin, shooting
6. Methadone, illegal
7. Other opiates/analgesics
(Percodan, Dialudid, opium,etc.)
8. Barbiturates, all routes
(Seconal "reds", etc.)
9. Barbiturates, oral
~0.

Barbiturates, shooting

11. Other sedatives!hypnoticsltranq. _ _ _ _ __
(Valium, Librium, Xanax, etc.)
12. Cocaine, total
13.Cocaine,snorting

14. Cocaine, shooting
1S.Cocaine,~basing

16. Crack Cocaine

17. All "speed"
18. Amphetamine, oral
(Dexedrine,"Bennies,
Black Beauties, etc)
SPECIFY
19. Amphetamine, shooting

'Continued)
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DRUG/ALCOHOL USE
LIFETIME USE
MONTHS

PAST 30 DAYS

AGE OF 1ST USE

20. Methamphetamine snorting
(Methedrine, "crystal meth")
21. Methamphetamine shooting
22. "Ice" smoking
23. Marijuana, hashish
THC, any cannabis
Specify - - - - - - - 24. Hallucinogens
(LSD, PCP,
mescaline. etc.)
Specify - - - - - - - 25. lnhalants,(glue gas,
solvents, etc)
Specify - - - - - - - - 26. More than one
substance per day
(including alcohol)

Note: Heroin, snorting and Heroin, shooting may add up to more than Heroin, total because both forms of administration may
be used on some or all of the same days or months of use. Detailed questioning may be necessary to determine these
differences. This also holds true for Barbiturates, all routes, Cocaine, total and All "speed".

COMMENTS
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19. Which substance is the major problem?
OO=No problem
PLEASE CODE AS ABOVE, OR
55=Alcohol & Drug (Dual addiction)
66=Polydrug
WHEN NOT CLEAR, ASK PATIENT

20. How long was your last period of voluntary abstinence from this
major substance? _ _ _ _ _ _ (OO=Never abstinent)
Months
21. How many months ago did this abstinence end?
(OO=Still abstinent, 99= No clean period)
22. How many times have you:
Had alcohol d.t.'s Chorrors")
Overdosed on drugs

23. In the past 30 days, how often did you have anything with alcohol to
drink like beer, wine, or liquor?
!=Never
2= 1 time per month or less
3=2-3 times per month
4=1-2 times per week

5=3--l times per week
6=nearly every day
7=0nceaday
8=Twice a day or more

23b. On those days, how much did you have usually'? _ _ _ _ __
(NUMBER OF DRINKS)
24. Doyousmokecigarettes? _ _ _ O=No l=Yes
25. About how many cigarettes per day did you smoke during the past 30 days? _ _ _ _ __
26. How many times during the past 30 days did you stay up past 4 am. because you were using drugs or alcohol?
O=None
3=Three times
!=Once
4=4 or more times
2=Twice
27. Do you sleep until after 11 am. most days?

O=No 1=Yes

27a IF YES, Is this because of your working hours? _ _ _ O=No !=Yes
28. How many times in your life have you been treated for:
Alcohol abuse:
Drug abuse:
29. How many of these were detox only?
Alcohol
Drug
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30. How much would you say you spent during the past 30 days on:
Alcohol
Drugs
31. How many days have you been treated in an outpatient setting for alcohol or drugs in the past 30 days?
(INCLUDE NA, AA) _ _ _ _ .
32. How many days in the past 30 have you experienced:
Alcohol problems
Drug problems

FOR QUESTIONS 33 & 34 PLEASE ASK PATIENT TO USE THE PATIENT'S RATING SCALE
33. How troubled or bothered have you been in the past 30 days by these:
Alcohol problems
Drug problems
34. How important to you NOW is treatment for these:
Alcohol problems
Drug problems

INTERVIEWER SEVERI1Y RATING
35. How would you rate the patient's need for treatment for:
Alcohol abuse
Drug abuse

CONFIDENCE RATINGS
Is the above information significantly distorted by:
36. Patient'smisrepresentation? _ _ O=No l=Yes
37. Patient's inability to understand? _ _ O=No l=Yes

COMMENTS
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LEGAL STATUS
1. Was this admission prompted or suggested by the criminal justice system
O=No l=Y~
Gudge, probation/parole officer, etc.)?

2. Are you on probation or parole now?

O=No l=Yes

How many times in your life have you been ~ed

and~ with the

following:

3. shoplifting
4. vandalism

S. parole/probation violation
6. drugcharges
7. forgery
8. weapons offense
9. burglary, larceny, B & E
10. robbery
II. assault
12. arson

13.rape
14. homicide/manslaughter
IS a prostitution
ISb.contempt of court
ISc.other- S p e c i f y - - - - - - - - -

16. How many of these charges resulted in convictions? - - - - - - - How many times in your life have you been charged with the following:
17. Disorderly conduct, vagrancy, public intoxication?
18. Driving while intoxicated?
19. Other major driving violation (reckless driving, speeding, no license, etc.)?
20. How many months were you incarcerated in your life?
21. How long was your last incarceration?
Months
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22.~atw~itfur?
----------------------------------------------------------------------(USE CODE 3- 15, 17- 19. IF MULTIPLE CHARGES, CODE MOST SEVERE)
Are you presently awaiting charges, trial or sentence? ___ O=No I =Yes
24. What for? (If multiple charges, use most severe) ______
25. How many days in the p~t 30 were you detained or incarcerated?
26. How many days in the p~t 30 have you engaged in illegal activities for profit? ______

FOR QUESTIONS 27 & 28 PLEASE ASK PATIENT TO USE PATIENT'S RATING SCALE
27. How serious do you feel your present legal problems are? (EXCLUDE CIVll.. PROBLEMS)
28. How important to you NOW is counseling or referral for these legal problems?

INTERVIEWER SEVERITY RATING
29. How would you rate the patient's need for legal services or counseling? _ __

CONFIDENCE RATINGS
Is the above information significantly distorted by:

30. Patient's misrepresentation? ___ O=No I=Yes
31. Patient's inability to understand?

O=No I=Yes

COMMENTS
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FAMILY HISTORY
Have any of your relatives had what you would call a significant drinking,
drug use or psych problem- one that did or should have led to treatment?
Father's Side
Ale

Mother's Side
Ale Drug Psy

Drug

Psy

Ale

Grandmother

Grandmother

Brother #l

Grandfather

Grandfather

Brother#2

Mother

Father

Sister #1

Aunt

Aunt

Sister #2

Uncle

Uncle

Siblings
Drug

Psy

Direction: Place "0" in relative category where the answer is clearly no for all relatives in the category; "1" where the answer is
clearly Yes for anv relative within the category; "X" where the answer is uncertain or"! don't know" and "N" where there never
was a xelatjve from that category. Code most problematic relative in cases of multiple members per category.

FAMILY /SOCIAL RELATIONSHIPS
l. Marital Status
!=Married
2=Remarried
3=Widowed

4=Separated
5=Divorced
6=Never Married

2. How long have you been in this marital status? (IF NEVER MARRIED, SINCE AGE 18)
Years

Months

3. Are you satisfied with this situation?
O=No !=Indifferent 2=Yes
4. Have you been homeless at all in the past 30 days?

O=No !=Yes

4a Where did you mostly stay during that homeless period?
!=Shelter
2=With friends
3=!n a car

4=In a building
5=0utside
6=0ther_______________________

5. Usual living arrangements (past 3 years)
!=With sexual partner and children
2=With sexual partner alone
3=With children alone
4=With parents
5=With family

6=With friends
7=Alone
8=Controlled envirorunent (residential setting like a jail or hospital)
9=No stable arrangements (include shelter)
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6. How long have you lived in these arrangements? (IF Willi PARENTS OR FAMILY, AND ALWAYS HAS BEEN,
SINCE AGE 18) - - - - - - - Years
Months
7. Are you satisfied with these arrangements (particularly the people you are living with)?
O=No l=lndifferent
2=Yes
8. Do you live with anyone who has a drug and/or alcohol problem? _ __
O=No l=Yes
9. With whom do you spend most of your free time?
l=Family
2=Friends
3=Alone
10. Are you satisfied with spending your free time this way?
O=No l=lndifferent
2=Yes
11. How many close friends do you have?
Direction for 11a- 20: Place "0" in relative category where the answer is clearly no fOr all relatives in the cate~ory: "1"
where the answer is clearly yes for aav relative within the category: 'X" where the answer is uncertain or "I don't know" and
"N" where there never was a relative from that cate~ory.

11 a. Would you say you have had close, long lasting, personal relationships
with any of the following people in your life:
O=No l=Yes

PAST30DAYS

IN YOUR LIFE

a. Mother
b. Father
c. Brothers/Sisters
d. Sexual Partner/Spouse
e. Children
f. Friends
12. How much do you feel cared about, liked or loved by the significant
people in your life (such as family members, friends, and so on)?
O=Not at all

1= A little

2=Somewhat

13. To what degree do you feel you need more emotional support?
O=Not at all

1= A little

2=Somewhat

3=A lot
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Have you had significant periods in which you have experienced serious problems getting along with:

O=No l=Yes

PAST30 DAYS

IN YOUR LIFE

14. Mother
15. Father
16. Brothers/Sisters
17. Sexual Partner/Spouse
18. Children
19. Other significant family

20. Close friends
21. Neighbors
22. Co-Workers

Did any of these people (14-22) or any others (strangers, acquaintances) abuse you:
O=No I=Yes
23.

Emotionally (make you feel bad through
harsh words, humiliation, manipulation)
(DO NQI INCLUDE VERBAL ABUSE BY
STRANGERS)

24.

Physically (cause or threaten to cause
physical hann such as: slapping,
punching, kicking, hitting with an
object, assaulting with a knife
or other weapon, etc.)

25.

Sexually (rape, forced sexual advances
or non-consensual sexual acts)

26.

Sexual Harassment (inappropriate
physical contact, stalking,
using threats to secure sexual
contact, etc.)

PAST30DAYS

IN YOUR LIFE

27. How many days in the past 30 have you had serious conflicts (problems which threaten your relationship):
A. with your family?
B. with other people? (excluding family)
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FOR QUESTIONS 28 - 31 PLEASE ASK PATIENT TO USE PATlENT'S RATING SCALE
How troubled or bothered have you been in the past 30 days by these:
28.

Family problems

29.

Social problems
How important to you NOW is treatment or counseling for these:

30.

Family problems

3 I.

Social problems

INTERVIEWER SEVERITY RATING
32.

How would you rate the patient's need for family and/or social counseling'?

CONFIDENCE RATINGS
Is the above information significantly distorted by:
33.

Patient's misrepresentation? _ _ _ O=No !=Yes

34.

Patient's inability to understand'?

O=No l=Yes

COMMENTS
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PSYCHIATRIC STATUS
l.

How many times have you been treated for any psychological or emotional problems?

a In a hospital
b. As an outpatient or private patient
2.

Do you receive a pension for a psychiatric disability? _ _ _ O=No 1=Yes
Have you had a significant period (that was not a direct result of drug/alcohol use), in which you have:
O=No l=Yes

PAST30DAYS

3.

Experienced serious depression ..

4.

Experienced serious anxiety or tension

5.

Experienced hallucinations

6.

Experienced trouble understanding,
concentrating or remembering

7.

Experienced trouble controlling
violent behavior

8.

Experienced serious thoughts of suicide

9.

Attempted suicide

10.

Been prescribed medication for any
psychological/emotional problem

1l.

Experienced anorexia, bulimia, or
other eating disorders

12.

In the past 30 days, to what degree were you bothered by past experiences involving:
O=Not at all

1= A little

2=Somewbat

IN YOUR LIFE

3=A lot

a Physical abuse
b. Sexual abuse

c. Rape
d. Sexual harassment

13. How many days in the past 30 have you experienced these psychological or emotional problems?
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FOR QUESTIONS 14 & 15 PLEASE ASK PATIENT TO USE THE PATIENT'S RATING SCALE
14.

How much have you been troubled or bothered by these psychological or emotional problems in the
past 30 days? _ __

15.

How important to you NOW is treatment for~ese psychological problems?

THE FOLLOWING ITEMS ARE TO BE COMPLETED BY THE INTERVIEWER
At the time of the interview, is patient:
O=No l=Yes
16.

Obviously depressed/withdrawn

17.

Obviously hostile

18.

Obviously anxious/nervous

19.

Having trouble with reality testing,
thought disorders, paranoid thinking

20.

Having trouble comprehending,
concentrating, or remembering

21.

Having suicidal thoughts

INTERVIEWER SEVERITY RATING
22

How would you rate the patient's need for psychiatric/psychological treatment?

CONFIDENCE RATINGS
Is the above information significantly distorted by:
23

Patient's misrepresentation? ___ O=No l=Yes

24

Patient's inability to understand?

O=No l=Yes

COMMENTS

TIME ENDED:

-

- - : - - - - I=A.M. 2=P.M. (circle one)
-tfu.S. GOVERNMENT PlllNTING omcE, J991 • ·1~/60505
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Profile of Mood States (POMS)
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•
•

NAME---------------------------------- DATE _____________

•

SEX:

•
•

Male®

Female@

•

Below is e list of words that describe feelings people have. Please reed each one
carefully. Then fill in ONE circle under the answer to the right which best describes
HOW YOU HAVE BEEN FEELING DURING THE PAST WEEK INCLUDING TODAY .

•

The numbers refer to these phrases .

•
•

•
•
•
•
•
•
•
•
•
•T
•
•
•
•
•
•
,•
•

•
•
•
•
•
•
•V

0 =Not at all
1 =A little
2 = Moderately
3 = Quite a bit
4 = Extremely

Col@

•
•

•

c

O.P.@

!c ~ :i ~ ~
b ~ g 5 ...
z

~

c

0

~

~

~

:

;

45. Desperate

.® 0 ® CD@

22. Relaxed

.® 0

®®0

46. Sluggish

.® 0 ® 0 0

23. Unworthy

.@ 0

®0 0

47. Rebellious

.® 0 ® 0@

24. Spiteful

.@0®00

48. Helpless

.®0@00

:

1. Friendly

.®0@00

25. Sympathetic

.®0®00

49. Weary

.®0@00

2. Tense

.®0®0@

26. Uneasy.

.®0®00

50. Bewildered

.®0@0@

3. Angry

.®@00@

27. Restless

.@0@0@

51. Alert

.®0@00

4. Worn out

. ~· 8

28. Unable to concentrate

®0 ®0 0

52. Deceived

.@ 0

5. Unhappy .

. ~)

.®0®®~·

53. Furious

.@0@(!)0

6. Clear-headed

.

7. Lively .

. ·2~ ·I·

8. Confused

. ~ ..!_. ~

56. Full of pep

.::£: (!:; i
.'~ 8

® 0)@

I: <i (~)@
1

2.: 7 i: 0:: ~

9. Sorry for things done . ·~

~-

·::!. ].

29. Fatigued

31. Annoyed

X

32. Discouraged

~

i- ~~

10. Shaky

. ® 0@ 0 !.!}

11. Listless .

. ® ::!.'@ 0

~·

®0 0

30. Helpful

·:i· ·~.

12. Peeved

•
•
•

11.1

11.1

~ ~ ffi ~ ..,
b
:; 8 5 ~
z c s 0 :

....
!:; ... ,..
..J
c...1 .., ~
c iD ..,

•

•

~

:I

G:·

I· G

(3'·

:4

~

1:·

33. Resentful

. ·~) '7' ® C!: ~~

57. Bad-tempered

:i. :i.' ~\

34. Nervous

. ®• 0 0 0@

58. Worthless

35. Lonely

. ~) ~@ G> GJ

59. Forgetful

36. Miserable

.® 0

~) (!) ·~:·
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A COMPARATIVE EVALUATION OF
COGNITIVE-BEHAVIORAL THERAPY AND INSIGHT-ORIENTED
PSYCHOTHERAPY IN THE TREATMENT OF COMORBID
SUBSTANCE ABUSE, ANXIETY, AND DEPRESSION IN SUBSTANCE
ABUSING FEMALES

Substance abuse accounts for over 200,000 deaths
annually in American females - - more than four times
the number who will die of breast cancer. While female
addiction is at epidemic proportions, treatment
continues to focus on males and their substance abuse.
Furthermore, it is questionable whether treatment
designed for male substance use can be generalized to
female substance users. This is compounded by the dearth
of studies that examine treatment of female substance
abuse.
A pretest-posttest comparative experimental design
was used to evaluate whether Cognitive Behavioral
Therapy or Insight-Oriented Psychotherapy was more
efficacious in the treatment of substance abuse in a
female population. The final sample for this study

consisted of 17 participants who were randomly assigned
to the two treatment conditions via a table of random
numbers.
Chi-square analysis indicated that there was no
significant difference between the two treatment
conditions on any demographic variable. Dependent
variables include Drug- and Alcohol-Status, Psychosocial
variables, anxiety and depression. Instruments used
included the Structured Clinical Interview using the
DSM, the Addiction Severity Index, and the Profile Of
Mood States. Each group counseling session lasted for 90
minutes and convened weekly for a period of eight weeks.
Statistical analyses included Means, standard
deviations, effect size, and MANOVA procedures. The
major findings in this study include: neither IOP or CBT
was effective in increasing psychosocial functioning of
the current sample; CBT was over ten times more
effective than IOP in the reduction of alcohol use; CBT
was four times more effective than IOP in the reduction
of drug use; CBT was two times more effective than IOP
in the reduction of anxiety; and, CBT was three times
more effective than IOP in the reduction of depression.
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The current findings suggest that (1)

IOP treatment

is not the treatment of choice for females with a
history of substance abuse who are in the early stages
of recovery;

(2) females can respond well to treatment

based on a cognitive-behavioral paradigm;

(3) treatment

approaches designed for male veterans can be applied to
a female population within an outpatient community
mental health setting.
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